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Abstract 
Antigen applied to the epidermis of 4-day-old mice results in antigen specific 
immune suppression and is linked to a decrease in the amount of antigen transported 
to the draining lymph node by epidermal Langerhans cells (LC). It was therefore 
proposed that a decrease in receptor-mediated endocytosis was responsible for the 
reduced antigen transport by the LC. Consequently the aims of this study were to 
characterise the expression of antigen uptake receptors during development of 
neonatal mice, evaluate their capacity to internalise antigens via receptor-mediated 
and fluid phase uptake and to assess antigen proteolysis and MHC-II complexing 
following exposure to maturation stimuli. 
Langerhans cells isolated from 4-day-old epidermis express reduced levels of the C-
type lectin receptors DEC-205 and Langerin in comparison to LC isolated from 6- 
week-old epidermis. Despite this reduction neonatal LC were efficient in the uptake 
of the mannosylated antigen FITC-dextran. When incubated in the presence of the 
macropinocytosis inhibitor wortmannin, antigen uptake was reduced to a greater 
extent in neonatal LC than adult counterparts. As such, neonatal LC preferentially 
utilise a wortmannin-sensitive fluid phase pathway, such as macropinocytosis, to 
internalise antigens such as FITC-dextran. 
Despite the presence of LAMP-1 +MHC-II+ vesicles within LC from neonatal 
epidermis, proteolysed DQ-OVA was localised to a MHC-II" compartment. This 
suggests that antigen was internalised via macropinocytosis and retained in a LAMP- 
macropinosome. As no differences were observed in DQ-OVA+ vesicle 
localisation, it was evident that neonatal and adult LC were associated with a 
comparable proteolytic activity. 24 hours following exposure to a maturation- 
inducing dose of LPS, membrane MHC-II:peptide complexes were evident on adult 
LC, but not on neonatal LC. Although neonatal LC demonstrated both CD86 up- 
regulation and MHC-II redistribution following LPS exposure, the transport of 
MHC-II:peptide complexes to the membrane was diminished. This reduced transport 
was not simply due to a defect in MHC-II recycling as LPS stimulation of LC caused 
a redistribution of MHC-II from an intracellular endosome to the cell surface. 
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Therefore the reduced transport of MHC-II:peptide to the cell surface was most 
likely a consequence of a failure to associate with MHC-II in the cytoplasm. 
The capacity of neonatal LC to sample their external environment without inducing 
immunity has important biological consequences for the protection against 
inappropriate responses during the developmental period. 
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Abbreviations 
7AAD 	7-amino-actinomycin D 
APC 	Antigen presenting cell 
Cat 	Cathepsin 
CLIP 	Class II-associated invariant chain peptides 
CTL 	Cytotoxic T lymphocyte 
°C 	Degrees centigrade 
DC 	Dendritic cell 
DMSO 	Dimethyl sulphoxide 
FCS 	Foetal bovine (calf) serum 
FITC 	Fluorescein isothiocyanate 
g 	 Grams 
GM-CSF 	Granulocyte/macrophage colony stimulating factor 
HEPES 	N-2-hydroxyethylpiperizine-N-2-etanesulphonic acid 
Ig 	Immunoglobin 
IFN 	Interferon 
IL 	Interleukin 
KC 	Keratinocyte 
LC 	Langerhans cell 
2ME 	2-mercaptoethanol 
MHC-I 	Major histocompatibility complex class I 
MHC-II 	Major histocompatibility complex class II 
lig 	Micrograms 
ptt Microlitre 
mg 	Milligrams 
mL 	Millilitre 
M 	Molar 
mM 	Millimolar 
1AL 	Micromolar 
ng 	Nanograms 
nM 	Nanomolar 
LAMP 	Lysosome associated membrane protein 
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LN 	Lymph node 
LPS 	Lipopolysaccharide 
OVA 	Ovalbumin 
PE 	Phycoerythrin 
PBS 	Phosphate buffered saline 
RBC 	Red blood cell 
TAP 	Transporter associated with antigen processing 
TCR 	T cell receptor 
TGF 	Transforming growth factor 
Th 1 	T helper type one 
Th2 	T helper type two 
TLR 	Toll-like receptor 
UV 	Ultraviolet 
Units 
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Chapter 1 
Literature Review 
1.1 Langerhans Cells. 
Langerhans cells (LC) were first identified in 1868 by Paul Langerhans (Langerhans 
1868). They were initially presumed to have a neuronal function due to an 
association with sensory nerve endings and reactivity with gold salts (Hunter 1985). 
It is now known that LC are the principle antigen-presenting cell (APC) of the 
epidermis and as such are critical to the induction of immunity to cutaneous antigen 
(Cruz and Bergstresser 1990). They are a mobile population of dendritic cell (DC), 
originating from bone marrow precursors (de Fraissinette et al. 1988; de Fraissinette 
et al. 1990). Within the epidermis they populate the stratum granulosum and 
spinosum, constituting approximately 2-4% of epidermal cells (Gielen et al. 1988; 
Schuler et al. 1991). The integrity of the LC network is maintained by attachment to 
neighbouring keratinocytes (KC), mediated by adhesion molecule interactions 
(namely E-cadherin) and Ca2+-dependent mechanisms (Tang et al. 1993). The 
capacity of LC to survey the extracellular environment surroundings is aided by long 
membranous extensions called dendrites, enabling LC to form an interconnecting 
network (Shelley and Juhlin 1976; Shelley and Juhlin 1977). Following antigenic 
exposure, or receipt of "danger signals" such as lipopolysaccharide (LPS) or 
epidermal cytokines, LC are mobilised from the epidermis (Cumberbatch et al. 1991; 
Kimber and Cumberbatch 1992; Cumberbatch et al. 2000). LC then traverse the 
epidermal-dermal barrier and migrate via the afferent lymphatics to the draining 
lymph node (LN) (Price et al. 1997; Ratzinger et al. 2002). During transit, LC 
undergo a process of differentiation, such that they acquire properties of immuno-
stimulatory APC, capable of inducing antigen-specific T cell responses (Larsen et al. 
1990; Cumberbatch et al. 1996). 
During the early neonatal period, antigen treatment of murine epidermis results in a 
deviation of the immune response from immunity to antigen-specific immune 
suppression (Dewar et al. 2001). It has been demonstrated that although neonatal LC 
maintain the capacity to migrate to the draining LN following treatment, they do so 
in reduced numbers and the amount of antigen they traffic, and thus present to naïve 
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T cells, is significantly reduced (Dewar et al. 2001). This review will summarise our 
current understanding of LC function, discussing antigen uptake and processing 
pathways, the stimuli essential for migration and maturation and finally the signals 
required for T cell activation and proliferation. The many gaps that remain in our 
understanding of neonatal immune function will also be discussed. 
1.2 Langerhans Cell Phenotype 
Langerhans cell phenotype and function is highly dependent on location and 
maturation status (Larsen et al. 1990; Romani and Schuler 1992; Shibalci et al. 1995). 
Whilst resident in the epidermis LC are primarily immature, and express low levels 
of surface molecules required for T cell activation (Witmer-Pack et al. 1988). Such 
molecules include the antigen presentation molecules, major histocompatibility 
complex type I and II (MHC-I, MHC-II), and costimulatory molecules CD40, CD80 
and CD86 (Schuler et al. 1985; Schuler and Steinman 1985; Witmer-Pack et al. 
1987). Although limited in their stimulatory potency, immature LC are adept at 
antigen uptake and processing, expressing recognition receptors for a range of 
foreign antigens (Shelley and Juhlin 1977; Katz and Sunshine 1986; Reis et al. 
1993). Receipt of maturation stimuli, such as epidermal cytokines or bacterial 
products, induces dramatic alterations in LC phenotype (Steinman 1988; Geissmann 
et al. 1999; Cumberbatch et al. 2000). Expression of antigen uptake receptors is 
down-regulated, whereas expression of MHC-I and II, CD40, CD80 and CD86 
becomes more apparent (Singh-Jasuja et al. 2000). Whilst no longer capable of 
internalising and processing exogenous antigen, mature LC produce biologically 
dynamic cytokines such as interleukin (IL)-1I3, IL-6 and IL-12 and are powerful 
promoters of MHC-I and II restricted T cell responses (Aiba and Katz 1990; Reis et 
al. 1993; Jonuleit et al. 1997; Belz et al. 2002b; Sundquist et al. 2003). Aside from 
producing pro-inflammatory cytokines, maturing LC express a range of chemokine 
receptors to facilitate their migration from the epidermis and subsequent interactions 
with lymphocytes in the regional LN (Yanagihara et al. 1998; Wang et al. 1999; 
Jakob et al. 2001). 
LC phenotype has also been shown to alter during in vitro culture and this has been 
proposed to model LC maturation during migration to the draining LN (Larsen et al. 
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1990). From a model using skin explants, where LC spontaneously migrate out of 
epidermal sheets, up-regulation of MHC-II expression was observed and compared 
to in situ LC (Larsen et al. 1990). As such, cultured systems such as these have 
become powerful tools for the study of LC maturation and APC function in vitro. 
1.3 Langerhans Cell Function 
The capacity of LC to induce immunity following internalisation of antigen is well 
illustrated in the immunological response known as contact hypersensitivity (Cruz 
1990; Enk and Katz 1995). Contact hypersensitivity is mediated by T cells, which 
respond to cutaneous antigens that have been internalised, processed and presented 
by LC in the draining LN (Wolff and Schreiner 1970; Cumberbatch et al. 1992). 
Using skin sensitising fluorescent antigens, such as fluorescein isothiocyanate 
(FITC) it has been demonstrated that topical exposure to antigen induces changes in 
the microenvironment of the skin (Kripke et al. 1990). Following exposure, LC 
deplete rapidly from the epidermis, resulting in an accumulation of LC in the 
regional LN, with a percentage of cells associated with high levels of fluorescent 
antigen (Kinnaird et al. 1989; Kripke et al. 1990; Cumberbatch et al. 2003). When 
the antigen bearing cells are isolated from the node they function as APC and are 
capable of initiating T cell activation in vitro (Kripke, 1990). The critical role of LC 
in contact hypersensitivity has been demonstrated in murine skin deficient in LC 
(Toews et al. 1980). Following exposure to antigen, these mice consequently fail to 
demonstrate a hypersensitivity response (Toews et al. 1980; Peeler and Niederkorn 
1986). 
1.4 Mechanisms of Antigen Uptake 
For T cells to respond to exogenous antigen it must be internalised, processed and 
presented by LC (Taylor et al. 1991; Scheicher et al. 1995; Kato et al. 1998; 
Stockwin et al. 2000). Antigen uptake can occur via three functionally distinct 
pathways, accommodating a vast array of possible antigens (Swanson and Watts 
1995; Watts 1997). Pinocytosis is the internalisation of non-binding or soluble 
antigens (Hanau et al. 1985; Swanson and Watts 1995). Receptor-mediated 
endocytosis and phagocytosis involves the ingestion of small and large particulate 
antigens following binding of antigen to cell surface uptake receptors (Reis et al. 
1993; Sallusto et al. 1995). The ability of LC to internalise and process antigen is 
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highly dependent on the stage of cell differentiation and receptor expression, limited 
to epidermal-resident LC as demonstrated in the seminal work of Romani and 
colleagues (Romani et al. 1989). Using T cell clones, it was demonstrated that the 
stimulatory capacity of LC varied with maturation (Romani et al. 1989). Whilst 
freshly isolated epidermal LC actively internalise and process intact myoglobin, they 
were incapable of presenting the protein in in vitro T cell stimulation assays. In 
contrast, although cultured LC and spleen DC were weakly endocytic, they actively 
presented the intact protein (Romani et al. 1989). The findings of Romani et al. 
(1989), combined with more recent investigations, have lead to the conclusion that 
DC function is centred around two distinct phenotypes that develop in succession. 
Firstly, DC recognise and internalise antigen in peripheral tissues, a prime example 
being sentinel LC of the epidermis. Following receipt of maturation stimuli, DC 
acquire T cell stimulatory capacity (Okada et al. 1988; Romani et al. 1989; Lutz et al. 
1996a; Lutz et al. 1996b) 
1.4.1 Pinocytosis 
Fluid phase endocytosis, or pinocytosis, refers to the non-specific bulk uptake of 
soluble antigen, and non-specialised cells can drink up to their volume in 
extracellular fluid every day (Swanson and Watts 1995; Amyere et al. 2002). The 
pinocytic pathway employed is influenced by antigen size (Watts and Marsh 1992). 
Micropinocytosis is the internalisation of antigen up to 100nm by clathrin-coated 
pits. In contrast, larger antigens are internalised by macropinocytosis, associated 
with actin-mediated membrane ruffling (Watts and Marsh 1992). 
1.4.1.1 Micropinocytosis 
Micropinocytosis, a constitutive process in the majority of DC, is the ingestion of 
small soluble antigens via clathrin coated pits (Amyere et al. 2002). Within these 
pits are a variety of receptors, including those specific for carrier proteins and 
essential nutrients, that enable concentration of antigen (Watts and Marsh 1992; 
Roberts and Sandra 1994; Amyere et al. 2002). Following internalisation of antigen 
and ligand release within the appropriate intracellular vesicle, receptors recycle 
rapidly to the cell surface (Brown and Swank 1983; Ciechanover et al. 1983) Using a 
novel human B/DC cell line, HBM-Noda, Toni and colleagues investigated the fate 
of antigen following internalisation by a range of uptake pathways. Using low- 
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density lipoprotein, LDL, the fate of pinocytosed soluble antigen was traced. It as 
demonstrated that following binding of LDL to the corresponding receptor, the 
antigen was internalised with the receptor into endosomes, which later fuse with 
lysosomes. Following this the receptor was dissociated by an increase in acidity, 
enabling recycling of the receptor to the plasma membrane (Toni et al. 2001). In so 
doing the cell is able to perform consecutive rounds of antigen internalisation. As 
such micropinocytosis plays an important role in both ingestion of antigen for 
processing and presentation as well as internalisation of nutrients for cell survival. 
1.4.1.2 Macropinocytosis 
Macropinocytosis is the non-specific, high volume uptake of large soluble antigens 
via actin-driven membrane ruffling (Swanson and Watts 1995). Following 
membrane extension the ruffles fuse, enclosing the antigen within large vesicles 
called macropinosomes (Swanson and Watts 1995). Initiation of macropinosome 
formation involves several steps (Amyere et al. 2002). Firstly plasma membrane 
signalling pathways are generated following binding of growth factors such as GM-
CSF, or after recruitment of activated oncogenes in transformed cells such as K-ras 
and v-src to the plasma membrane (Fincham et al. 1996; Veithen et al. 1998; Amyere 
et al. 2000). The second step involves amplification of these signals by activation of 
phosphatidylinosito1-3-kinase (PI3K) and phosphoinositide-specific phospholipase 3- 
lipase (PLC) (Amyere et al. 2000). Following these early enzymatic steps is the 
activation of actin remodelling, induced by calcium release or Rho-GTPases under 
the influence of PI3K and PLC (Mackay and Hall 1998; Nobes and Hall 1999). 
Actin remodelling then leads to membrane ruffling and filopodia extension (Amyere 
et al. 2002). These various processes are abrogated by the irreversible PI3K inhibitor 
wortmannin, which prevents ruffle fusion (Stein and Waterfield 2000). The kinetics 
of macropinocytosis varies between cell types, possibly as a result of differences in 
surface area to volume ratio (Swanson and Watts 1995). Swanson and Watts 
proposed that cells more capable of forming cytoplasm protrusions are also more 
likely to membrane ruffle and hence form macropinosomes (Swanson and Watts 
1995). Macropinocytosis is associated with the internalisation of large volumes of 
fluid. To dispose of excess fluid, and thereby concentrate antigen, the 
macropinosome shrinks through loss of water (Racoosin and Swanson 1993). As the 
macropinosome is routed through the cell, markers of mature proteolytic 
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compartments are acquired prior to delivery of degraded antigen to MHC-II 
processing compartments (Sallusto et al. 1995; Lutz et al. 1997). 
Although this is the most documented pathway of macropinocytosis, a divergence 
has been demonstrated in the macrophage lineage. It has been demonstrated that 
following macropinosome formation, the vesicle is trafficked through the cell, 
bypassing intracellular processing pathway (Amyere et al. 2002). The 
macropinosome is then shuttled to the cell membrane, where the vesicle contents are 
exocytosed back to the extracellular space (Amyere et al. 2002). Hewlett and 
colleagues demonstrated a similar pathway in the human cell line A431. Very little 
interaction of macropinosomes and processing compartments was observed. Rather 
antigen was retained within the cell before eventually recycling to the cell membrane 
and exocytosing its content to the extracellular space (Hewlett et al. 1994). 
Therefore macropinocytosis can be employed by a cell for processing and 
presentation, or as a scavenging and clearance mechanism. 
Macropinocytosis in LC may be related to the expression of aquaporins (de Baey and 
Lanzavecchia 2000). Aquaporins are a family of water channels involved in the 
regulation of osmotic pressure and may be required after ingestion of high volumes 
of water in macropinocytic vacuoles (de Baey and Lanzavecchia 2000). 
Macropinocytosis is associated with immature DC, as after a few days of culture this 
activity vanishes as processed peptides are presented (Sallusto et al. 1995). 
1.4.2 Receptor mediated endocytosis 
Receptor-mediated endocytosis is the internalisation of small particulate antigens 
following binding to antigen recognition receptors (Reis et al. 1993; Lutz et al. 
1997). Following ligation, a cascade of events is induced that leads to the 
internalisation and subsequent trafficking of antigen to intracellular processing 
compartments (Sallusto et al. 1995). The efficacy of receptor-mediated endocytosis 
is influenced by the affinity of the receptor for the corresponding ligand, in addition 
to the concentration of the ligand-receptor complexes on the plasma membrane 
(Watts 1997). 
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1.4.2.1 Lectin Receptors 
As professional APC, LC must be able to internalise mannose, as the majority of 
glycoproteins are mannosylated (Buentke et al. 2000). To enhance the efficacy of 
binding, LC express members of the C-type lectin receptor family (Kato et al. 1998). 
Lectin receptors are divided into two broad classes on the basis of their antigen 
reactivity, type I and type II (Chen 1997). 
1.4.2.1.1 DEC-205 
DEC-205, an example of a type I receptor, is a 205kD membrane glycoprotein, 
homologous to the macrophage mannose receptor (Jiang et al. 1995). It has been 
suggested to initiate uptake and strongly enhance presentation of mannose-
conjugated antigen (Kato et al. 1998; Kato et al. 2000). The efficiency of DEC-205 
for uptake and antigen-specific T cell activation was illustrated using anti-receptor 
antibodies (Jiang et al. 1995). LC expressing the receptor demonstrated a 100-fold 
increase in the presentation of anti-DEC-205 antibody to T cells compared antibody 
that was not directed to DEC-205 (Jiang et al. 1995). 
Following ligand binding, the receptor:antigen complex is internalised and routed to 
endocytic compartments for processing and presentation (Jiang et al. 1995). 
Although DEC-205 shares homology with the macrophage mannose receptor, 
Mahnke and colleagues demonstrated that DEC-205 targets antigen to mature 
processing vesicles, and is far superior to the macrophage mannose receptor in 
presenting bound anti-receptor antibodies to T cells (Mahnke et al. 2000). 
Kato and co-workers demonstrated that during maturation there are alterations in 
DEC-205 expression by subtypes of DC (Kato et al. 2000). Analysis of expression 
by real—time PCR demonstrated that DEC-205 mRNA in immature blood DC, LC 
and immature monocyte derived DC was low. Subsequent to maturation stimuli 
DEC-205 expression increased, suggesting that DEC-205 may serve as an indication 
of maturation.(Kato et al. 2000). These findings were later developed by Ebner et al 
(2004), who furnished evidence for in situ alterations in DEC-205 expression by 
epidermal LC. Whilst resident in the epidermis the level of DEC-205 expression was 
low. However, following maturation in skin organ explant cultures the level of 
expression increased (Ebner et al. 2004). In contrast to LC, maturation of blood DC 
21 
Literature Review 
did not result in no DEC-205 upregulation, suggesting an increase in intracellular 
localisation. As a consequence of these findings it has been proposed that aside from 
functioning as an endocytic receptor, DEC-205 may also play a role in antigen 
processing and presentation (Kato et al. 2000). 
1.4.2.1.2 Langerin 
Langerin is a type II lectin receptor, expressed in the LC of the skin and epithelia 
(Valladeau et al. 2003). It is involved in endocytosis of mannose-conjugated antigen 
and the endocytic function of Langerin agrees with its restricted expression on 
immature LC (Valladeau et al. 2003). In contrast to the mannose receptor, Langerin 
does not co-localise with markers of late endosomes and early lysosomes (Valladeau 
et al. 2003). In addition, internalisation of anti-Langerin antibody does not result in 
routing into MHC loading compartments. Together these results strongly suggest that 
the function of Langerin is unrelated to antigen processing within the MHC-II 
pathway. It has been proposed that Langerin is employed to route extracellular 
antigen into the MHC-I pathway for the induction of cytotoxic T cell responses 
(Valladeau et al. 2003). This is plausible as it is known that LC are highly efficient 
at endocytosis of apoptotic debris and subsequent trafficking of internalised material 
for presentation on MHC-I molecules (Albert et al. 1998a). 
Several lines of evidence indicate that Langerin is down-regulated following LC 
maturation (Tripp et al. 2004). Firstly, reactivity of anti-Langerin antibody alters 
following culture of epidermal explants and in maturation stimuli (Bechetoille et al. 
2001). Secondly, Langerin antigen has not been detected to a significant degree in 
secondary lymphoid organs (Valladeau et al. 2002). 
1.4.2.2. Fc Receptors 
Fc receptors are involved in the recognition of antibody and as such are crucial to the 
internalisation of opsonised antigen (Esposito Farese et al. 1995). Endocytosis 
mediated by Fc receptors was illustrated using gold labelled antibodies directed 
against the outside domain of the receptor (Esposito-Farese et al. 1995). Following 
internalisation, antibody was localised to a variety of intracellular organelles, 
including vesicles and endosomes, suggesting that Fc receptors target antigen to 
processing compartments (Esposito Farese et al. 1995). Fc receptors signal through 
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tyrosine-based activation motifs and following binding of antigen these motifs 
become phosphorylated (Lofgren et al. 1999). Phosphorylation recruits the tyrosine 
kinase syk, whose role is to initiate several intracellular pathways leading to 
transcriptional activation, cytokine release and rearrangement of the cytoskeleton 
(Sedlik et al. 2003). Therefore, recognition of antigen via Fc receptors increases the 
efficiency of presentation by delivering antigen to processing vesicles and inducing 
the secretion of pro-inflammatory cytolcines. 
1.4.2.3 Complement Receptors 
Complement receptors are involved in the recognition of antigen opsonised with 
activated complement components, such as C3b (Stingl et al. 1977; Ross and 
Vetvicka 1993). Akin to expression of lectin and Fc receptors, expression of 
complement receptors is thought to be restricted to the immature stage of LC 
differentiation, as expression has been shown to decrease following short-term 
culture of 1-3 days (Stingl et al. 1977a; Schuler and Steinman 1985). Aside from the 
significant role in bacterial clearance, the function of complement receptors is varied 
(Ross and Vetvicka 1993). It has been proposed that complement receptors may 
allow for physical contact between LC and naïve T cells expressing C3 (Muto et al. 
1993). 
1.4.2.4 Heat Shock Protein Receptors 
Exposure to stress stimuli such as temperature extremes or viruses stimulates the 
production of pro-inflammatory molecules called heat shock proteins (Schlesinger 
1994). Heat shock proteins enhance the immune response via several mechanisms 
initiated following binding to surface receptors (Born et al. 1990; Hightower 1991; 
Maytin 1995). Following exposure to heat shock proteins, DC up-regulate molecules 
associated with professional APC function including CD40, CD83 and CD86, whilst 
monocytes and macrophages secrete pro-inflammatory cytokines (Matzinger 1994; 
Kuppner et al. 2001). It has also been postulated that heat shock proteins enhance 
recognition of malignancies by NK cells, with heat shock proteins located on the 
surface of some tumour cells, including sarcomas, lung and colon carcinomas 
(Multhoff et al. 1995; Multhoff et al. 1997; Botsler et al. 1995). 
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1.4.2.5 CD36 
It is essential that apoptotic debris is cleared from the extracellular environment to 
prevent induction of self-reactive immune responses (Urban et al. 2001). Uptake of 
apoptotic cells is enhanced via expression of the scavenger receptor CD36 (Ren et al. 
1995). The functional significance of apoptotic uptake was elucidated by Urban and 
colleagues (Urban et al. 2001). It was demonstrated that despite receipt of 
maturation stimuli, DC remained immature following ingestion of apoptotic cells. In 
addition, exposure to apoptotic cells resulted in a deviation from the expected 
secretion of pro-inflammatory cytokines to secretion of anti-inflammatory, tolerance-
inducing cytokines such as IL-10 (Urban et al. 2001). As such, prevention of 
reactivity to self-cells is maintained via expression of CD36. 
1.4.2.6 Toll-like receptors 
Seminal work by Janeway and colleagues have hypothesised that the host immune 
system senses invading pathogens via germ line-encoded pattern recognition 
receptors (Stout and Bottomly 1989; Medzhitov and Janeway 1998). One such 
group of receptors is the Toll-like receptor (TLR) family. Toll-like receptors are 
involved the recognition of variety of microbial antigens, including LPS and 
lipoprotein (Bulut et al. 2001; Werts et al. 2001). Ligand engagement of TLR results 
in enhancement of protective immune responses. Binding induces activation of the 
transcription factor NK-1(13 and leads to the up-regulation of costimulatory molecules 
and cytokines required for the activation of the adaptive immune response (Bulut et 
al. 2001). 
1.4.3 Phagocytosis 
Phagocytosis is the actin-dependent, receptor-mediated ingestion of large particulate 
antigen (Aderem and Underhill 1999). Through expression of a range of receptors 
specific for prokaryote membrane antigens and innate opsonins, APC such as 
macrophages and dendritic cells are equipped with a means by which to selectively 
bind a broad range of possible microbes, as well as self-antigen derived from dead or 
dying cells (Reis et al. 1993; Fanger et al. 1996; Albert et al. 1998a; Nauta et al. 
2004). Following receptor ligation, actin is recruited to the plasma membrane to 
drive pseudopodia extension to engulf the antigen (Greenberg et al. 1991). Once 
pseudopodia fuse, the antigen is drawn into the cell to form a phagosome (Reis et al. 
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1993). This vesicle matures, acquiring proteolytic markers, before fusing with 
degradative lysosomes (Rabinowitz et al. 1992; Desjardins et al. 1993; Desjardins et 
al. 1994; Beron et al. 1995). The mature phagolysosome continues to interact with 
lysosomes throughout the endocytic pathway, replenishing degradative enzymes to 
guarantee efficient degradation of phagocytosed antigen (Oh et al. 1996). 
1.5 LC Maturation 
Whilst LC are resident in the epidermis they are proficient at acquiring antigen, 
however, their ability to present these antigens to nave T cells is inept (Mellman et 
al. 1998). Only following exposure to inflammatory stimuli do APC, such as LC 
begin a process of maturation involving conversion of the ingested material into 
immunogenic MHC:peptide complexes, migration to the draining LN and 
presentation of antigen to naïve T cells (Roake et al. 1995; Tsang et al. 2000). 
Maturation is associated with a down regulation of antigen uptake receptor 
expression and macropinocytosis, whilst the expression of molecules required for T 
cell activation, namely antigen presentation and costimulatory molecules, becomes 
more evident. Ligation of these two classes of molecules with ligands on the surface 
of the T cell provides the two signals require for full activation of effector responses. 
By tying antigen presentation and migration with maturation ensures LC reach full 
APC potency prior to interaction with naïve T cells (Mellman et al. 1998) 
1.6 Antigen Processing 
For T cells to respond to antigen it must be processed and presented in association 
with surface MHC molecules (Watts 1997). Depending on antigen origin, processing 
can occur via two pathways (Kalish 1995). Intracellular antigen, such as those 
derived from viral particles or self peptides, are processed via the endogenous 
pathway (Kalish 1995). Ingested extracellular antigen is in turn processed via the 
exogenous pathway (Cohen and Katz 1992). Within DC, maturation from the 
processing to presenting phenotype is accompanied by an up regulation of MHC 
biosynthesis and export to the cell surface (Cella et al. 1997a; Pierre et al. 1997). 
1.6.1. Exogenous pathway 
Central to the initiation of an immune response to exogenous antigen is the capacity 
to convert proteins into peptides within the exogenous pathway (Ziegler and Unanue 
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1981). Following uptake, antigen-containing vesicles are routed to lysosomal 
organelles, where exposure to low pH initiates unfolding of the antigen via reduction 
in disulfide bonds, exposing the substrate to proteolytic enzymes (Collins et al. 
1991). One such enzyme is y-IFN-inducible lysosomal thiol reductase (GILT), 
which at low pH catalyses the reduction of disulfide bonds (Arunachalam et al. 2000; 
Lennon-Dumenil et al. 2002c). Complete degradation of antigen however, is not 
favourable, as MHC-II selects for peptides of a particular length, namely 9-16 
residues (Mellman et al. 1998). Thus, for effective antigen processing proteolysis 
cannot run to completion (Lautwein et al. 2002). How processing is regulated is 
unknown, but it is conceivable that molecular chaperones, protease inhibitors, 
cystatins and certain proteases or even specialised intracellular compartments halt 
proteolysis before the antigen is completely catalysed (Pure et al. 1990; Lennon-
Dumenil et al. 2002b). 
Occurring simultaneously to antigen proteolysis is the assembly of the a and 13 
MHC-II chains within the endoplasmic reticulum (Cresswell 1994; Cresswell 1996). 
The linking of the two subunits forms a single peptide-binding groove at the top of 
the dimer, accounting for the subtle but crucial differences in the range of peptides 
that can be bound (Mellman et al. 1998). During assembly, MHC-II associates with 
a chaperon molecule termed the invariant chain (Ii), whose function is to direct class 
II molecules into the endocytic pathway (Bakke and Dobberstein 1990; Lotteau et al. 
1990; Cresswell 1996), and to protect the empty MHC-II from binding endogenous 
antigen within the endoplasmic reticulum (Roche and Cresswell 1990; Teyton et al. 
1990; Cresswell 1994; Cresswell 1996). The requirement of the Ii for the transport 
of MHC complexes can be demonstrated when unfolded MHC a13 dimers are 
retained within the endoplasmic reticulum in the absence of Ii (Cresswell 1996). 
Following exit from the endoplasmic reticulum and trans-Golgi network, the Ii-
MHC-II complex is directed to the late endosomal/pre-lysosomal antigen processing 
compartments, which are positive for the lysosome-associated membrane protein-1 
(LAMP-1) (Kornfeld and Mellman 1989; Guagliardi et al. 1990; Mellman et al. 
1998). The first event that occurs within the endosomal pathway is cleavage of the Ii 
(Roche 1996). Firstly, Ii is cleaved by an aspartyl protease generating an N-terminal 
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fragment of 101cDa (p10). An internal Ii peptide remains bound to the dimers, 
termed class II-associated invariant chain peptides (CLIP) (Cresswell 1996). CLIP 
has two main functions: firstly to maintain the complex of Ii trimer and the cti3 
dimers (Bijlmakers et al. 1994; Ghosh et al. 1995). The second function is to prevent 
premature loading of peptides onto the class II dimer, especially peptides originating 
from endogenous antigen (Cresswell 1996). Via a lysosomal targeting sequence 
located in the cytoplasmic tail of Ii, the MHC-II:CLIP complex is retained in an 
intracellular location (Lipp and Dobberstein 1986; Bakke and Dobberstein 1990; 
Lotteau et al. 1990). Complete degradation of Ii is prevented by cystatin C (Pierre 
1998), which inhibits the proteolytic activity of the cysteine protease cathepsin S, 
responsible for the breakdown of Ii (Riese et al. 1996; Villadangos et al. 1997). 
However, following receipt of maturation signals the expression of cystatin C is 
downregulated (Pierre and Mellman 1998). This allows cathepsin S to be functional 
(Pierre and Mellman 1998), and when the MHC-II:CLIP complex reaches the 
appropriate compartment for antigen loading, CLIP is proteolysed by a combination 
of cathepsin S and acidic pH, thereby releasing the ap dimers from the nonomer 
(Roche 1996; Mellman et al. 1998). Some MHC-II molecules bind CLIP very 
tightly, and an additional MHC-related accessory protein, (H2-M in mouse, or HLA-
DM in human), plays an important role (Roche 1995; Denzin et al. 1996). H2-M 
binds to MHC-II and at low pH catalyses the release of CLIP from the class II 
peptide-binding groove (Denzin and Cresswell 1995; Sloan et al. 1995; Denzin et al. 
1996). Confirmation that cathepsin S is accountable for Ii degradation was furnished 
by studies utilising leupeptide, a general protease inhibitor, or cathepsin S specific 
inhibitors, both of which resulted in an accumulation of MHC-II complexes within 
the cell (Blum and Cresswell 1988; Neefjes and Ploegh 1992; Riese et al. 1996). 
There are several important consequences of Ii cleavage. Firstly disassociation of 
CLIP ultimately allows for high-affinity peptides to associate with class II molecules 
(Mellman et al. 1998). Secondly the removal of the lysosomal targeting sequence, 
which mediates intracellular retention, permits transport of MHC-II:antigen 
complexes from lysosomal compartments to the cell membrane (Mellman et al. 
1998). 
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It can be concluded that increased membrane MHC-II expression reflects several 
intracellular modifications. A major contributing factor is the activation of 
Cathepsin S, which in turn instigates the post-Golgi degradation of Ii and re-routing 
of MHC-II to the cell surface (Lipp and Dobberstein 1986; Bakke and Dobberstein 
1990a; Lotteau et al. 1990). Secondly, during maturation antigen internalisation is 
downregulated, possibly due to the diminished expression of surface antigen uptake 
receptors. As a consequence, surface expression time is increased, thereby 
amplifying complex half-time and total expression of surface MHC-II complexes 
(Inaba et al. 2000). 
Antigen processing and presentation is regulated at many levels. The effect of 
inflammatory stimuli on MHC-II:antigen complex expression by DC was 
demonstrated in the seminal work of Cella and colleagues (Cella et al. 1997a). It 
was shown that following exposure to maturation stimuli the synthesis of MHC-
II:antigen complexes was increased as was the surface half-life. These findings were 
developed further by the study by Inaba et al. (2000). It was found that immature 
DC were efficient at uptake of hen egg lyso some (HEL) and sequestered the antigen 
within cytoplasmic vesicles (Inaba et al. 2000). However, the processed peptide was 
not loaded onto MHC-II until the cell had received a maturation stimulus, with 
vesicles remaining in a cytoplasmic location for several days until exposed to LPS 
(Inaba et al. 2000). As such, antigen presentation is not simply a consequence of 
antigen uptake alone. For maturing DC to load MHC-II with internalised antigen, 
uptake must be accompanied, or followed by, maturation stimuli. By only permitting 
complexing of antigen with intracellular MHC-II in the presence of maturation 
stimuli, ensures immunogenic TCR ligands are formed only under inflammatory, and 
not steady state, conditions (Pierre et al. 1997; Inaba et al. 2000). Studies by 
Mellman demonstrated that proteolytic activity is another candidate stage of 
regulation within the exogenous pathway. Antigen positive vesicles within immature 
DC were found to contain high levels cystatin C. By regulating the activity of 
cystatin C, and thereby cathepsin s, the cell has control over invariant chain 
proteolysis and thus antigen transport to the cell surface (Pierre et al. 1997; Steinman 
et al. 1999). 
28 
Literature Review 
1.6.2 Endogenous Pathway 
MHC-I, which is expressed on all nucleated cells, presents antigens derived from 
cytosolic proteins, including peptides from virally infected cells, intracellular 
bacteria and possibly cancer cells (Watts 2004). The first step in the processing of 
endogenous antigen is the tagging of protein for destruction by the protein ubiquitin 
(Yang et al. 1996; Ben-Neriah 2002). Multi-ubiquitinated proteins are then 
recognised by an intracellular organelle called the proteasome, where antigen is 
proteolysed into smaller peptide fragments (Ben-Neriah 2002). The majority of 
antigen is then degraded by cytosolic enzymes. However a few peptides are 
translocated across the lumen of the endoplasmic reticulum, mediated by the 
transporter-associated with antigen processing (TAP) (Androlewicz et al. 1994). 
Within the endoplasmic reticulum antigen binds to newly assembled MHC-I plus 
microglobulin complex (Motal et al. 1993; Prasarma and Nandi 2004). Binding of 
antigen stabilises the complex and enables transport to the cell membrane (Motal et 
al. 1993). The resulting MHC-I:peptide complex is then recognised by CD8+ T cells, 
inducing antigen-specific cytotoxic effector responses (Huang et al. 1994). 
1.6.3 Cross Presentation 
The concept of cross-presentation was first proposed by Bevan and colleagues 
(Bevan 1976a; Bevan 1976b). It was noted that exposure to cells presenting foreign 
self-minor histocompatibility complex antigen induced CD8 + rather CD4+ T cell 
priming, as would normally be expected for foreign antigens. These results suggest 
that host DC had engulfed the cells expressing foreign histocompatibility complex 
and presented the degraded cells in association with MHC class I (Bevan 1976b; 
Bevan 1976a). Combined with more recent investigations, it is well accepted that 
DC possess the unique capacity to present not only intracellular but also extracellular 
antigen on class I molecules to naïve CD8+ T cells (Brossart and Bevan 1997; Heath 
and Carbone 1999; Belz et al. 2002a). This occurs, for example, when a virally 
infected or cancer cell is engulfed by a professional APC and processed via the 
endogenous, rather than the typical exogenous pathway (Dhodapkar et al. 2002; 
Furumoto et al. 2004). This distinctive characteristic of APC is not seen in other 
nucleated cells (Huang et al. 1994; Kurts et al. 1996; Kurts et al. 1997). 
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Recent studies have proposed that the class of antigen determines the way in which 
antigen is engulfed for cross-presentation. Firstly microbial associated antigen or 
peptides from dead or dying cells are phagocytosed and cross-presented by DC 
(Albert et al. 1998a; Yrlid et al. 2000). In contrast to particulate antigens, 
concentrations of soluble antigen above physiological concentrations is necessary for 
cross-presentation following macropinocytosis (Rock et al. 1990; Norbury et al. 
1997). Following internalisation by DC, antigen is transferred from endocytic 
compartments to the cytosol, a feature not demonstrated in other cells (Rock et al. 
1990; Norbury et al. 1997; Rodriguez et al. 1999). Within the cytosol, the 
proteosome degrades the antigen and subsequent peptides are transported across the 
ER lumen or alternatively into the lumen of the phagosome by TAP. It is here that 
MHC-I is loaded with the exogenous peptides and transported to the cell surface 
(Guermonprez et al. 2002; Ackerman et al. 2003; Guermonprez et al. 2003; Houde et 
al. 2003). 
In a similar fashion to the MHC-II processing pathway, cross-presentation is 
stringently regulated during DC maturation (Gil-Torregrosa et al. 2004). Gil-
Torregrosa and colleagues (2004) analysed an array of molecular mechanisms 
involved in the regulation of FcR-mediated cross-presentation during DC maturation 
(Gil-Torregrosa et al. 2004). It was demonstrated that cross-presentation of immune 
complexes by DC was upregulated following LPS treatment. However, this 
upregulation was short lived, diminishing after several hours as maturation continued 
(Gil-Torregrosa et al. 2004). The upregulation of cross-presentation in intermediate 
DC was proposed to involve two mechanisms. Firstly, an increase in endocytosis 
and transport of ingested antigens into the cytosol. Secondly, and to a lesser extent, 
an enhanced activity of the proteo some and TAP (Gil-Torregrosa et al. 2004). When 
fully mature, the cross-presentation pathway in DC is down regulated, possibly as a 
consequence of a cessation in antigen uptake (Gil-Torregrosa et al. 2004). It can be 
concluded therefore that cross-presentation is effective for only a short duration and 
is terminated in fully mature DC. Despite the down regulation of cross-presentation, 
MHC-I presentation of endogenous antigen remains fully competent. By regulating 
the presentation of cytosolic antigen, DC can effectively control the presentation of 
MHC-I restricted presentation of endogenous and exogenous antigens (Gil-
Torregrosa et al. 2004). Via cross-presentation LC are equipped to present 
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exogenous antigen via MHC-I and MHC-II for effective anti-tumour and anti-
pathogen responses respectively (Brossart and Bevan 1997). 
1.6.4 Extracellular antigen processing 
Recent investigations have indicated a significant proportion of DC surface MHC-II 
is expressed on the plasma membrane in an empty, peptide-receptive formation 
(Santambrogio et al. 1999). Via expression of HLA-DM on the membrane and 
exocytosis of proteases, immature DC are equipped with a means by which to 
process and present antigen in the extracellular space (Carven et al. 2000; 
Santarnbrogio et al. 2000a; Santambrogio et al. 2000b). Following ingestion of 
antigen it is sequestered in endocytic vesicles prior to receipt of maturation stimuli 
(Turley et al. 2000). As- such, for the survival of ingested antigen, it must be able to 
ensure endocytic conditions prior to loading onto intracellular MHC-II. Labile 
antigens cannot be retained in an extremely proteolytic endosomal environment 
(Santambrogio et al. 2000a). Extracellular processing enables such antigens to be 
presented. Membrane-associated empty class II could also function as an antigen 
uptake receptor, collecting non-binding peptide that is not internalised by fluid phase 
uptake (Santambrogio et al. 2000a). 
Two hypotheses have been proposed to explain how empty MHC-II is expressed on 
the DC surface. The first hypothesis states that MHC-II-Ii complexes traffic to the 
cell surface before fusion with endosomal loading vesicles (Santambrogio et al. 
1999). As HLA-DM is found on the plasma membrane, Ii can be degraded and 
exchanged for extracellular antigen cleaved by secreted proteases. Due to the 
targeting sequence within Ii, any MHC-II still in association with Ii are endocytosed 
and trafficked to endosomal compartments. The second hypothesis suggests that 
empty class II is derived from class II molecules that have not associated with Ii in 
the endoplasmic reticulum (Stern et al. 2000). By possessing an alternative antigen-
processing pathway, such as that described by Santambrogio L et al., DC are able to 
present a broader array of antigens to naïve T cells (Santambrogio et al. 2000a). 
1.7 Langerhans Cell Migration 
Naïve T cells do not migrate into peripheral tissue under normal physiological 
conditions (Alferink et al. 1998; Banchereau and Steinman 1998). Consequently, for 
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T cells to be activated by antigen, the antigen must be presented by APC in regional 
LN (Banchereau and Steinman 1998). LC migration has been observed using skin 
sensitisation models (Enk and Katz 1992a). Following topical application of contact 
allergens, LC migrate from the epidermis with a subsequent accumulation of antigen-
bearing LC in the draining LN (Enk and Katz 1992a). In order to migrate following 
exposure to antigen, LC must possess the capacity to down-regulate their attachment 
to the epidermal network and cross the basement membrane (Cumberbatch and 
Kimber 1992). 
LC mobilisation is triggered following exposure to inflammatory stimuli, including 
the mandatory cytokines TNF-a and IL-10, and bacterial products such as LPS 
(Chang et al. 1994; Jakob and Udey 1998). These mediators promote LC 
competence for migration by inducing specific changes in chemokine receptor 
expression, LC responsiveness and loss of adhesion to the epidermal network 
(Cumberbatch et al. 2000). 
1.7.1 Tumour Necrosis Factor-a and Interleukin 1-0 
Tumour necrosis factor (TNF)-a is secreted by KC and synthesis is rapidly up-
regulated following exposure to antigen, LPS and CD40 ligation (Kock et al. 1990; 
Enk and Katz 1992a; Roake et al. 1995; Moodycliffe et al. 2000). Seminal studies by 
Cumberbatch and colleagues indicated the critical influence of TNF-a on LC 
migration (Cumberbatch et al. 1994). Following intradermal exposure to TNF-a LC 
density was significantly reduced, with a subsequent increase in LN-resident LC 
(Enlc and Katz 1992a; Cumberbatch et al. 1994). Moreover, investigations by Enk 
and Katz demonstrated that intraperitoneal injection with neutralising anti-TNF-a 
antibody prior to skin sensitisation with the potent contact allergen oxazolone 
resulted in substantial inhibition of allergen-induced DC accumulation in the 
draining LN and a less efficient acquisition of contact sensitisation (Enk and Katz 
1992a). 
Although TNF-a is essential for LC migration, for effective mobilisation LC require 
signalling from IL-113 (Enk et al. 1993a). Analogous to TNF-a, intradermal injection 
with recombinant IL-113 induces LC depletion from the epidermis (Enk et al. 1993b). 
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In addition, if the availability of this cytokine is compromised by systemic 
administration of neutralising antibody, migration, and subsequent contact 
sensitisation, is dramatically reduced (Cumberbatch et al. 1997). In summary, it is 
believed IL-l3 and INF-a act synergistically to stimulate the dissociation of LC 
from the epidermal network and migration to the regional LN (Cumberbatch et al. 
1997). Firstly, IL-113 stimulates the production of INF-a by KC. INF-a and IL-113 
then stimulate LC through cytokine specific receptors to down-regulate attachment to 
neighbouring KC and enable mobilisation (Cumberbatch et al. 1997). 
• Within the skin are homeostatic mechanisms that guarantee the migratory stimuli 
provided to LC are stringently regulated. For example, it has been suggested that 
secretion of IL-10 within the epidermis may inhibit LC migration secondary to an 
inhibition of INF-a production and that IL-4 may negatively regulate INF-a 
receptor expression (de Waal Malefyt et al. 1991a; de Waal Malefyt et al. 1991b; 
Hsu et al. 1992; Kutsch et al. 1993). Furthermore, the signal transduction pathways 
that are activated following IL-113 receptor binding may be controlled by receptor 
antagonists (Kutsch et al. 1993). 
1.7.2 Modulation of Adhesion Molecule Expression 
Adhesion molecule interactions, mediated by intracellular adhesion molecules and 
integrins, are involved in preserving the integrity of the epidermal network (De 
Panfilis et al. 1991; Tang et al. 1993). However E-cadherin has been postulated to be 
critical in retaining LC within the epidermis (Jakob et al. 1997). E-cadherin is 
expressed by LC and KC, mediating the retention of LC within the epidermis (Jakob 
et al. 1997). Following exposure to pro-inflammatory cytokines, such as INF-a, E-
cadherin expression is down regulated (Jakob and Udey 1998; Jakob et al. 2001). 
LC are able to dissociate from neighbouring KC and cross the basement membrane 
via a reduction in E-cadherin mediated adhesion (Jakob and Udey 1998). When 
resident in the regional LN, epidermal derived LC express little or no E-cadherin 
(Schwarzenberger and Udey 1996). 
Following dissociation from KC, LC migrate through the dermal matrix to the 
draining lymphatics (Cumberbatch et al. 2000; Romani et al. 2001). This trafficking 
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requires crossing the basement membrane at the interface between the epidermis and 
dermis (Weinlich et al. 1998). Interaction with the basement membrane is facilitated 
by expression of the very late antigen 6 (VLA-6), a membrane complex of a6 and pl 
integrins conferring to LC laminin-binding properties (Price et al. 1997). In order to 
pass through the interface the membrane must be proteolysed. Via possession of the 
collagenase matrix metalloproteinase-9 (MMP-9) LC are able to overcome the 
obstacle of the basement matrix and pass through into underlying dermal tissue 
(Kobayashi et al. 1999; Ratzinger et al. 2002). 
1.7.3 Chemokine receptors and ligands 
Once dissociated from the epidermal network LC migrate via the lymphatics to the 
draining LN. The migration of LC is aided by secretion of chemokines, a 
superfamily of small cytokines which, when secreted, can direct the movement, or 
chemotaxis, of cells along a concentration gradient (Adams and Lloyd 1997). 
It has been suggested that chemokine receptor binding plays a significant role in 
maintaining LC within the epidermis (Boismenu et al. 1996; Wang et al. 1999; Jakob 
et al. 2001). With this is in mind, LC migration out of epidermis following receipt of 
a maturation stimulus must involve down regulation of such receptors, so as not to 
impede migration from the skin. Aside from altering adhesion molecule expression, 
cytokines also influence the expression of chemokine receptors and in doing so 
modulate LC responsiveness (Sallusto et al. 1999). Such receptors include CCR1 and 
CCR5, with the expression of both becoming less apparent with maturation (Lin et 
al. 1998; Sallusto et al. 1999) 
In order for LC to enter lymphatic vessels, and therefore home to the draining LN, 
they must up-regulate their expression of various chemokine receptors, most 
importantly CCR7, and to a lesser extent CCR2 (Lin et al. 1998). It has been shown 
that following exposure to pro-inflammatory cytokines, LC up-regulate CCR7, 
enabling responsiveness to the receptor ligands (Dieu et al. 1998). An example of a 
CCR7 ligand is macrophage inflammatory protein (MIP) 3-13 (CCL19), secreted by 
cells within the node and directs LC localisation to the correct region for interaction 
with naïve T cells (Boismenu et al. 1996; Dieu et al. 1998; Lin et al. 1998; Sallusto et 
al. 1999). An additional CCR7 ligand is secondary lymphoid organ chemokine 
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(SLC/CCL21), expressed constitutively on stromal cells and high endothelial venules 
in secondary lymphoid organs and endothelium of afferent lymphatics (Luther et al. 
2000). The results of Saeki and colleagues have proposed a key role of SLC and 
CCR7 in the directed movement of DC from peripheral sites to draining LN (Saeki et 
al. 1999a; Saeki et al. 1999b). Firstly, using confocal microscopy of dual labelled 
murine dermis, this group were able to demonstrate MHC-I1 + cells within SLC+ 
dermal lymphatic vessels. Secondly using skin organ culture, SLC was shown to 
increase by 2.5-fold the emigration of MHC-II+ DC compared to control explants. 
The capacity of mature DC to respond to SLC was demonstrated by real-time PCR 
analysis of LC, which demonstrated mature, but not resting, LC expressed CCR7. 
Finally addition of neutralising anti-SLC antibody significantly inhibited the in vivo 
migration of DC from footpad explants, suggesting the potency of SLC as a 
chemoattractant for mature DC (Saeki et al. 1999a; Saeki et al. 1999b). Combined 
these results established the key role of CCR7 and the corresponding ligand SLC in 
the directed migration of mature peripheral DC via draining lymphatics to regional 
LN (Saeki et al. 1999a; Saeki et al. 1999b). In concert with MIP-3a, these 
chemokines enhance the likelihood of T cell activation, by inducing the migration 
DC to T cell rich areas of regional LN. 
1.8 Two Signal Model of T Cell Activation 
Seminal findings of Lafferty and Cunningham demonstrated that in addition to 
recognition of antigen presented in association with MHC (Kosugi et al. 1987; Cruz 
and Bergstresser 1990; Kalergis 2003), naïve T cells require an APC-derived signal 
for activation, namely the costimulatory signal (Bretscher and Cohn 1970). The 
two-signal theory of T cell activation was later expanded by Schwartz, Matzinger et 
al. and Jenkins (Schwartz 1990; Jenkins et al. 1991; Schwartz 1992; Matzinger 
1994). Provision of signal one alone is insufficient to stimulate T cell activation. 
Significantly, antigen presentation in the absence of signal 2 can lead to 
unresponsiveness of the naïve T cell (Gimmi et al. 1993). Signal two is provided by 
ligation of costimulatory molecules, such as CD40, CD80, CD86 and ICOSL, with 
complimentary ligands on the surface of the T cell, being CD4OL, CD28 and ICOS 
respectively (Bernard and Bernard 1999; Bocko et al. 2002). Provision of 
costimulation prevents anergy and promotes the full activation response (Jenkins et 
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al. 1991; Boussiotis et al. 1993; Ramarathinam et al. 1994; Cerdan et al. 1995; 
Pericle et al. 1997). Interestingly, activated memory T cells can receive signal two 
from any cell, not just professional APC (Zinkemagel 2000). However both effector 
and memory T cells can be rendered anergic if antigen is presented again in the 
absence of signal two (Zinkemagel 2000). When LC are freshly isolated from the 
epidermis they express relatively low levels of MHC-II and limited amounts of 
CD80 and CD86 on the cell membrane (Yokozeki et al. 1996). As these cells mature 
in culture (paralleling migrating LC in vivo) the expression of CD80 and CD86 
becomes more apparent corresponding with acquisition of APC function (Weinlich et 
al. 1998; Aiba et al. 2000). 
1.9 Outcome of T Cell Activation 
Within two days of antigen presentation, T lymphocytes begin to proliferate, 
resulting in antigen-specific clones. On recognition of antigenic peptide presented 
by APC the resulting effector T cell responds in ways that serve to eradicate the 
infection. Exogenous antigen-specific CD4 cells and endogenous-specific CD8 cells 
perform separate functions, and their patterns of differentiation are distinct 
(Mosmann et al. 1986; Mosmann and Coffman 1989; Mosmann and Sad 1996). 
1.9.1 CD 4 cells 
In 1986, Mossman and colleagues identified two discrete subgroups of CD4 T cells, 
T helper I (Thl) and T helper 2 (Th2) (Mosmann et al. 1986). The two subsets of 
clones are classified on the basis of functional characteristics and cytokine secretion 
(Kim et al. 1985; Mosmann et al. 1986; Stout and Bottomly 1989). CD4 helper cells 
play a central role in immune regulation as the two panels of cytokines secreted by 
these subpopulations drive two distinct immune reactions, allowing a specific 
response against a range of possible antigens (Mosmann et al. 1986; Mosmann and 
Coffman 1989; Mosmann and Sad 1996). In many situations the progression of 
disease parallels the balance of Thl cytokines, which are pro-inflammatory, and non-
inflammatory Th2-type cytokines (Kuchroo et al. 1995a; Kuchroo et al. 1995b; 
Krenger et al. 1996a; Krenger et al. 1996b). Differentiation to either subset is 
decided during T cell priming, and although many factors influence development, the 
most discussed is the impact of the cytokine milieu (Paul and Seder 1994; Seder et 
al. 1994). The key cytokines for the differentiation of Thl cells are APC secreted IL- 
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12 and IFN-y (Swain et al. 1990; Seder et al. 1993), whilst IL-4 has the greatest 
influence on Th2 differentiation (Swain et al. 1990). A third subset of T helper cell, 
Th0 has also been identified which secretes a mixture of the two cytokine patterns. 
Given the broad array of possible cytokines that can be secreted by a T cell it is 
impossible for there to be a complete dichotomy of Thl and Th2 cells. Rather it is 
now well accepted that a gradient exists in the presence of Thl to Th2 cells (Paliard 
et al. 1988; Firestein et al. 1989). 
1.9.1.1 CD4 T Helper 1 cells 
The principle function of Thl cells is to promote cell-mediated inflammation 
(Mosmann and Coffman 1989; Romagnani 1992a). One of the potent pro-
inflammatory cytokines secreted by Thl cells is IFN-y, named due to its interference 
with viral infection (Cher and Mosmann 1987; Abbas et al. 1991; Abbas et al. 1996). 
IFN-y is a potent activator of macrophages and stimulates the production of 
antibody-isotypes that promote the phagocytosis of microbes (Adams et al. 1986; 
Reed 1988; Finkelman et al. 1991; Wira et al. 1991; Fanger et al. 1996). These 
antibodies can either bind directly to Fc receptors on phagocytes or activate 
complement, generating opsonising products (Koppenheffer 1987; Cutler et al. 1991; 
Fanger et al. 1996; Devaux et al. 2004). IFN-y also amplifies the immune response 
by heightening the potency of APC and the resistance to immune suppression 
(Gaczynska et al. 1993; Luft et al. 2002). This is demonstrated by the up-regulation 
of MHC-II and costimulatory molecule expression on APC, and limited proliferation 
of Th2 in the presence of IFN-y (Fiorentino et al. 1991; Gaczynska et al. 1993; Noble 
et al. 1993; Bradley etal. 1995; Lutz et al. 1996a; Luft et al. 2002). 
1.9.1.2 CD4 T Helper 2 Cells 
Th2 cells are primarily involved in humoral immune responses, providing 
stimulation to B cells for T-dependent antigen responses (Mosmann and Coffman 
1989; Abbas et al. 1996). Th2 cells secrete a particular set of cytokines including IL-
4 and IL-5, and whose principle functions are to firstly stimulate IgE production and 
eosinophil/mast cell-mediated immune reactions and secondly, to down-regulate Thl 
responses via production of IL-10 (Mosmann et al. 1986; Haas et al. 1992; Oswald et 
al. 1992; Romagnani 1992b; Noble et al. 1993; Gajewski et al. 1994; Schwarz et al. 
1994; Ullrich 1994). 
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1.9.2 CD8 cells 
CD8 positive T cells are otherwise known as cytotoxic or cytolytic T cells (CTL). 
Their major effector function is to recognise and kill host cells infected with viruses 
or other intracellular microbes (Rivas et al. 1989; Gelfanov et al. 1996; Albert et al. 
1998b). Infected cells present the intracellular antigen on MHC-I, which is then 
recognised via the TCR (Albert et al. 1998b). CTL killing of infected cells involves 
the release of cytoplasmic granules whose contents include membrane pore-forming 
proteins and enzymes that cause DNA fragmentation and apoptosis (Kagi et al. 1994; 
Gelfanov et al. 1996). 
1.10 Tolerance 
A lesser-characterised role of the host immune system is the maintenance of 
tolerance to self-antigen (Adkins et al. 2004a). Self-tolerance is initiated primarily in 
the thymus, the organ of T cell development, and is termed central tolerance (Jones 
et al. 1990; Sprent and Kishimoto 2002). Central tolerance involves the programmed 
differentiation of immature thymocytes leading to functional, non-self reactive T 
cells (Jones et al. 1990; Sprent and Kishimoto 2002). During maturation, developing 
T cells are subject to two selection processes (Jones et al. 1990; Sprent and 
Kishimoto 2002). T cells fit to recognise foreign antigen presented in the context of 
MHC are given the signal to survive and undergo further differentiation (positive 
selection) (Kisielow and von Boehmer 1990; von Boehmer and Kisielow 1990). 
TCR that do not recognise MHC:foreign antigen complexes are deleted through 
programmed cell death (Jones et al 1990; vonBoehmer et al. 1990). Secondly, T 
cells with high affinity for self-antigen are terminated (negative selection) (Sprent 
and Kishimoto 2002). The clonal deletion of inappropriate T cells through central 
tolerance is critical for the understanding of self and the avoidance of deleterious 
autoimmune responses (Jones et al. 1990). 
Although central tolerance is stringently regulated, some self-reactive cells do 
circumvent negative selection within the thymus (Jones et al. 1990). There are two 
scenarios that result in avoidance of central tolerance. Firstly, T cells that 
demonstrate low affinity for self-antigen may escape deletion within the thymus, and 
enter the periphery (Fazekas de St. Groth 2001). Secondly, some self-antigens may 
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not be expressed in the thymus or secreted in serum and thus incapable of gaining 
access to the thymus for presentation. Examples of such antigens include harmless 
environmental antigens and apoptotic debris generated during normal tissue turnover. 
It is essential that hyper-responsiveness to these antigens is avoided (Fazekas de St. 
Groth 2001). 
It is well documented that DC are key inducers of pro-inflammatory immune 
responses (Banchereau and Steinman 1998; Banchereau et al. 2000). However, 
recent investigations have demonstrated the pivotal role DC play in peripheral 
tolerance under steady state conditions (Steinman et al. 2000). Verification of the 
tolerising effect of DC came from experiments analysing the outcome of T cells 
presented with peripheral self-antigen (Steinman et al. 2000). The results 
demonstrated that under defined circumstances, DC trafficked peripheral self-antigen 
to the draining LN and activated antigen-specific T cell tolerance (Steinman et al. 
2000). What remained unclear however was how DC selected between induction of 
immunity or tolerance. It has since been proposed that the fate of mature T cells is 
controlled under normal physiological conditions by the circumstances under which 
they recognise antigen-MHC and the maturation status of the APC (Schuler and 
Steinman 1985; Dewar et al. 2001; Woods et al. 2001; Gad et al. 2003; Simpson et 
al. 2003). Mechanisms that avert self-reactive peripheral T cells inducing 
autoimmune reactions are termed peripheral tolerance (Walker and Abbas 2002). 
These mechanisms fall into three mutually exclusive groups: maintenance of 
immaturity (failure to respond to antigen or presentation of antigen below a 
measurable response), deletion following antigen presentation and survival/memory 
responses, which involves T cell deviation and long-term survival following 
interaction with antigen (Fazekas de St. Groth 2001),It is possible that all three 
mechanisms can operative simultaneously for a single antigen (Fazekas de St. Groth 
2001).This is demonstrated in the phenomenon of antigen dose (Zinkernagel 2000). 
Firstly, antigen presented in the LN in minimal doses is ignored by the naïve T cell. 
In contrast, antigen already expressed in the LN, or if expressed in high amounts for 
long time periods, results in T cell deletion (Zinkernagel 2000). For the purpose of 
this literature review maintenance of naivety, anti-idiotypic networks and the role of 
DC in peripheral tolerance in regard to the induction of anergy, regulatory T cells, 
apoptosis and T cell deviation will be discussed in depth. 
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1.10.1 Maintenance of a naïve status. 
Two mechanisms have been hypothesised to maintain T cells in a naïve phenotype 
following presentation of antigen to the TCR. Firstly T cells that have low avidity or 
affinity for self-antigen escape central tolerance, remaining naïve after leaving the 
thymus (Liu et al. 1995). When self-antigen is presented to the low affinity self-
reactive TCR, the cell does not respond and fails to differentiate in an antigen-
specific manner (Anderson et al. 1994a; Anderson et al. 1994b; Heath et al. 1998; 
Girgis et al. 1999; Anderson et al. 2000). In doing so, anti-self responses are not 
generated (Fazekas de St. Groth 2001). Secondly, peripheral antigen may remain in 
the tissues, sequestered in a site away from secondary lymphoid organs such as the 
spleen and LN (Barker and Billingham 1977). If such antigens are incapable of 
reaching the thymus, even T cells with high affinity for self antigen will remain 
unresponsive and naïve (Fazekas de St. Groth 2001). A prime example of such an 
antigen is transgenic antigen expressed by insulin-secreting cells in the pancreas 
(Ohashi et al. 1991). Peripheral T cells cannot gain access to such tissue, and only 
become primed to the pancreatic antigen once inflammation is induced (Ohashi et al. 
1991). During inflammation local APC transport the self-antigen from the pancreas 
to the draining LN for presentation to naïve T cells (Ohashi et al. 1991). 
1.10.2 Idiotypes and anti-idiotypes 
During an immune response to foreign antigen, autoantibodies are generated 
simultaneously to anti-antigen antibodies (Borghesi and Nicoletti 1996). These 
autoantibodies can then react to the variable region (idiotype) of the antigen-specific 
antibody (Borghesi and Nicoletti 1996). As a consequence these autoantibodies must 
be regulated to avoid anti-self reactions (Borghesi and Nicoletti 1996). The 
regulation of the idiotypic sequences in inununoglobins, as well as the variable 
region of the TCR (which in itself is self antigen) (Shoenfeld 1989-90), is involved 
in both central and peripheral tolerance induction (Durkin and Waksman 2001). 
Although can be maintained, the precise mechanism is yet to be defined. It has 
postulated to involve regulatory T cells that interact through idiotypic receptors on 
the surface of self-reactive T and B cells, leading to their deletion or suppression 
(Shoenfeld 1989-90). This hypothesis is supported by several studies. Firstly, 
following exposure to anti-idiotypic antibodies to staphylococcal nuclease, nude 
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mice were unable to synthesise idiotype-bearing immunoglobin. In contrast, in 
immune competent mice helper T cells were lysed by complement or anti-idiotype 
(Miller et al. 1981). In another study, the lysis of idiotype-bearing T suppressor cells 
by anti-idiotype and complement was also evident (Sercarz and Metzger 1980). 
The idiotype network first proposed by Jerne (1974) has been demonstrated to be 
involved in the regulation of various immune reactions (Jerne 1974b; Jerne 1974a; 
Jerne 1974-75). Such reactions include B cell tolerance (Brown and Bhoghal 1975), 
tolerance during ageing (Szewczuk and Campbell 1980), rejection suppression in 
pregnancy (Suciu-Foca et al. 1985) as well as playing a critical role in various 
immune disorders. 
1.10.3 T cell anergy 
For effector T cell activation and differentiation two signals must be provided by the 
APC (Lafferty and Cunningham 1975; Jenkins et al. 1991). The first signal is 
generated following ligation of the TCR with MHC:antigen complexes on the APC 
surface (Kosugi et al. 1987; Cruz and Bergstresser 1990; Kalergis 2003). Signal two 
is provided by binding of costimulatory molecules, namely CD80 and CD86, with 
the corresponding T cell receptors (Lafferty and Cunningham 1975; Jenkins et al. 
1991). Presentation of antigen alone renders the T cell anergic, refractory to a later 
encounter with the same antigen, even if costimulation is provided (Burkly et al. 
1989; Mueller et al. 1989; Clark et al. 1999). This failure to provide the second 
signal is brought about by DC immaturity, diminished expression of costimulatory 
molecules, or the cytokine milieu present during DC:T cell interaction, namely the 
immunosuppressive cytokines IL-10 and TGF-13 (Gad et al. 2003). The influence of 
cytokines has been demonstrated in vitro, where T cells were cultured with 
supernatants collected from IL-10 treated human DC (Steinbrink et al. 1997b; 
Steinbrink et al. 1998; Steinbrink et al. 1999; Brossart et al. 2000; Faulkner et al. 
2000b). Following exposure there was a significant reduction in the secretion of pro-
inflammatory cytokines, such as IL-113 and TNF-a, and a complete absence of IL-12 
(Steinbrink et al. 1997; Steinbrink et al. 1998; Steinbrink et al. 1999; Brossart et al. 
2000; Faulkner et al. 2000). Following exposure to IL-10, DC are not only 
inefficient stimulators of Thl responses but prompt antigen-specific tolerance 
41 
Literature Review 
through the induction of T cell allergy (Enk et al. 1993c; Enk et al. 1994; Steinbrink 
et al. 1998; Steinbrink et al. 1999). As opposed to immature DC, mature DC are not 
responsive to the inhibitory effects of IL-10 (Allavena et al. 1998; Steinbrink et al. 
1999; Cavani et al. 2000). As such the function of DC, exposed to immune 
suppressive cytokines such as IL-10, is modulated such that there is diminished T 
cell response, characterised by reduced antigen-specific activation and reduced 
secretion of pro-inflammatory cytokines (Steinbrink et al. 1997; Steinbrink et al. 
1999). 
1.10.4 T regulatory cells 
In some cases auto-reactive T cells are not ignorant or rendered anergic to self-
antigen. Such cells can be prevented from reacting to self-antigen by the presence of 
other T cells, namely suppressor or regulatory T cells (Sakaguchi et al. 1994; Mason 
and Powrie 1998). In a similar fashion to anergic T cells, the principle inducers of 
regulatory T cell proliferation and differentiation is immature DC (Shevach 2000). 
However, semi-mature DC, those that have not fully responded to inflammatory 
signals, can also activate regulatory T cells (Gad et al. 2003). The mechanism by 
which DC induce the activation of regulatory and suppressor T cell populations is 
obscure (Gad et al. 2003), however it has been proposed to be as crucial as anergy in 
the maintenance of tolerance (Thompson and Thomas 2002; Bilsborough et al. 
2003). One subset of CD4+ regulatory T cells, CD4+CD25+, has been demonstrated 
to be potent inhibitors of CD4 + and CD8÷ T cell activation via an antigen non-
specific mechanism (Powrie et al. 1993; Jonuleit et al. 2000; Read et al. 2000; 
Salomon et al. 2000; Hara et al. 2001). A characteristic of these cells is that they are 
anergic and inhibit the secretion of IL-2, critical to T cell activation(Gad et al. 2003). 
Addition of IL-2 breaks the anergic state and suppression induced by the T 
regulatory cell, highlighting the importance of the cytokine milieu (Takahashi et al. 
1998; Thornton and Shevach 1998; Read et al. 2000; Strober et al. 2002). DC 
possess the exclusive ability to stimulate specific regulatory T cells that protect 
peripheral tissue from potential autoimmune reactions (Gad et al. 2003). Via the 
secretion of various cytokines and inhibitory costimulatory molecules, regulatory T 
cells can further modulate DC function, to either regulate activated T cells or prime 
new regulatory T cells (Thompson and Thomas 2002). 
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1.10.5 T cell deletion 
Under specific conditions DC are capable of inducing apoptosis, leading to the 
deletion of self-reactive T cells (Ferguson et al. 2003). One mechanism employed by 
DC to induce apoptosis is ligation of the death ligand FasL (Singer et al. 1994; 
Crispe 1994; Nagata and Golstein 1995). It has been demonstrated that FasL-
expressing murine spleen DC induce apoptosis in activated CD4 + T cells following 
binding of Fas on the T cell surface (Suss and Shortman 1996). An additional ligand 
is TNF-related apoptosis-inducing ligand, TRAIL, whereby expression translates to 
an ability to kill TRAIL-sensitive targets, including activated T cells (Fanger et al. 
1999). TRAIL has been demonstrated to be critical in the induction of tolerance, 
especially in immune privileged sites (Lee et al. 2002). In the eye anti-self 
responses, which may be tolerated in larger organs such as the skin, are detrimental 
to the retina. As such tolerance has become the default pathway, through expression 
of TRAIL on ocular tissue. Following binding to TRAIL, incoming lymphoid cells 
are deleted via apoptosis (Lee et al. 2002). In contrast to effector T cells, which are 
prone to FasL-mediated apoptosis, regulatory T cells appear to be resistant (Banz et 
al. 2002). Thus in terminating a T cell response, DC and regulatory T cells can 
function simultaneously (Gad et al. 2003). 
Interestingly, the apoptotic T cell inadvertently plays an active role in the 
maintenance of tolerance (Griffith et al. 1996). It was postulated that within dying 
cells were molecules capable of initiating tolerance. It was observed that following 
Fas-mediated apoptosis of T cells was a rapid induction of IL-10 secretion by these 
cells. Antigen presenting cells that had internalised the dying IL-10-secreting T 
cells, deviating the outcome of antigen presentation away from Thl responses and 
towards Th2 tolerance inducing responses. This response was not observed in IL-10 - 
/- mice, demonstrating the dependence on IMO (Gao et al. 1998). 
1.10.6 Immune deviation 
Immune deviation involves directing the immune response away from the generation 
of potentially auto-reactive Thl cell-mediated responses and towards humoral, 
potentially suppressive Th2-type responses. The ability of DC to deviate the 
immune response is influenced by the nature of the stimulating antigen and the local 
microenvironment (Langenkamp et al. 2000; Manickasingham et al. 2003). An 
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example of the latter is the immunosuppressive cytokine IL-10 (Corinti et al. 2001). 
When exposed to IL-10 in the periphery, DC migrate to the draining LN in an 
immature state, associated with a diminished expression of costimulatory molecules 
and reduced capacity for IL-12 synthesis (Xia and Kao 2003). The level of IL-12 has 
a direct effect on Th2 polarisation, with diminished IL-12 secretion at the DC:T cell 
interface resulting in a skewing in the response towards Th2 (Gately et al. 1998). 
The importance of IL-10 in immune deviation was further supported by studies 
demonstrating that treatment with neutralising anti-IL-10 antibodies resulted in a 
pronounced increase in TNF-a and IL-12 secretion and restored the immune 
response towards Thl (Corinti et al. 2001). Interestingly, it has also been reported 
that exposure to antigen during the early neonatal period leads to a bias towards Th2 
cells at a second encounter with the same antigen (Adkins et al. 2001). Although 
self-reactive T cells survive peripheral tolerance during the neonatal period, the 
memory inherent in T cell deviation ensures that if the same self-antigen is 
encountered when the animal reaches maturity then self-reactive immune responses 
will be avoided (Adkins et al. 2001). 
1.11 Immune Function During the Early Neonatal Period 
Seminal studies by Medawar and colleagues identified the early neonatal period as 
critical for distinguishing self. If a neonatal rat was injected with allogenic 
haematopoietic cells, it was be able to successfully accept a tissue transplant from the 
same donor as an adult (Billingham et al. 1953; Billingham and Medawar 1953; 
Banz et al. 2002). These findings combined with more recent studies, suggest that 
neonatal animals are more susceptible to tolerisation (Nossal 1983; Waite et al. 1988; 
Adorini 1990; Ernst et al. 1993). The precise mechanisms for immune tolerance are 
unknown but investigations to date have primarily focused on lymphocytes of the 
neonatal immune system and their functional and phenotypical differences compared 
to adult lymphocytes (Adkins and Hamilton 1992; Adkins et al. 1993). Two theories 
for neonatal tolerance were originally proposed. The first theory suggests a passive 
acquisition of tolerance via negative selection of antigen reactive T cells within the 
thymus, in a similar fashion as natural self-tolerance (Gammon et al. 1986a; 
Gammon et al. 1986b; Sercarz et al. 1989; Gammon et al. 1991). Active models 
propose that mainly suppressive, deviated and anti-idiotypic Th2 immune responses 
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are generated (Bellgrau et al. 1981; Roser 1989). T cells from both human cord blood 
and neonatal mice proliferate poorly in response to antigenic stimulation and secrete 
reduced levels of pro-inflammatory cytokines such as IFN-y and IL-12 (Petty and 
Hunt 1998; Dakic et al. 2004). In contrast to adult DC, a study by Langrish and co-
workers demonstrated that following exposure to LPS, neonatal DC secrete Th2- 
promoting cytokines such as IL-10 and little or no IL-12 (Langrish et al. 2002). 
Rather than a consequence of either passive or active mechanisms, it is now accepted 
that both models act simultaneously to maintain tolerance induced during the early 
neonatal period. This is reflected in the tolerance response following presentation of 
varying doses of antigen (Zinkernagel 2000). While low amounts of antigen 
presented to the TCR resulted in immunological ignorance, presentation of high 
levels of antigen resulted in T cell deletion (Zinkernagel 2000). The memory 
inherent in immune deviation and suppression ensures that if the same antigen is 
presented again at a later stage, tolerance is maintained. 
The recent observation that under certain conditions neonatal T cells can mount 
effective anti-pathogen responses has prompted several research groups to revisit the 
paradigm of neonatal tolerance induction. It suggested that as neonatal T cells 
possess the capacity to respond to antigen exposure, they are not the primary inducer 
of tolerance (Salio et al. 2003) . As such, studies are now focusing on APC and their 
capacity to elicit T cell activation through signals provided at the T cell:DC interface 
during the early neonatal period (Elbe-Burger et al. 2001; Chang-Rodriguez et al. 
2004). Recent reports have suggested that activation of regulatory T cells, such as 
CD4+CD25+ T cells and y8 T cells is initiated during the interaction of nave T cells 
and DC. This is of particular importance as y8 T cells play crucial roles in tumour 
tolerance, oral tolerance and tolerance induction in immune privilleged sites such as 
the testes (Mukasa et al. 1995; Seo and Egawa 1995; Ke et al. 1997; Skelsey et al. 
2001). Studies utilising contact hypersensitivity as a model of cutaneous immune 
responses has demonstrated that the reduced capacity of neonatal mice to induce 
immunity to topically applied antigen was a consequence of inability of neonatal 
epidermal LC to provide the two signals essential for T cell activation, via a 
diminished expression of MHC-II and CD4O-CD4OL costimulatory pathway 
(Simpson et al. 2003). 
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The neonatal skin microenvironment is dramatically different in antigen composition 
compared to adult counterparts (Hoeger and Enzmann 2002). Due to a thickening of 
the neonatal epidermal barrier, the capacity of environmental antigens to access 
underlying tissues is less compared to adult counterparts. In contrast, epidermal 
maturation following birth results in increased cell turnover and death. As a result 
the relative concentration of self tissue and protein antigen is increased (Hoeger and 
Enzmann 2002). As hyper-responsiveness to self-tissue and harmless soluble 
antigen can lead to autoimmune responses and chronic inflammation respectively, a 
mechanism must be in place to prevent induction of inappropriate immune responses. 
Research from this department has demonstrated that during the early neonatal 
period, cutaneous antigen treatment resulted in a deviation in the T cell response 
from immunity to antigen specific immune suppression (Dewar et al. 2001). The 
number of LC migrating away from antigen-treated epidermis was reduced and the 
amount of antigen presented in the context of MHC-II was significantly less 
compared to adult counterparts (Dewar et al. 2001). Combined with the dramatically 
reduced expression of CD86, the capacity of neonatal LC to function as potent 
professional APC is compromised. It was proposed that due to a decreased 
expression of antigen uptake receptors on LC from neonatal mice that LC were 
inefficient at the internalisation of antigen via receptor-mediated endocytosis. 
(Dewar et al. 2001). As the epidermal LC network increased in maturity, the 
capacity to present processed peptide was acquired. By 20 days following birth LC 
exhibited morphology and phenotype consistent with adult counterparts and it was at 
this stage of development that antigen presentation elicited the activation of naïve T 
cells 
During infancy the ability to induce tolerance is an invaluable mechanism to 
maintain non-reactivity to self-antigen, beneficial skin commensals and harmless 
protein antigens. Although it is clear that tolerance is a prerequisite to normal skin 
development the involvement of LC in this process is yet to be fully understood. The 
primary aim of this study was to characterise the antigen handling capacity of LC 
during the early developmental period. As the amount of antigen presented in the 
context of MHC-II can influence the outcome of T cell activation (Sallusto et al. 
1995), the divergence in the pathways utilised by neonatal LC to internalise and 
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process antigen has important implications for the generation of immune 
suppression. By understanding the underlying mechanisms of cutaneous tolerance 
during the neonatal period it will be possible to gain more insight to immune 
function and to possibly utilise such knowledge for developing strategies for either 
enhancing the immune response for anti-pathogen or cancer protection or 
suppressing anti-self responses in autoimmune diseases. 
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Research Proposal 
Antigen treatment of 4-day-old epidermis results in a decrease in the amount of 
antigen transported to the draining lymph node (LN) by epidermal Langerhans cells 
(LC). It was proposed that a decrease in receptor-mediated endocytosis was 
responsible for the reduced antigen transport to the LN. The central aim of this study 
will be to investigate the capacity of LC to handle antigen during the developmental 
period. To characterise the capacity of LC to internalise antigen during development 
the following criteria will be assessed: 
I. To characterise the ontogeny of antigen uptake receptors during development. 
2. To analyse the capacity of LC isolated from neonatal, juvenile and adult 
epidermis to internalise a variety of antigens via receptor-mediated and fluid 
phase uptake. 
3. To assess antigen proteolysis and MHC-II complexing following exposure to 
maturation stimuli in vitro. 
By studying the various aspects of antigen handling. I will be able to determine if the 
way in which antigen is internalised and presented dictates the direction of T cell 
activation. 
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Chapter 2 
Materials and Methods 
Table 2.1 Commonly used reagents and suppliers. 
Reagent Supplier Catalogue 
Number 
7-Aminoacetic acid (7AAD) Sigma A9400 
Acetone BDH Laboratory 
Supplies 
52090201 
Bovine serum albumin (BSA), cell culture 
grade 
CSL Ltd. 52090201 
Deoxyribonuclease 1 (DNase) Invitrogen 18047-019 
Dimethyl sulfoxide (DMSO) Sigma D-5879 
Dispase Invitrogen 17105-041 
Di-sodium hydrogen orthophosphate 
Anhydrous (NaN3HPO4) 
AnalaR 010249.0500 
Ethylene diamine tetraacetic acid — 
disodium salt 
Serva 39761.02 
Fetal calf serum (FCS) CSL 09702301 
Fluorescein Isothiocyanate Sigma F-7250 
Gentamicin David Bull 
Laboratories 
2724A 
Glucose Ajax Chemicals 713 
L-Glutamine CSL 09871901 
Glycine BDH (Merck) 0101109.0500 
N-2-Hydroxyethylpiperaine-N'-2- 
ethanesulfonic acid (HEPES) 
Sigma 49329 
Hanks Balanced Salt Solution (HBSS) Invitrogen 21250-014 
L-lysine (poly-lysine) Sigma L-5501 
Mannan from Saccharomyces cerevisiae Sigma M-7504 
D(+)-Mannose Sigma M-6020 
2-Mercaptoethanol (2-ME) Sigma M-6250 
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Paraformaldehyde BDH BH151TD 
Permafluor Coulter 0752 
Roswell Park Memorial Institute 1640 
media (RPMI 1460) 
Invitrogen 21875-034 
Saponin (Practical Grade) ICN Biomedicals 
Inc. 
102855.80 
Sodium azide (NaN3) BDH 30111 
Sodium chloride (NaC1) BDH (Merck) 10241 .AP 
Sodium chloride anhydrous (NaC1) Astral 0241 
Di-Sodium hydrogen (ortho)phosphate 
(anhydrous, Na2HPO4) 
Ajax Chemicals 621 
Sodium dihydrogen (orthoOphophate 
hydrated (NaH2PO4.2H20) 
AnalaR 4140 
Sodium hydrogen carbonate (NaHCO3) BDH Chemicals 102247 
Sodium Pyruvate JHR Biosciences 59203-77P 
Trypan Blue Sigma T-0776 
Wortmannin from Penicillium fumiculosum Sigma W-1628 
Table 2.2 Commonly used disposables and suppliers 
Reagent 	 T Supplier Catalogue 
,Number 
Acrodisk® PF Gelman 
Biosciences 
4187 
13mm round cover slips ProSciTech G402 
Cell strainers, 4011m BD Falcon 352340 
15mL polystyrene tubes Iwaki 2712-002 
50mL polystyrene tubes Iwaki 2340-050 
Specimen containers Techno-Plas C5744UU 
10mL syringes Terumo 3SS-10ES 
20mL syringes Terumo 3SS-20ES 
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Table 2.3 Equipment 
Equipment Supplier Model Number 
Flow cytometer Coulter EPICS Elite 
ESP 
DMLB2 fluorescent microscope Leica - 
DM IRB inverted fluorescence microscope Leica - 
Bench top minifuge Eppendorf 5415D 
Bench top centrifuge Sorvall® RT6000D 
2.1 Reagents, disposables and equipment 
Reagents, disposables and equipment are listed in Tables 2.1, 2.2 and 2.3 
respectively. Antibodies for flow cytometry are listed in Table 2.4 and 2.5. 
Antigens and tracers for analysing in vitro antigen uptake and processing are listed in 
Table 2.6. Primary and secondary antibodies for analysing in vitro maturation are 
listed in Table 2.7. 
2.2 Animals 
Adult (6-12 weeks old), juvenile (7 and 14 days old) and neonatal (4 day old) male 
and female BALB/c (H-2d) mice were obtained from the University of Tasmania 
Central Animal House. Animals were housed in the Discipline of Pathology animal 
rooms, and provided with food and water ad libitum. Animals were used in 
accordance with the University of Tasmania Ethics Committee; permit numbers 
98013, 5519, A5620 and 6063. 
2.3 Solutions 
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2.3.1 Phosphate Buffered Saline (PBS) 
20x PBS was prepared as follows: 
NaCl 170g 
Na2HPO4 21.4g 
NaH2PO4.2H20 7.8g 
Salts were added to 900mL of Milli-Q® water (Millipore Corporation, USA) and 
dissolved using a magnetic stirrer. Once dissolved the volume was increased to 1L. 
Sterile PBS was prepared by filtering the solution through a 0.224m filter (Millipore 
Corporation, USA). 20x PBS was diluted 1 in 20 with Milli-Q8 water to give a 
working lx solution. The solution was stored at room temperature 
2.3.2 PBS / 5 %FCS / 0.1 % NaN3 
FCS 	 50mL 
NaN3 	 0.1g 
FCS and NaN3 were dissolved in 900mL of PBS using a magnetic stirrer. Once 
dissolved the volume was increased to 1L with PBS. The solution was stored at 4°C. 
2.3.3 PBS / 5% FCS 
FCS 	 50mL 
FCS was added to 900mL of PBS and mixed using a magnetic stirrer. Once 
dissolved the volume was increased to 1L with PBS. The solution was stored at 4°C. 
2.3.4 HBSS / 20mM HEPES 
HBSS 	 I sachet (9.5g) 
HEPES 	 4.77g 
NaHCO3 	 0.35g 
HBSS (without CaCl2 , MgC12, MgSO4, NaHCO3) was reconstituted using 950mL of 
Milli-Q® water. HBSS was supplemented with HEPES and NaCH03 and dissolved 
using a magnetic stirrer. The pH was adjusted to 7.4 using 1M NaOH or HC1, and 
the volume increased to 1L using Milli-Q® water. The solution was stored at 4°C. 
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2.3.5 4% Paraformaldehyde 
NaH2PO4.2H20 	1.56g 
Na2HPO4 (anhydrous) 5.68g 
Paraformaldehyde 20g 
Salts were dissolved in 450mL of Milli-Q water using a magnetic stirrer. 
Paraformaldehyde was added and the solution stirred over gentle heat, without 
boiling, for 3 to 5 hours. The volume was increased to 500mL with Milli-Q® water. 
The solution was aliquoted into 50mL polystyrene tubes and stored at —20°C. Once 
thawed 4% paraformaldehyde was used within one week. 
2.3.6 Saponin Buffer 
NaN3 0.10g 
saponin 0.10g 
EGTA 0.38g 
BSA 2.00g 
NaN3 , saponin and EGTA were dissolved in 900mL of PBS using a magnetic stirrer. 
BSA was then added and allowed to settle. Once dissolved the volume was 
increased to 1L with PBS. The solution was stored at 4°C 
2.3.7 FACS Fixative 
40% formaldehyde lmL 
D-glucose 	lOg 
15 % NaN3 in PBS 1.09mL 
Formaldehyde, glucose and NaN3 were dissolved in 450mL of PBS using a magnetic 
stirrer. Once dissolved the volume was increased to 500mL with PBS. The solution 
was stored at 4°C 
2.3.8 7-amintoactinomycin D (7-AAD) 
7AAD was reconstituted to 1 mg/mL with sterile water for injection. Working 
aliquots were stored at —20°C protected from light. 
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2.3.9 Trypan Blue 
Trypan Blue 	0.25g 
Milli-Q 	 100mL 
Trypan Blue powder was added to 100mL of Milli-Q water and sterilised through a 
0.22iim filter. Aliquots were stored at 4°C. 
2.4 Media 
2.4.1 RPMI 1460-FCS 
FCS 	 10% 
L-glutamine 	2mM 
Sodium pyruvate 	1mM 
2-ME 	 5 x 10-5M 
Gentamicin 	30mg/mL 
RPMI was supplemented under sterile conditions and stored at 4°C. 
2.4.2 IMDM-FCS 
FCS 	 10% 
L-glutamine 	2mM 
Sodium•pyruvate 	1mM 
Gentamicin 	30mg/mL 
IMDM was supplemented under sterile conditions and stored at 4°C. 
2.5 Isolation of Murine Langerhans Cells. 
2.5.1 Preparation of epidermal cell suspensions 
Adult and juvenile mice were sacrificed by carbon dioxide inhalation. Neonatal 
mice were anaesthetised by cooling at 4°C followed by decapitation. Fur was 
removed with clippers and depilatory cream (Veet: Reckitt and Colman). Skin was 
thoroughly washed with warm tap water, excised and cut into 1 cm 2 sections. Skin 
sections were incubated in HBSS/0.5% dispase/100U/mL DNase for 2 hours at 37°C, 
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with slight agitation. Adult and juvenile epidermis were mechanically separated 
from the dermis by scraping with a small spatula, or for neonatal epidermis, gently 
peeled with fine forceps. The resulting epidermal scrapings were incubated in 
HBSS/0.5% dispase/100U/mL DNase for 40 minutes at 37°C, with slight agitation. 
Following incubation an equal volume of complete RPMI 1460-FCS (supplemented 
with 10% foetal calf serum, Gentamicin, 2mM L-glutamate, 1mM sodium pyruvate 
and 5 x 10-5 M 2-mercaptoethanol) was added and swirled at room temperature for 5 
minutes. To remove particulate matter, the epidermal preparation was filtered 
through cotton wool and a 40pm cell strainer and centrifuged twice at 400g for 5 
minutes with RPMI 1460-FCS. After a final wash with RPMI 1460-FCS the pellet 
was resuspended in lmL of RMPI 1640-FCS. 
2.5.2 Preparation of spleen cell suspensions. 
The spleen was removed from adult mice and placed in a small culture dish 
containing 5mL of RPMI 1640-FCS. The spleen was then cut with scissors and 
gently passed through a cell sieve using the plunger of a 10mL syringe. To lyse red 
blood cells the suspension was incubated for 10 minutes in 10mL/spleen of RBC 
lysis buffer. Following incubation, the suspension was washed at 800 g for 10 
minutes at 4-10°C. Supernatant was aspirated and pellets resuspended in 5mL of 
RPMI. Cell suspensions were washed a further two times at 800 g, for 5 minutes at 
4-10°C with 5mL of RPMI 1640-FCS. 
2.6 Flow Cytometric Analysis of Epidermal Langerhans Cells Phenotype 
During the Early Neonatal Period. 
Table 2.4  Primary anti-mouse antibodies and isotype-matched controls 
Antibody Isotype Concentration 
(pg/5 x .105 
cells 
Supplier Catalogue 
Number 
Purified anti- B220 Rat IgG2a,, x 1 PharMingen 553084 
Biotin anti- CD1 lb Rat IgG2b,, 
K 
1 PharMingen 553309 
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PE anti-CD11c Hamster 
IgG I , K 
1 PharMingen 553802 
FITC anti-CD1 lc Hamster 
IgG I , K 
0.5 PharMingen 553801 
Purified anti-CD 14 Rat IgG I , lc 0.5 PharMingen 553738 
Biotin anti-CD18 Rat IgG2a, lc 0.5 PharMingen 557439 
Purified anti- 
CD32/CD16 
Rat IgG2b, K 1 PharMingen 553142 
Biotin anti-CD40 Rat IgG2a, 'lc 0.0625 PharMingen 553789 
Biotin anti-CD54 Hamster 
IgG I , lc 
1 PharMingen 553251 
Biotin anti-CD80 Hamster 
IgG2, K 
1 PharMingen 553767 
Biotin anti-CD86 Rat IgG2a , -lc 1 PharMingen 553690 
PE anti-I-A/I-E Rat IgG2b, lc 0.0125 PharMingen 557000 
FITC anti-I-A/I-E Rat igG2a, K 1 PharMingen 553623 
Biotin anti-B7RP-1 
(ICOS-L) 
Rat IgG2a, lc 2 eBioscience 13-5985 
Biotin anti-DEC-205 Rat IgG 2a, ic 1 Serotec MCA949 
Biotin anti-TLR4/MD- 
2 , 
Rat IgG2a, K 2 eBioscience 13-9924 
Purified anti-Langerin Rat IgG2a, lc 1 Gift from 
Sem Saeland 
Clone HD24 
Rat IgG2a, lc - 1 PharMingen 553926 
Rat IgG2b, K - 1 PharMingen 553987 
Hamster IgG I , ic - 1 PharMingen 553970 
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Table 2.5 Secondary fluorescent conjugated antibodies 
Antibody Isotype Concentration 
(p.g/5 x 10 5 
cells 
Supplier Catalogue 
Number 
Streptavidin-APC - 0.05 PharMingen 554067 
Streptavidin-FITC - 1 PharMingen 554057 
Streptavidin-PE - 1 PharMingen 554061 
Anti-rat-FITC - 1 PharMingen 554016 
2.6.1 Single colour staining of epidermal suspensions 
Approximately 5 x 10 5 cells/mL were transferred to labelled eppendorf tubes. To 
inhibit binding of antibody to surface Fc receptors, cells were incubated with purified 
anti-mouse CD 16/32 (FcyIII/II, Fc Block) for 30 minutes at 4°C (excluding those 
cells that will be stained with goat anti-rat secondary antibody). Following blocking, 
cells were incubated with primary antibody, as listed in Table 2.4, for 30 minutes at 
4°C. Following incubation, cells were washed three times with lmL of PBS/5% 
FCS/NaN3 by pulse spinning at maximum speed for 10 seconds. The final pellet was 
resuspended in 5001AL of PBS/5% FCS/0.1% NaN3. Cells were incubated with the 
corresponding fluorescently conjugated secondary antibody as listed in Table 2.5 for 
30 minutes at 4°C. Following incubation, cells were washed three times with lmL of 
PBS/5% FCS/0.1 NaN3 by pulse spinning at maximum speed for 10 seconds. 
Following the final wash, cells were resuspended in 100gL of PBS/5% FCS/0.1% 
NaN3 and transferred to labelled tubes in preparation for analysis via flow cytometry. 
Controls for antibody staining included cells stained with isotype-matched controls, 
cells incubated with secondary antibody alone and unstained cells. 
2.6.2 Multiple colour staining of epidermal suspensions 
Approximately 5 x 10 5 epidermal cells were incubated at 4°C with purified anti-
mouse CD 16/32 (FcyIII/II, Fc block) to block non-specific binding of antibody to Fc 
receptors. Following incubation cells were incubated for 30 minutes at 4°C with 
primary antibodies, as listed in Table 2.4. Following incubation cells were washed 
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three times in PBS/5% FCS/0.1% NaN3 by pulse spinning at maximum speed for 10 
seconds. Following the final wash, cells were resuspended in 50011L and incubated 
in the corresponding FITC-conjugated secondary antibody, as listed in table 2.5 for 
30 minutes at 4°C. After three pulse washes, cells were incubated for 30 minutes at 
4°C with phycoerythrin (PE) conjugated rat anti-mouse I-A/I-E and 7- 
aminoactinymycin D (7AAD) and incubated at 4°C for 30 minutes. After three pulse 
washes the cells were resuspended in 1001.IL of PBS/5% FCS/0.1% NaN3 and 
transferred to PPN tubes in preparation for analysis via flow cytometry. Controls for 
antibody staining included cells stained with the isotype-matched control, cells 
incubated with secondary alone and cells that were unstained. 
2.6.3 Analysis 
The fluorescence intensity of epidermal cell suspensions was analysed using a 
Coulter ELITE ESP flow cytometer equipped with a Coherent Innova 90 argon laser. 
Using CELLQuestTM software version 3.2.1 (Becton Dickinson, San Jose, CA), dead 
cells (7AAD+) were excluded and LC identified on the basis of MHC-II staining. 
The measure of receptor expression on MHC-II + cells was determined via the 
intensity of the FITC-conjugated secondary antibody. 
2.7 In Vitro Assessment of Antigen Uptake by Epidermal Langerhans Cells. 
Table 2.6 Fluorescent antigens and tracers 
Antigen Supplier Catalogue 
Number 
FITC-dextran ICN Biomedicals 02158062 
80 
Lucifer Yellow Sigma L0259 
Zymosan A (from Saccharomyces cerevisae) Molecular Probes Z2844 
BioParticles® BODIPY® FL conjugate 
Zymosan A BioParticles®, opsonising reagent 
(purified rabbit polyclonal IgG) 
Molecular Probes Z2850 
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E.coli (K-12 strain) BioParticlese, FITC conjugate Molecular Probes E2861 
E.coli BioParticles®, opsonising reagent 
(purified rabbit polyclonal IgG) 
Molecular Probes E2870 
2.7.1 Reconstitution and storage 
2.7.1.1 Fluorescein isothiocyanate (FITC)-dextran 
FITC dextran was reconstituted to 2mg/mL in complete RPMI 1640-FCS and 
vortexed gently to dissolve aggregates. FITC-dextran was reconstituted on the day 
of use and stored at 4°C, protected from light. 
2.7.1.2 Lucifer Yellow (L Y) 
Lucifer Yellow was reconstituted to 2mg/mL in complete RPM! 1640-FCS and 
vortexed gently to dissolve aggregates. Lucifer Yellow was reconstituted on the day 
of use and stored at 4°C, protected from light. 
2.7.1.3 Zymosan A 
Zymosan A from Saccharomyces cerevisiae was reconstituted in PBS and then in 
RPMI 1640-FCS to 2Ong/mL and stored in working aliquots at -80°C. When 
required, aliquots were thawed slowly at room temperature. Aliquots were 
resuspended in 5004 of PBS and total yeast particles/mL determined with a 
haemocytometer. 
2.7.1.4 Zymosan A polyclonal IgG opsonising reagent 
Zymosan opsonising reagent (polyclonal IgG, Molecular Probes) was resuspended in 
lmL of tissue culture grade water and stored at 4°C. 
2.7.1.5 E.coli 
E.coli was reconstituted in PBS and then in RPMI 1640-FCS to 2Ong/mL and stored 
in working aliquots at -80°C. When required, aliquots were thawed slowly at room 
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temperature. Aliquots were resuspended in 5004 of PBS and total yeast 
particles/mL determined with a haemocytometer. 
2.7.1.6 E.coli A polyclonal IgG opsonising reagent 
E. coli opsonising reagent (polyclonal IgG, Molecular Probes) was resuspended in 
lmL of tissue culture grade water and stored at 4°C. 
2.7.2 In vitro antigen uptake assays using FITC-dextran and Lucifer Yellow 
Cell suspensions were pulsed with FITC-dextran or Lucifer Yellow (LY) at 37°C and 
4°C. The 4°C control was included to determine the degree of non-specific or non-
metabolically active binding of antigen to cells. At set time points, cells were 
removed and uptake ceased by the addition of ice-cold PBC/5% FCS/0.1 % NaN 3 . 
Cells were washed three times by pulse spinning at maximum speed for 10 seconds. 
Cells were resuspended in 5001AL in PBS/5% FCS/0.1% NaN3. 
2.7.2.1 Inhibition of FITC-dextran uptake by mannan and mannose 
For blocking of marmose-type receptors, epidermal suspensions were pre-incubated 
with 10 mg/mL of mannan from Saccharomyces cerevisiae and 10mg/mL of D(+)- 
mannose at 37°C and 4°C for 10 minutes. Cells were transferred to 7°C and 
incubated with 1 mg/mL of FITC-dextran for 15 minutes in the continuous presence 
of marman and mannose. 
2.7.2.2 Inhibition of Lucifer Yellow uptake by wortmannin 
For the inhibition of macropinocytosis, epidermal suspensions were incubated with 
10uM wortmannin, from Penicillium fumiculosum for 30 minutes at 37°C. Cells 
were transferred to 37°C and incubated in 1 mg/mL of FITC-dextran or LY for 15 
minutes in the continuous presence of wortmannin. 
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2.7.3 Phagocytosis of Zymosan and E.coli by epidermal LC 
Cell suspensions were pulsed with Zymosan A and E.coli at 37°C and 4°C, at a 
particle to LC ratio of 20:1. At set time points, cells were removed and uptake 
ceased by the addition of ice-cold PBC/5% FCS/0.1 % NaN3. Cells were washed 
three times by pulse spinning at maximum speed for 10 seconds. Cells were then 
resuspended in 500gL of PBS/5% FCS/0.1% NaN3. 
2.7.4 Phagocytosis of opsonised Zymosan and E.coli by epidermal LC 
To opsonise Zymosan and E.coli, equal volumes of opsonising reagent were added to 
particles, vortexed gently and incubated at 37°C for 1 hour. Following incubation, 
particles were washed three times at 1500 g for 5 minutes to remove excess antibody 
and NaN3 . Homogeneity was analysed with a light microscope and vortexed if 
required. Cell suspensions were pulsed with opsonised Zymosan A and E.coli at a 
ratio of 1:20 at 37°C and 4°C. At set time points, cells were removed and uptake 
ceased by the addition of ice-cold PBC/5% FCS/0.1% NaN3. Cells washed three 
times by pulse spinning at maximum speed for 10 seconds. Cells were resuspended 
in 5004 of PBS/5% FCS/0.1% NaN3. 
2.7.5 Identification of Langerhans cells in whole suspensions. 
Following antigen uptake assays approximately 5 x 10 5 epidermal cells were 
incubated for 30 minutes at 4°C with PE rat anti-mouse I-A/I-E and 7AAD to 
identify viable LC. Cells were washed three times by pulse spinning at maximum 
speed for 10 seconds. Cells were resuspended in 1004 of PBS/5% FCS/0.1% NaN 3 
and transferred to labelled tubes for analysis via flow cytometry. 
2.7.6 Analysis 
The fluorescence intensity of epidermal cell suspensions was analysed using a 
Coulter ELITE ESP flow cytometer equipped with a Coherent Innova 90 argon laser. 
Using CELLQuestTM software version 3.2.1 (Becton Dickinson, San Jose, CA), dead 
cells (7AAD÷) were excluded and LC identified on the basis of MHC-II staining. 
To assess the rate of antigen internalisation, the mean fluorescence intensity at 37°C 
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was divided by the mean fluorescence intensity at 4°C. This normalisation procedure 
was crucial as it enabled analysis of antigen uptake by neonatal, juvenile and adult 
LC, which was performed on separate days. Data was analysed via Cricket Graph 
III, version 3 (Computer Associates). 
2.8 In Vitro Analysis of Antigen Processing Pathways in Epidermal Langerhans 
Cells. 
Table 2.7 Proteolytic antigens and maturation stimuli 
Antigen Supplier Catalogue' - 
Number 
DQTM ovalbumin Molecular Probes D12-53 
Lipopolysaccharides from Escherichia coli 
strain 0111:B4 
Sigma L3012 
Table 2.8  Primary anti-mouse antibodies and isotype-matched controls 
Antibody Isotype Concentration 
(p.g/5 x 105 
cells 
Supplier Catalogue 
Number 
Biotin- I-A/I-E Rat I,,2G2a, K l PharMingen 5553622 
FITC-LAMP-1 Rat IgG i , x 1 PharMingen 553793 
Purified- I-A/I-E 
(TIB 120) 
Rat IgG2a, lc 1 American Tissue 
Culture 
Collection. 
Hyridoma clone 
M5/114.15.2 
- 
Purified LAMP-1 Rat IgG I , x 1 PharMingen 553792 
Rat igG2a, K - 1 PharMingen 553926 
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Table 2.9 Secondary fluorescent conjugated antibodies 
Antibody Isotype Dilution Supplier Catalogu 
e 
Number 
Streptavidin, Alexa 
Fluor® 488 
conjugate 
- 1/1000 Molecular Probes S32354 
Streptavidin, Alexa 
Fluor® 594 
conjugate 
- 1/2000 Molecular Probes S32356 
Alexa Fluor® 488 
goat anti-rat IgG 
(H+L)) 
- 1/1000 Molecular Probes A11006 
Alexa Fluor® 594 
goat anti-rat IgG 
(H+L) 
- 1/1000 Molecular Probes Al 1007 
Anti- 
fluorescein/Oregon 
Greene, goat IgG 
fraction, Alexa 
Fluor® 
- 1/5000 Molecular Probes Al 1096 
2.8.1 Reconstitution and storage 
2.8.1.1 DQ-OVA 
DQ-OVA was reconstituted to 0.5mg/mL with sterile PBS and vortexed gently to 
dissolve aggregates. Once reconstituted DQ-OVA was stable for 2 weeks at 4°C, 
protected from light. 
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2.8.1.2 Lipopolysaccharide 
Lipopolysaccharide (LPS) was reconstituted to 1 mg/mL in RPM! 1460-FCS and 
vortexed gently to dissolve aggregates. Once reconstituted small working aliquots 
were stored at —20°C. Care was taken to avoid repeated freeze thawing. 
2.8.2 Pulse chase antigen processing assays 
Cell suspensions were pulsed with DQ-OVA at 37°C and 4°C for 4 hours. The 4°C 
control was included to determine the degree of non-specific binding of antigen to 
cells. At 4 hours cells were washed three times with PBS-5% FCS at 800 g for 15 
minutes at 4°C to remove free antigen. The suspensions were resuspended in IMDM 
and returned to 37°C and 4°C and incubated for 24 hours. At set time points, cells 
were removed and processing ceased by the addition of ice-cold PBC/5% FCS/0.1% 
NaN3. Cells were washed three times by pulse spinning at maximum speed for 10 
seconds. Cells were resuspended in 5001aL of PBS in preparation for adherence to 
lysine-coated coverslips. 
2.8.3 Coating of cover slips with poly-lysine 
13mm round glass cover slips were placed in a 24 well plate at 1 slip/well: Slips 
were coated with 1 mL of a 1 mg/mL poly-L-lysine/PBS solution for 15 minutes at 
room temperature. Following incubation lysine was aspirated 
2.8.4 Adherence of epidermal LC to lysine coated cover slips 
Cell concentration was determined with a haemocytometer and adjusted to between 
0.5 and 1 x 106 cells/mL in PBS. 500pt of cells were added to each well and 
allowed to adhere at room temperature for 30 minutes. Following incubation, non-
adhered cells were aspirated. lmL of 4% paraformaldehyde buffer was to each well 
and incubated for 10 minutes at room temperature. Following incubation 
paraformaldehyde was aspirated. Coverslips were washed twice in 1 mL of saponin 
buffer for 5 minutes with gentle agitation on a horizontal shaker. 
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2.8.5 Multiple colour immunofluorescent staining of adhered epidermal cells 
Coverslips were incubated at room temperature with the desired rat-anti mouse 
primary antibody or isotype control, as listed in table 2.8, for 30 minutes with gentle 
agitation. Following incubation, slips were washed three times in lmL of saponin 
buffer for 5 minutes with gentle agitation. Following washing, coverslips were 
incubated with 500uL of secondary-anti-rat Alexa conjugated antibody, as listed in 
table 2.9, for 45 minutes at room temperature, protected from light. Coverslips were 
washed three times with lmL of saponin buffer for 5 minutes with gentle shaking. 
Slips were stained with a sequential biotin-conjugated primary antibody for 30 
minutes at room temperature with gentle agitation. Following another 3 washes in 
saponin buffer, cells were stained with 500uL of secondary streptavidin Alexa 
conjugated antibody for 45 minutes at room temperature, protected from light. 
Following incubation slips were washed three times in lmL of saponin for 5 minutes 
with gentle shaking. Following the final wash, slips were allowed to air dry. Each 
cover slip was then inverted onto a slide bearing a drop of Permafluor mounting 
media. The slides were then allowed to set at room temperature before storage at 
4°C, protected from light. 
2.8.6 Microscopy 
The fluorescence intensity and antibody localisation of adhered epidermal cells was 
analysed using Leica standard and inverted fluorescence microscopes fitted with a 
digital camera. Using MagnaFireTM software, images were taken in monochrome 
mode and merged within Adobe PhotoShopTM Version 7 (Adobe Systems 
Incorporated). Due to the intensity of Alexa 594 staining there was significant 
background staining. Using Adobe PhotoShopTM the contrast was increased, thereby 
reducing background level of staining. The reduction of background fluorescence 
was the only imagine manipulation performed. 
2.9 In Vitro Analysis of Antigen Trafficking and Maturation by Epidermal 
Langerhans Cells Following Exposure to LPS. 
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2.9.1 Pulse chase antigen processing assays in the presence of LPS 
DQ-OVA processing assays outlined in section 2.7.1 were repeated in the continuous 
presence of LPS. Antigen localisation was assessed via fluorescence microscopy as 
outlined in section 2.7.6. 
2.9.2 Detection of intracellular versus extracellular MHC-II:peptide complexes. 
24 hours following incubation in the presence or absence of LPS, epidermal 
suspensions were adhered to coated coverslips and LC identified as outlined in 
sections 2.7.2 through to section 2.7.4. MHC-II localisation was assessed via 
fluorescence microscopy as outlined in section 2.7.6. 
2.9.3 Analysis of CD86 expression 
24 hours following incubation in the presence or absence of LPS, epidermal 
suspensions were dual stained for expression of CD86 and MHC-II as outlined in 
section 2.6.2. CD86 and MHC-II expression was assessed via flow cytometry as 
outlined in section 2.6.3. 
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Chapter 3 
The Ontogeny of Antigen Uptake Receptors on Langerhans Cells 
During the Early Neonatal Period 
3.1 Introduction 
Epidermal Langerhans cells (LC), are involved in the uptake and processing of 
exogenous antigens (Chain et al. 1986; Cella et al. 1997b). The pathways utilised by 
LC to internalise antigen are influenced by antigen complexity and size (Steinman 
and Swanson 1995; Watts 1997). Soluble and non-binding antigens can be engulfed 
via non-specific fluid-phase micro- or macropinocytosis (Watts and Marsh 1992). 
Small particulate antigens are internalised via receptor-mediated endocytosis, whilst 
larger particulate antigens, such as microbes, are captured via phagocytosis (Aderem 
and Underhill 1999; Stepney and De Camilli 2000). For effective receptor-mediated 
endocytosis or phagocytosis, it is essential that LC express a diverse range of 
receptors capable of recognising microbial-associated antigens, immune complexes 
and activated complement components (Aderem and Underhill 1999; Stepney and 
De Camilli 2000). LC possess lectins specific for components of microbial cell 
walls, including CD14 that recognises LPS (Aderem and Underhill 1999). LC also 
express members of the C-type lectin family of receptors, including DEC-205 and 
Langerin, essential to the recognition of terminal marmose residues commonly found 
on microbial surfaces (Kato et al. 1998; Kato et al. 2000; Valladeau et al. 2000; 
Valladeau et al. 2003). Antibody-antigen complexes are recognised by Fc receptors, 
including FcyRII (CD16/32) and Fc6R1 (Esposito Farese et al. 1995; Fanger et al. 
1996), whilst complement complexed antigen is recognised by CD1 1 b/CD18 (CR3) 
and CD11c/CD18 (CR4) (Okada et al. 1988). 
Uptake of mannosylated antigen is a function of endocytic receptor expression, and it 
has been proposed that an absence of mannose-type receptors negatively impacts on 
the scavenging capacity of LC (Jiang et al. 1995; Sallusto et al. 1995). During the 
early neonatal period, the epidermal LC network is phenotypically and functionally 
immature, with an absence of DEC-205 expression 4 days following birth (Dewar et 
al. 2001). It was hypothesised that LC isolated from neonatal epidermis had a 
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diminished capacity to internalise antigen via a receptor-mediated pathway. This 
hypothesis was further supported when, following application of antigen through 3- 
day-old epidermis, the amount of antigen transported by LC to the draining LN was 
less compared with adult counterparts (Dewar et al. 2001). Following presentation 
of cutaneous antigen by neonatal LC there was a deviation in the T cell response 
from immunity to antigen-specific immune suppression (Dewar et al. 2001; Simpson 
et al. 2003). As the amount of antigen presented in the context of MHC-II can 
influence the outcome of T cell activation (Langenkamp et al. 2002), the divergence 
in the pathways utilised by neonatal LC to internalise and process antigen has 
important implications for the generation of suppression. In order to assess the 
capacity of LC to internalise antigen during development it was first necessary to 
determine the ability of these cells to recognise exogenous antigen. This chapter 
examined the phenotype and expression of a range of antigen uptake receptors 
expressed by LC during the early neonatal period. 
3.2 Results 
3.2.1 Selecting for Viable MHC-II+ Cells in Epidermal Suspensions. 
In order to identify viable MHC-II + LC in whole epidermal preparations it was 
necessary to develop an appropriate gating strategy. However, during dispase 
digestion of excised epidermis a moderate degree of cell death occurs. To assess cell 
death and to therefore exclude the non-specific autofluorescence associated with 
dead cells the viability dye 7-AAD was employed and fluorescence analysed using 
CellQuestTmsoftware. Figure 3.1 (a) is a representative of data for adult epidermal 
suspensions and demonstrates the viability gating strategy. To distinguish viable 
cells in whole suspensions a gate was drawn around the live, 7-AAD - population. 
These viable cells were further gated to identify MHC-II+ cells in a PE-MHC-II 
fluorescence intensity versus forward scatter dot plot. Gates were drawn to include 
98% of MHC-II+ cells. As shown in Figure 3.1 (b) a discrete MHC-II + population is 
present. The high level of MHC-II expression suggests that LC are present in 
epidermal suspensions. This gating strategy was employed for all analyses. 
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Figure 3.1 Identification of viable MHC-II+ cells in adult epidermal suspensions. A 
gating strategy is shown for the identification of LC in epidermal suspensions. 
Epidermal suspensions were prepared from murine adult epidermis 6 weeks 
following birth by digestion with dispase and stained with anti-major 
histocompatibility complex class II (MHC-II). To select for viable cells, a gate was 
drawn around the 7-aminoactinomycin D-negative (7-AAD-) population (a). To 
select for MHC-II+ cells, a gate was placed to include 98% of MHC-II + cells. LC 
are represented by the discrete population of viable MHC-I[' cells (b). Data is 
representative of three or more experiments. 
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3.2.2 Phenotype of epidermal cells during the developmental period 
Prior to analysis of antigen uptake receptor expression, it was first essential to 
ascertain the phenotype of MHC-II+ epidermal cells. The primary aim was to 
confirm that the gating strategy did not contain T and B cells but also to assess if LC 
express the lineage markers CD4, CD8 and B220 during the developmental period. 
3.2.2.1 MHC-II expression on viable LC during the developmental period 
To assess the expression of MHC-II during the developmental period, PE-conjugated 
anti-MHC-II was used. Figure 3.2 is a representative experiment, where the 
expression of MHC-II on LC from 4-, 7- and 14-day- and 6-week-old epidermis is 
shown. It is evident that MHC-II+ cells are identifiable at 4 days following birth and 
that the level of expression increases with age. The mean fluorescence intensity 
demonstrated by adult LC is 2-fold greater than that associated with neonatal LC. 
This suggests that adult LC express more surface MHC-II than neonatal LC. 
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Figure 3.2 MHC-II expression on viable LC during the developmental period. 
Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of the antigen presentation molecule MHC-II. The filled 
histogram represents the profile of anti-MHC-II antibody staining. The open 
histogram represents binding of the isotype-matched control antibody. The mean 
fluorescence intensity of anti-MHC-II staining is shown in parenthesis at the top 
right hand corner of each histogram. Data is representative of three or more separate 
experiments. 
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3.2.2.2 Expression of CD4 and CD8 on viable MHC-It LC during the 
developmental period. 
To confirm the gating strategy to identify LC amongst the epidermal population did 
not contain cells with other lineage markers, staining for CD4 and CD8 was 
undertaken. By carrying out such analyses it was also possible to ascertain if LC 
express T cell surface molecules during development. It has been previously 
demonstrated that some subtypes of dendritic cells can express low levels of CD4 or 
CD8. Figure 3.3 and 3.4 summarises the CD4 and CD8 expression on MHC-II + cells 
during development. It is evident that at no point in LC development do they express 
CD4 or CD8. The absence of these markers strongly argues for the LC phenotype of 
MHC-II+ and demonstrates that there is no contamination of epidermal preparations 
with CD4 or CD8 T cells. It also demonstrates that, during the developmental period, 
Langerhans cells do not display a transient expression of CD4 or CD8. 
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Figure 3.3 CD4 expression on viable MHC-II + LC during the developmental period. 
Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the T cell marker CD4. The filled histogram 
represents the profile of anti-CD4 antibody staining. The open histogram represents 
binding of the isotype-matched control antibody. The mean fluorescence intensity of 
anti-CD4 staining is shown in parenthesis at the top right hand corner of each 
histogram. Data is representative of three or more separate experiments. 
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Figure 3.4 CD8 expression on viable MHC-II ± LC during the developmental period. 
Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the T cell marker CD8. The filled histogram 
represents the profile of anti-CD8 antibody staining. The open histogram represents 
binding of the isotype-matched control antibody. The mean fluorescence intensity of 
anti-CD8 staining is shown in parenthesis at the top right hand corner of each 
histogram. Data is representative of three or more separate experiments. 
74 
Ontogeny of Uptake Receptors 
3.2.2.3 Expression of B220 on viable MHC-It LC during the developmental period 
To determine if MHC-II ÷ contain a population of B cells, analysis of expression of 
the B cell marker B220 was employed. Figure 3.5 summarises B220 expression 
during development and demonstrates an absence of contaminating B cells. It is 
evident that during development MHC-II+ do not express B220. 
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Figure 3.5 B220 expression on viable MHC-II± LC during the developmental period. 
Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the B cell marker B220. The filled histogram 
represents the profile of anti-B220 antibody staining. The open histogram represents 
binding of the isotype-matched control antibody. The mean fluorescence intensity of 
anti-B220 staining is shown in parenthesis at the top right hand corner of each 
histogram. Data is representative of three or more separate experiments. 
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3.2.3 The ontogeny of antigen uptake receptors during the developmental period. 
The remainder of this chapter will focus on investigating the expression profile of a 
representative range of antigen uptake receptors essential for LC function. The 
expression of marmose binding, IgG and complement receptors was assessed in 
neonatal, juvenile and adult LC. 
3.2.3.1 DEC-205 expression on viable MHC-It LC during the developmental period 
To characterise the capacity of LC during development to bind antigen that contains 
mannose residues, epidermal suspensions were prepared from 4-, 7- and 14-day- and 
6-week-old mice, and stained for expression of the lectin receptor DEC-205. As 
evident in Figure 3.6, DEC-205 was absent on LC from 4-day-old epidermis. As the 
epidermal network matured there was a gradual increase in the level of expression, 
with DEC-205 identified at 7 days following birth. By day 14 the level of expression 
was comparable with that demonstrated within adult epidermis. 
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Figure 3.6 DEC-205 expression on viable MHC-If+ LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the mannose-specific uptake receptor DEC-
205. The filled histogram represents the profile of anti-DEC-205 antibody staining. 
The open histogram represents binding of the isotype-matched control antibody. The 
mean fluorescence intensity of anti-DEC-205 staining is shown in parenthesis at the 
top right hand corner of each histogram. Data is representative of three or more 
separate experiments. 
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3.2.3.2 Analysis of Langerin expression on permeabilised LC during the 
developmental period 
To further assess expression of mannose-type lectin receptors during development, 
permeabilised epidermal suspensions were prepared from neonatal, juvenile and 
adult mice and analysed for expression of lectin-specific receptor Langerin. It is 
crucial to permeabilise the cells as the anti-mouse Langerin antibody only binds 
intracellular portions of the molecule. Figure 3.7 demonstrates permeablisation 
resulted in positive staining for the receptor. Langerin expression was first identified 
at 4 days following birth, however the level of staining was only slightly higher than 
the level of binding associated with the isotype-matched control. As such the level 
of expression at 4 days following birth was low. As the epidermal network matured 
there was a gradual increase in the level of expression with a two-fold increase in 
intensity of anti-Langerin staining by day 7 following birth. By day 14 the level of 
expression had increased and was comparable with staining demonstrated in adult 
epidermis. 
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Figure 3.7 Langerin expression on viable, permeabilised MHC-II+ LC during the 
developmental period. Epidermal suspensions were prepared from mice at 4 days 
(top panel), 7 days (second top panel), 14 days (second bottom panel) and 6 weeks 
(bottom panel), permeabilised and stained for expression of MI-1C-II and the 
mannose-specific uptake receptor Langerin. The filled histogram represents the 
profile of anti-Langerin antibody staining. The open histogram represents binding of 
the isotype-matched control antibody. The mean fluorescence intensity of anti-
Langerin staining is shown in parenthesis at the top right hand corner of each 
histogram. Data is representative of three or more separate experiments. 
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3.2.3.3 Analysis of CD16/32 expression of viable MHC-It LC during the 
developmental period. 
Opsonisation of particulate antigen, whether through deposition of antibody such as 
IgG or activated complement components such as C3b, increases the likelihood of 
uptake and clearance (Esposito Farese et al. 1995; Galon et al. 1997). The potential 
of LC to bind opsonised antigen was first investigated by assessing the expression of 
the IgG receptor CD 16/32 on LC isolated from neonatal, juvenile and adult mice. 
Analysis of cell suspensions via flow cytometry demonstrated that CD16/CD32 was 
present from an early stage in epidermal development, with LC isolated from 4-day-
old epidermis associated with a moderate level of expression (Figure 3.8). It is also 
evident that as the animal matured the level of expression fluctuated, with LC from 
epidermis of 4-day- and 6-week-old mice associated with greater fluorescence 
intensity than LC from 7-day- and 14-week-old mice. 
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Figure 3.8 CD16/32 expression on viable MHC-II+ LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the IgG receptor CD16/32. The filled 
histogram represents the profile of binding of the anti-CD 16/32 antibody. The open 
histogram represents binding of the isotype-matched control antibody. The mean 
fluorescence intensity of anti-CD 16/32 staining is shown in parenthesis at the top 
right hand comer of each histogram. Data is representative of three or more separate 
experiments. 
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3.2.3.4 Analysis of CD1lb expression on viable MHC-It LC during the 
developmental period. 
To further assess the expression of opsonin receptors during development, LC 
isolated from neonatal, juvenile and adult epidermis were analysed for expression of 
CD1 1 b, a component of complement receptor 3 (CR3) (Okada et al. 1988). Figure 
3.9 demonstrates a discrete population of MHC-II +CD1 1 b+ cells isolated from 4-day-
old mice. However by day 7 two populations of MHC-II + were present, MHC-
II+CD1 1b and MHC-II +CD11b+ . It is also evident that as the epidermal network 
matured there were fluctuations in the level of expression associated with the MHC-
II+CD11b+ population, with the highest level of expression associated with LC 
isolated from 14-day-old mice. By 6 weeks following birth the level of expression 
on CD! 1b11  LC was decreased and similar to that expressed by LC isolated from 4- 
day-old mice. 
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Figure 3.9 CD1 lb expression on viable MHC-II+ LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the complement receptor CD11b. The filled 
histogram represents the profile of binding of the anti-CD1 1 b antibody. The open 
histogram represents binding of the isotype-matched control antibody. The mean 
fluorescence intensity of anti-CD1 lb staining is shown in parenthesis at the top right 
hand corner of each histogram. Data is representative of three or more separate 
experiments. 
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3.2.3.5 Analysis of CD18 expression on viable MHC-It LC during the 
developmental period 
To further characterise the expression of the complement receptors during 
development, LC isolated from neonatal, juvenile and adult epidermis were analysed 
for expression of CD 18, the second component of CR3 (Okada et al. 1988). Figure 
3.10 demonstrates a discrete CD 18 positive population present at each stage during 
development. Results also demonstrate that the level of expression increased during 
development until day 14, when the level of expression was similar to that expressed 
by LC isolated from 6-week-old mice. 
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Figure 3.10 CD18 expression on viable MHC-II + LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the integrin CD18. The filled histogram 
represents the profile of binding of the anti-CD18 antibody. The open histogram 
represents binding of the isotype-matched control antibody. The mean fluorescence 
intensity of anti-CD 18 staining is shown in parenthesis at the top right hand corner of 
each histogram. Data is representative of three or more separate experiments. 
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3.2.3.6 Analysis of CD11c expression on viable MHC-11 + LC during the 
developmental period 
To further assess the expression of opsonin receptors during development, LC 
isolated from neonatal, juvenile and adult epidermis were analysed for expression of 
CD! lc, a component of CR4. Figure 3.11 demonstrates that at no point during LC 
development were MHC-II + cells positive for CD1 lc. 
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Figure 3.11 CD1 1 c expression on viable MHC-II+ LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the complement receptor CD1 1 c. The filled 
histogram represents the profile of binding of the anti-CD1 1 c antibody. The open 
histogram represents binding of the isotype-matched control antibody. The mean 
fluorescence intensity of anti-CD1 1 c staining is shown in parenthesis at the top right 
hand corner of each histogram. Data is representative of three or more separate 
experiments. 
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3.2.3.7 Analysis of CD14 expression on viable MHC± LC during the developmental 
period 
To characterise the expression of LPS receptors during development, LC isolated 
from neonatal, juvenile and adult epidermis were analysed for expression of CD 14. 
Figure 3.12 demonstrates LC were negative for the LPS receptor CD14. This 
suggests that LC do not bind LPS via CD 14. It is important to note that dermal DC 
express CD 14, thus this result also demonstrates that contamination with dermal DC 
did not occur during isolation of epidermal cells. 
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Figure 3.12 CD14 expression on viable MHC-II± LC during the developmental 
period. Epidermal suspensions were prepared from mice at 4 days (top panel), 7 days 
(second top panel), 14 days (second bottom panel) and 6 weeks (bottom panel) and 
stained for expression of MHC-II and the LPS receptorCD14 expression. The filled 
histogram represents the profile of binding of the anti-CD 14 antibody. The open 
histogram represents binding of the isotype-matched control antibody. The mean 
fluorescence intensity of anti-CD 14 staining is shown in parenthesis at the top right 
hand corner of each histogram. Data is representative of three or more separate 
experiments. 
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3.3 Discussion 
Langerhans cells are the resident APC of the epidermis and are critical to the 
induction of immunity to cutaneous antigen (Shelley and Juhlin 1976; Shelley and 
Juhlin 1977). Following capture of antigen LC migrate to regional LN where they 
trigger nave T cell activation (Kripke et al. 1990). One pathway employed by LC to 
internalise antigen is receptor-mediated endocytosis, involving the internalisation of 
antigen following binding of antigenic peptides to surface receptors (Aderem and 
Underhill 1999; Stepney and De Camilli 2000). LC express a range of uptake 
receptors enabling recognition of a vast array of possible antigens, of both extrinsic 
and intrinsic origin (Aderem and Underhill 1999; Stepney and De Camilli 2000). LC 
express CD 16/32 that facilitates efficient capture of IgG complexed antigen 
(Esposito Farese et al. 1995; Fanger et al. 1996). Terminal mannose residues, a 
common component of microbial membranes, are recognised by the C-type lectin 
receptors DEC-205 and Langerin (Kato et al. 1998; Kato et al. 2000; Valladeau et al. 
2000; Valladeau et al. 2003), whilst complement-opsonised antigens are bound by 
CD11b/CD18 and CD11c/CD18 (Okada et al. 1988). Following receptor binding, a 
cascade of events is initiated, leading to the internalisation, processing and 
subsequent presentation of antigen for T cell activation (Taylor et al. 1991; Peguet-
Navarro et al. 1992; Dai et al. 1993). It can be seen that expression of a broad 
spectrum of antigen-specific receptors is crucial to APC function. The present study 
sought to investigate the capacity of LC to bind antigen during the developmental 
period. The receptors analysed in this study were selected to represent the capacity to 
internalise the major classes of antigens, including antibody and complement-
complexed antigens, mannose residues and LPS. By assessing a representative panel 
of receptors it was possible to investigate the potential of LC to internalise antigen 
via receptor-mediated endocytosis. 
To determine the expression of receptors on LC it was first necessary to identify LC 
in whole epidermal suspensions. As sorting or density gradient centrifugation can 
lead to unwanted activation of freshly isolated cells, LC in epidermal cell 
preparations were identified on the basis of MHC-II expression. Results herein 
demonstrate that MHC-II+ cells were present at 4 days following birth, with the level 
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of expression gradually increasing with maturation. This increase in expression may 
reflect a redistribution of MHC-II from a cytoplasmic location to the cell membrane 
and dendrites during development. This hypothesis is supported by previous studies 
that demonstrated that in situ, LC exhibit rounded cell morphology and an absence of 
MHC-II stained dendritic processes (Dewar et al. 2001). These results suggest that 
during the early stages of development the epidermal network is immature. To 
determine if this immaturity of the epidermal network impacted on the capacity to 
bind antigen, LC isolated from neonatal, juvenile and adult epidermis were analysed 
for expression of a range of uptake receptors. 
The ability to bind mannose is of particular importance to APC function, as the 
majority of glycoproteins derived from bacteria and yeast are mannosylated (Buentke 
et al. 2000). To facilitate binding, LC express members of the C-type lectin family 
of receptors, including DEC-205 and Langerin (Kato et al. 1998). DEC-205 has 
been suggested to initiate uptake and strongly enhance MHC-restricted presentation 
of antigen, and is up regulated during maturation (Reis et al. 1993; Kato et al. 1998). 
Analysis of Langerin and DEC-205 expression on LC isolated from 4-day-old 
epidermis demonstrated a marked decease in receptor expression compared to LC 
isolated from adult epidermis. Results also demonstrate a gradual increase in receptor 
expression during development. By day 14 following birth the level of expression 
was parallel to that observed on LC isolated from adult epidermis. These results are 
supported by previous studies from this department analysing the expression of lectin 
receptors on LC in situ, utilising epidermal sheets from 4-day and 6-week-old mice. 
These results suggest that the functional maturity of LC is acquired during 
development. The factors influencing receptor up-regulation are not fully 
characterised but it is highly plausible that the external milieu may play an important 
role (Longoni et al. 1998). The recent finding from our research group that 
demonstrated the maturation status of the epidermal network can be accelerated by 
topical application of antigen supports this hypothesis (Wozniak. BSc(Hons) thesis). 
It is possible that LC resident in neonatal epidermis learn from their environment 
during antigen capture and up-regulate receptor surface expression accordingly. 
Aside from antigen exposure, the presence of certain cytokines can elicit alterations 
in receptor expression (Bieber et al. 1989; Doyle et al. 1994; Brown and Hural 
1997). Longoni and colleagues demonstrated a heightened uptake of mannosylated 
92 
Ontogeny of Uptake Receptors 
antigens in monocyte-derived DC exposed to the immuno-suppressive cytokine IL-
10 during culture. When added to culture during the last 24 hours of a 7-day culture, 
IL-10 elicited an increase in the uptake of fluorescently labelled FITC-dextran. This 
increase in endocytosis was mirrored by a 4-fold increase in expression of the 
marmose receptor (Longoni et al. 1998). It was postulated that due to the increased 
endocytic activity of immature DC antigen would be effectively cleared from the 
extracellular environment, contributing further to the tolerogenic effect of IL-10. It 
would appear that these findings contradict those of Faulkner and collegues 
(Faulkner et al. 2000a). Using bone marrow derived DC it was demonstrated that IL-
10 did not induce any significant increase in phagocytosis. However this disrepency 
may be reflected in the two distinct uptake pathways investigated in these two 
studies. FITC-dextran was utilised in the Longoni study (Longoni et al. 1998) as an 
indication of receptor-mediated endocytosis of small particulate antigen. 
Phagocytosis in contrast involves the uptake of large particulate antigen, therefore 
IL-10 may exert differing effects, depending on the pathway utilised by DC to 
internalise antigen. By 6 weeks of age the epidermal network has matured to the 
extent that antigen exposure results in maturation of LC to full APC potency, 
possibly involving a shift in cytokine secretion to pro-inflammatory cytokines. 
Although it is highly possible that IL-10 is in the extracellular milieu during 
development, LC isolated from 4-day-old epidermis do not express DEC-205. 
Chang-Rodriguez demonstrated that neonatal epidermal leukocytes do not express 
IL-10 receptor till 5 days following birth (Chang-Rodriguez et al. 2004). As a 
consequence it is unlikely that LC isolated from mice 4 days following birth will 
have up-regulated DEC-205 in response to IL-10. However as the epidermal 
network matures there is an up-regulation of DEC-205, possibly as a result of 
upregulation of IL-10 receptors. This hypothesis is supported by the finding that 
DEC-205 is present 7 days following birth. By day 14 following birth the level of 
DEC-205 expression remains constant. It is possible that secretion of IL-10 is down-
regulated at this stage in development, enabling up-regulation of APC potency 
following exposure to antigen. 
The absence of DEC-205 and reduced expression of Langerin suggests that during 
the early neonatal period LC are significantly reduced in their capacity to internalise 
marmose-conjugated antigen via a receptor-mediated pathway. In contrast receptors 
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for opsonised antigen are expressed from an early age. What remains unclear is why 
mannose specific receptors are absent during early development yet opsonin 
receptors for IgG and C3b are expressed from an early age. This phenomenon may 
be explained by discussing the nature of antigen and antibody classes present in the 
extracellular environment during the early developmental period. IgG is capable of 
crossing through epithelia and traversing the placenta (Adkins et al. 2004b). As such 
maternal IgG provides immunity for the first few months of life when the newborn is 
incapable of producing antibodies (Nelson et al. 1994; Kovarik and Siegrist 1998; 
Siegrist 2001). These immunoglobins can then pass through the intestinal epithelia of 
the neonate and into the blood stream. Once in the blood stream and subsequently in 
the tissues, maternal antigen-specific IgG is available to opsonise foreign antigen. 
Expression of IgG receptors during the neonatal period would be expected to enable 
responsiveness to maternal IgG complexed antigen. This study has demonstrated 
that CD 16/32, the receptor responsible for IgG recognition (Espositofarese et al. 
1995; Galon et al. 1997; Cohen-Solal et al. 2004), is expressed during the early 
neonatal period, at a level comparable with LC isolated from adult epidermis. Via 
expression of CD16/32 neonatal LC retain the capacity to internalise opsonised 
antigen. It is highly possible that via expression of CD 16/32 the neonate is protected 
at a time when their developing immune system is insufficient. Expression of 
CD 16/32 may also aid in the regulation of immune responses as maternal IgG will 
preferentially bind foreign antigen and not self tissue (Esposito Farese et al. 1995; 
Fanger et al. 1996). 
In a similar fashion as CD 16/32, the C3b receptor CD1 1 b is expressed during the 
developmental period, and may offer additional protection at a time when the 
neonatal immune system is developing. Microbial surfaces can activate complement 
via the alternative pathway without the necessity of bound antibody (Koppenheffer 
1987). One can propose that if antigens were to penetrate the neonatal epidermal 
barrier, LC may use complement receptors to bind microbial antigens until the more 
specific, carbohydrate recognition receptors such as DEC-205 are expressed. An 
alternative hypothesis is that neonatal LC may utilise complement receptors to 
maintain tolerance to self-tissue. One of the antigens that can be opsonised by C3b is 
apoptotic debris, and it is now accepted that uptake of apoptotic bodies via C3b on 
DC results in antigen-specific immune suppression (Nauta et al. 2004). This is 
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essential to ensure non-reactivity to self-antigens and its importance following 
cutaneous UV exposure is well characterised (Aubin 2003). The transition of 
neonatal epidermis to mature adult skin involves tissue remodelling and formation of 
new epidermal layers (Haake and Polakowska 1993). As a consequence of this high 
cell turnover and death, apoptosis is to be expected (Haake and Cooklis 1997; Haake 
et al. 1997). Expression of receptors for C3b opsonised apoptotic cells ensures that 
self-tolerance during infancy is maintained, whilst the absence of receptors for 
mannosylated antigens and LPS ensures that the reactivity to harmless skin 
commensals is avoided. 
Interestingly, analysis of CD1lb expression also demonstrated alterations in the 
staining profile with maturation of the epidermis. At 4 days following birth a single 
population of MHC-II+CD1 lb + cells was identified. By day 7 two populations were 
present, CD11b - and CD11b+. Little evidence exists in the literature on the 
expression of CD1 lb in the developing epidermis, however due to a single 
population of CD1 lb positive cells in the epidermis at 4 days following birth it is 
possible that expression of CD1lb may correlate with induction of immune 
suppression. As the epidermal network matures there is an alteration in the 
expression profile of both MHC-II and CD1 1 b. It is possible that as the epidermis 
matures there is a transition from foetal/neonatal LC that emigrate into the epidermis 
to neonatal/adult LC consisting of both CD1 1 b + and CD1 1 b". As the ability to induce 
immunity increases with development these results suggest that the functional 
maturity of the epidermal network is acquired during development. It is not possible 
to determine from this study if the staining profile from 7 days following birth 
represents two separate cell populations or a down regulation of expression on a 
subset of cells during development. However, it is interesting to speculate that 
CD1 lb expression is influenced by antigen encountered in the periphery. During the 
neonatal period antimicrobial substances present on the skin surface combined with a 
dramatic thickening of the keratin layer, enhance the physical protection provided by 
the skin. As a consequence it can be proposed that the proportion of potential 
pathogens gaining access to the underlying epidermis is less compared to adult 
counterparts. In contast, during the neonatal period there is a greater proportion of 
self-antigen than potential pathogens in the extracellular environment due to 
apoptotic debris generated during postnatal modification of the epidermis (as 
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reviewed by Adkins et al. 2004). As the antigenic composition of the epidermis 
shifts to mature adult epidermis, possible receptors for self-antigen, such as CD1 lb 
are downregulated on a proportion of cells whilst DEC-205 and Langerin become 
more aparent. 
This chapter has furnished further evidence of a divergence in LC function during 
the early neonatal period, demonstrated by a decreased capacity to recognise 
mannosylated antigens. It is likely that the external environment is a key factor that 
drives immune function. During the early neonatal period the infant is subject to a 
vast array of possible antigens, ranging from innocuous commensal organisms, and 
self-antigen to potentially deleterious pathogens that manage to breech the thickened 
keratin layer. If neonatal LC possessed the ability to respond vigorously to all 
antigens, this would lead to a constant state of hyper-responsiveness. Such responses 
could lead to tissue and organ damage through acute inflammation as well as 
progression of autoimmune disorders. Therefore, neonatal LC regulate such 
responses by the flexible expression of surface receptors. The absence of mannose 
specific receptors translates to an ability to regulate and hence avoid hyper-
responsiveness to skin commensals. In contrast, by expressing receptors for 
immunoglobins and opsonins translates to an ability to induce immunity to antigens 
opsonised by maternal antibody and tolerance to self-tissues respectively. As the 
neonatal immune system evolves in competence the external environment influences 
the expression of mannose specific receptors, as reflected in the up-regulation of 
DEC-205 following exposure to antigen on the day of birth. As a consequence, the 
immune system can maintain low responsiveness under non-threatening conditions 
but mature responses when the level of danger is high. 
In conclusion, this chapter has shown a reduction in both classes of C-type lectin 
receptors, DEC-205 and Langerin, during the early neonatal period. As a 
consequence of reduced receptor expression I hypothesise that neonatal LC are 
associated with a decreased capacity to internalise antigen via a receptor-mediated 
pathway. As the amount of antigen presented in the context of MHC-II has 
important implications on the generation of effective immunity (Langenkamp et al. 
2002) the pathways utilised to bind and internalise exogenous antigens has important 
biological implications on the generation of immune suppression. 
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Chapter 4 
Characterisation of Antigen Uptake by Epidermal Langerhans Cells 
During the Developmental Period. 
4.1 Introduction 
Epidermal LC possess distinct endocytic pathways that accommodate a range of 
possible of antigens, including small and large particulate antigens, as well as soluble 
peptides (Steinman et al. 1999). Soluble antigen is internalised in the fluid phase by 
non-specific pinocytosis, which can occur via two distinct mechanisms (Watts and 
Marsh 1992). Small molecules (-0.1 1.1m) are internalised via clathrin-coated pits 
(micropinocytosis). Uptake of larger vesicles (0.5-3 1.1m) is mediated by 
cytoskeleton-dependent membrane ruffling (macropinocytosis) (Watts and Marsh 
1992). Macropinocytosis enables LC to engulf a large volume of fluid, from which 
soluble antigens are then concentrated for processing and presentation or exocytosis 
(Sallusto et al. 1995). 
Small particulate antigens can be internalised via receptor-mediated endocytosis, 
which involves uptake of antigen following recognition by membrane receptors 
(Slepnev and De Camilli 2000). Motifs that can be recognised by uptake receptors 
include activated complement components (i.e. CD11b/CD18), IgG complexed 
antigens (CD 16/32) and terminal mannose residues (i.e. Langerin and DEC-205) 
(Reis et al. 1993; Esposito Farese et al. 1995; Fanger et al. 1996; Kato et al. 1998; 
Valladeau et al. 2003). Antigens too large to be internalised via receptor-mediated 
endocytosis can be engulfed via phagocytosis (Reis et al. 1993). Phagocytosis is the 
ATP-dependent, cytoskeleton-mediated ingestion of antigen following binding of 
microbial peptides to LC surface receptors (Reis et al. 1993). Phagocytic receptors 
are unique in their capacity to differentiate between self and prokaryotic antigens, 
including LPS and peptidoglycan (Aderem and Underhill 1999; Takeuchi et al. 1999; 
Aderem and Ulevitch 2000; Werts et al. 2001). Following receptor binding and 
phagocytosis, a cascade of events is initiated that leads to augmentation of the 
immune response by inducing secretion of pro-inflammatory cytokines and up-
regulation of costimulatory molecules (Winzler et al. 1997). 
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Chapter 3 demonstrated that LC from 4-day-old epidermis lack expression of the 
mannose-binding receptor DEC-205 and express reduced levels of Langerin when 
compared to adult counterparts. These results suggest that during the early neonatal 
period the capacity of LC to uptake antigen via a mannose-type receptor-mediated 
pathway is diminished. The central aims of this chapter were to assess the 
acquisition of endocytic function during development and to determine if a 
correlation exists between expression of antigen uptake receptors and in vitro antigen 
uptake. To do so the uptake of soluble, and small and large particulate antigens was 
assessed in neonatal, juvenile and adult mice. 
4.2 Results 
4.2.1 Characterisation of receptor-mediated endocytosis during the developmental 
period. 
Fluorescein isothiocyanate-dextran (FITC-dextran) is a widely used fluorescent 
antigen for the study of receptor-mediated endocytosis. It is believed that FITC-
dextran is internalised via mannose-type receptors as pre-incubation of cells with 
bacterial monosaccharides such as mannose competitively inhibit uptake (Reis et al. 
1993; Lutz et al. 1997). FITC-dextran was employed in this chapter to determine the 
capacity of LC to internalise antigen via a receptor-mediated pathway during the 
developmental period. 
4.2.1.1 Identification of FITC-dextran uptake by adult MHC-IT - epidermal LC. 
In order to evaluate the capacity of LC to internalise antigen via a receptor-mediated 
pathway it was first necessary to develop an appropriate gating strategy to identify 
LC in epidermal suspensions. Epidermal suspensions were prepared from 6-week-old 
epidermis and incubated at 37°C with FITC-dextran. At set time points, a sample of 
suspension was removed, washed extensively to remove free antigen and LC 
identified via staining with anti-MHC-II antibody. The fluorescence intensity of 
epidermal cells was then assessed via flow cytometry. 
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The strategy for gating viable cells outlined in chapter 3.2.1 was employed to 
identify viable MHC-II + in adult epidermal suspensions. Briefly, to select for viable 
cells, a gate was drawn around the live, 7-AAD" population on a 7AAD versus cell 
size dot plot. These viable cells were further gated to identify MHC-II + cells in a 
PE-MHC-II fluorescence intensity versus forward scatter dot plot. The viability gate 
was used to construct a third dot plot of MHC-II-PE versus FITC-dextran fluorescent 
intensity (Figure 4.1 a). Figure 4.1 (a) demonstrates a single MHC-II + FITC-
dextran+ population present at each time point during incubation. It must also be 
noted that a population of MHC-II - cells are also positive for FITC-dextran. This 
population is most likely to be keratinocytes. As keratinocytes do not express 
mannose specific-receptors, it is possible that the FITC-dextran fluorescence 
demonstrated by these cells is either a consequence of antigen associating with the 
cell membrane in a non-specific manner, or that keratinocytes are able to internalsie 
FITC-dextran in the fluid phase. To determine the FITC-dextran fluorescence 
associated with this population a second gate was constructed. This gate was used to 
create a histogram of cell count versus FITC-dextran fluorescence intensity (Figure 
4.1 (b). Using CellQuestTM analysis the mean fluorescence intensity of each peak can 
be determined, and is shown in parentheses. Figure 4.1 (b) demonstrates a time 
dependent increase in the FITC-dextran fluorescence associated with MHC-II+ LC. 
These results show uptake of antigen by LC in a time dependent manner. 
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Figure 4.1 Identification of FITC-dextran uptake by MHC-IT± LC in adult epidermal 
suspensions. Epidermal suspensions were prepared from 6-week-old mice and 
incubated with FITC-dextran at 37°C. At 5 minutes (top panel), 10 minutes (middle 
panel) and 120 minutes (bottom panel) cells were removed, washed and stained for 
MHC-II expression. Using CellQuest software a gate was drawn around each FITC-
dextran+MHC-II+ population (a). This gate was used to construct a histogram of 
FITC-dextran fluorescence intensity versus cell count (b). FITC-dextran mean 
fluorescence intensity is shown in parenthesis at the top right hand corner of each 
histogram. Data is representative of three or more separate experiments. 
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4.2.1.2 Uptake of FITC-dextran by epidermal MHC-H + LC during the developmental 
period 
To assess the capacity of LC to internalise antigen via a mannose-type receptor-
mediated pathway during the developmental period, epidermal suspensions from 4-, 
7- and 14-day- and 6-week-old mice were incubated at 37°C and 4°C with FITC-
dextran. The 4°C sample was included as an indication of non-specific or non-
metabolically active binding of antigen to cells. Figure 4.2 demonstrates that LC 
isolated at each age point were capable of accumulating FITC-dextran, demonstrated 
by a time dependent increase in FITC-dextran fluorescence at 37°C. It was also 
evident that there were alterations in fluorescence intensity at 37°C with age of the 
animal. The fluorescence intensity associated with LC isolated from 6-week-old 
mice was greater than LC from 4-day-old mice, however the intensity at 4°C was 
also significantly higher (Figure 4.3). 
101 
Characterisation of Antigen Uptake 
Figure 4.2 Uptake of FITC-dextran by MHC-II + LC during development. In vitro 
uptake of FITC-dextran at 37°C and 4°C was assessed in epidermal cells isolated 
from mice at 4 days (top panel), 7 days (second top panel), 14 days (second bottom 
panel) and 6 weeks (bottom panel) following birth. The filled squares represent the 
fluorescence intensity at 37°C. The open squares represent the fluorescence intensity 
at 4°C. Data is representative of two or more experiments. 
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Figure 4.2 Uptake of FITC-dextran by MHC-II+ LC during development 
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Figure 4.3 Uptake of FITC-dextran by MHC-II + LC isolated from 4-day and 6- 
week-old mice. In vitro uptake of FITC-dextran via receptor-mediated endocytosis at 
37°C and 4°C was assessed in epidermal cells isolated from mice at 4 days and 6 
weeks following birth. The filled squares represent the fluorescence intensity at 
37°C. The open squares represent the fluorescence intensity at 4°C. Data is 
representative of two or more experiments. 
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4.2.1.3 Ratio daia of FITC-dextran uptake by MHC-It epidermal LC during the 
developmental period. 
In order to determine metabolically active uptake of FITC-dextran it was necessary 
to account for fluctuations in fluorescence intensity at 4°C. To account for these 
variations, the fluorescence intensity at 37°C was divided by the intensity at 4°C, 
generating a ratio at each time point (Figure 4.4). When ratio values were calculated 
it was evident that in comparison to LC isolated from 6-week-old epidermis, LC 
from 4-day-old epidermis continued to internalise antigen over a longer period of 
time. It can be seen from the ratio data that the end point of antigen uptake is 
reduced with age, as LC from 4-day-old mice reached a higher ratio value than 6- 
week-old mice. 
105 
U U 
3 - 
2 - 
Characterisation of Antigen Uptake 
4 - 
I 	I 
0 
	
40 80 
Tune (minutes) 
1 , 
120 
—0— Adult 
Day 4 
Figure 4.4 Ratio data for uptake of FITC-dextran by MHC-II + LC during 
development. In vitro uptake of FITC-dextran at 37°C and 4°C was assessed in 
epidermal cells isolated from mice at 4 days and 6 weeks following birth. To account 
for any variations in non-specific or receptor binding of the antigen at 4°C, the mean 
fluorescence intensity at 37°C was divided by the mean fluorescence at 4°C, 
generating a ratio at each time point. To directly compare differences between the 
different age points, ratio data was calculated for each time point for each age group. 
As shown, LC from 4-day-old mice took longer to reach maximum uptake compared 
with adult LC. Each value is representative of three separate experiments. 
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4.2.2 Characterisation of macropinocytosis during the developmental period. 
Lucifer Yellow (LY) was utilised to assess the capacity for macropinocytosis during 
the developmental period. It has been previously demonstrated that pre-incubation 
with mannose and mannan does not inhibit uptake of LY, and as such LY is accepted 
to be a definitive tracer for fluid phase macropinocytosis (Sallusto et al. 1995). 
4.2.2.1 Uptake of Lucifer Yellow by epidermal MHC-I1 + LC during the 
developmental period 
To assess the capacity of LC to internalise antigen via macropinocytosis during the 
developmental period, epidermal suspensions from 4-, 7- and 14-day- and 6-week-
old mice were incubated with LY at 37°C and 4°C. Using the same gating protocol 
outlined in 4.1, LY fluorescence intensity was determined at each time point for all 
age groups. Figure 4.5 demonstrates that LC isolated at each age point were capable 
of accumulating LY, supported by a time-dependent increase in LY fluorescence at 
37°C. It was also evident that there was an increase in fluorescence intensity at 37°C 
with age of the animal. Figure 4.6 demonstrates that the fluorescence intensity 
associated with LC isolated from 6-week-old mice was greater than LC from 4-day-
old mice, however the intensity at 4°C was also significantly higher. 
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Figure 4.5 Uptake of Lucifer Yellow by MHC-II ÷ LC during development. In vitro 
uptake of Lucifer Yellow at 37°C and 4°C was assessed in epidermal cells isolated 
from mice at 4 days (top panel), 7 days (second top panel), 14 days (second bottom 
panel) and 6 weeks (bottom panel) following birth. The filled squares represent 
Lucifer Yellow fluorescence intensity at 37°C. The open squares represent the 
Lucifer Yellow fluorescence intensity at 4°C. Data is representative of two or more 
experiments. 
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Figure 4.6 Uptake of Lucifer Yellow by MHC-II + LC isolated from 4-day and 6- 
week-old mice. In vitro uptake of Lucifer Yellow at 37°C and 4°C was assessed in 
epidermal cells isolated from mice at 4 days and 6 weeks following birth. The filled 
squares represent the fluorescence intensity at 37°C. The open squares represent the 
fluorescence intensity at 4°C. Data is representative of two or more experiments. 
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4.2.2.2 Ratio data of Lucifer Yellow uptake by epidermal MHC-It LC during the 
developmental period. 
To account for variations in antigen binding at 4°C, LY fluorescence intensity at 
37°C was divided by the intensity at 4°C. This generated a ratio value for both age 
groups throughout the assay (Figure 4.7). When ratio values were calculated it was 
evident that whilst the initial rate of uptake was comparable between neonatal and 
adult LC, neonatal LC continued to internalise antigen over a longer period of time. 
This translated to a higher ratio value at end point compared to adult counterparts, 
with LC from 4-day-old mice obtaining a higher ratio value than LC from 6-week-
old mice. 
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Figure 4.7 Ratio data for uptake of Lucifer Yellow by MHC-II LC during 
development. In vitro uptake of Lucifer Yellow via at 37°C and 4°C was assessed in 
epidermal cells isolated from mice at 4 days, 7 days and 6 weeks following birth. To 
account for any variations in non-specific or receptor binding of the antigen at 4°C, 
the mean fluorescence intensity at 37°C was divided by the mean fluorescence at 
4°C, generating a ratio at each time point. To directly compare differences between 
the different age points, ratio data was calculated fir each point for each time point, 
as shown LC from 4-day-old mice took longer to reach maximum uptake compared 
with LC isolated from 6-week-old mice. Each value is representative of three 
separate experiments. 
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4.2.3 Effect of mannan, mannose and wortmannin on the uptake of FITC-dextran by 
MHC-II+ epidermal LC during the developmental period. 
To ascertain the pathway employed to internalise FITC-dextran, FITC-dextran 
uptake assays were repeated in the presence of inhibitors of receptor-mediated 
endocytosis and macropinocytosis. To competitively block antigen uptake via 
mannose-type receptors, LC from 4-day- and 6-week-old mice was pre-incubated 
with the bacterial monosaccharides marman and mannose. To inhibit fluid phase 
uptake, cells were incubated with the phosphatidylinositol 3-kinase inhibitor 
wortmannin. Figure 4.8 is a representative of the percent decrease in FITC-dextran 
uptake in various conditions, calculated as a percent when compared to epidermal 
suspensions incubated with antigen in the absence of inhibitor. When LC were pre-
incubated with mannan and mannose it was evident that FITC-dextran uptake by LC 
from 6-week-old mice was inhibited to a greater extent than LC from 4-day-old 
mice, with mannan associated with a greater inhibitory effect than mannose. It was 
also evident that the percent decrease was grater at 37°C than 4°C. In contrast, 
wortmannin inhibited FITC-dextran internalisation to a greater extent in LC from 4- 
day-old mice than from 6-week-old mice. Consequently, neonatal LC rely to a 
greater extent on macropinocytosis than endocytosis. In contrast, adult LC rely on 
endocytosis to a greater extent than macropinocytosis 
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Figure 4.8 The effect of mannan, mannose and wortmannin on the uptake of FITC-
dextran by adult and day 4 MHC-II + LC. The in vitro uptake of FITC-dextran in the 
continuous presence of mannan, mannose and wortmannin was assessed in epidermal 
cells isolated from mice at 4 days (filled squares) and 6 weeks (open squares) 
following birth. Cells were pre-incubated with inhibitors at either 37°C or 4°C prior 
to incubation with FITC-dextran at 37°C. The percent inhibition in uptake was 
calculated as the percentage decrease of FITC-dextran mean fluorescence intensity at 
37°C, in the presence of inhibitors, compared with cells that were not pre-incubated 
with inhibitors. Data is representative of two separate experiments. 
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4.2.4 Characterisation of phagocytosis during the developmental period 
To assess the potential of LC to phagocytose particulate antigen during the 
developmental period two fluorescently labelled particulate antigens were used; 
BODIPY-labelled Zymosan A and FITC-labelled E.coli. To investigate the effect of 
opsonisation on internalisation, particles were incubated with antigen-specific 
polyclonal IgG prior to incubation with epidermal suspensions. 
4.2.4.1 Phagocytosis of Zymosan by MHC-I1+ epidermal LC during the 
developmental period 
To characterise the capacity of LC to recognise and phagocytose particulate antigen 
via mannose-specific receptors epidermal suspensions from 4-, 7-, 14-day- and 6- 
week-old mice were incubated at 37°C and 4°C with the fluorescently labelled cell 
wall derivative of Saccharomyces cerevisiae (Zymosan A). The 4°C sample was 
included as an indication of non-specific or non-metabolically active uptake. Figure 
4.9 demonstrates that in contrast to receptor-mediated endocytosis, LC internalised 
very little antigen via phagocytosis, evident as a slight increase in fluorescence 
intensity with time. Results also indicate that the level of phagocytosis remains 
constant with development (Figure 4.10). It must also be noted that due to 
fluctuations in binding of antigen at 4°C the ratio plot appeared variable. 
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Figure 4.9 Uptake of Zymosan by MHC-II ÷ LC during development. In vitro uptake 
of Zymosan at 37°C and 4°C was assessed in epidermal cells isolated from mice at 4 
days (top panel), 7 days (second top panel), 14 days (second bottom panel) and 6 
weeks (bottom panel) following birth. The filled squares represent Zymosan-
BODIPY fluorescence intensity at 37°C. The open squares represent Zymosan-
BODIPY fluorescence intensity at 4°C. Data is representative of two or more 
experiments. 
116 
20 
16 
12 
8 
4 
—0-- 4"C 
Day 4 
37'C 
0 	60 120 180 240 
20 Day 7 
16 - 
12 - 
8 - 
4- 
37*C 
4'C 
37'C 
-0- 4" C 19:1!!r•C: 
0 	60 120 180 240 
Day 14 20 
I 
60 120 lee 240 
Adult 
37•C 
— 
20 - 
16 - 
12 - 
8 - 
4 - 
Characterisation of Antigen Uptake 
0 	60 120 180 240 
Time (minutes) 
Figure 4.9 Uptake of Zymosan by MHC-II LC during development 
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Figure 4.10 Uptake of Zymosan by MHC-II ± LC isolated from 4-day and 6-week-
old mice. In vitro uptake of Zymosan at 37°C and 4°C was assessed in epidermal 
cells isolated from mice at 4 days and 6 weeks following birth. The filled squares 
represent the fluorescence intensity at 37°C. The open squares represent the 
fluorescence intensity at 4°C. Data is representative of two or more experiments. 
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4.2.4.2 Ratio data of Zymosan uptake by epidermal MHC-Ir LC during the 
developmental period. 
To account for variations in antigen binding at 4°C, BODIPY fluorescence intensity 
at 37°C was divided by the intensity at 4°C. This generated a ratio value for both age 
groups throughout the assay (Figure 4.11). When ratio values were calculated it was 
evident that LC were associated with a low phagocytic capacity, evident as a slight 
increase in ratio values over the assay. 
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Figure 4.11 Ratio data for uptake of Zymosan by MHC-II + LC during development. 
In vitro uptake of Zymosan at 37°C and 4°C was assessed in epidermal cells isolated 
from mice at 4 days, 7 days and 6 weeks following birth. To account for any 
variations in non-specific or receptor binding of the antigen at 4°C, the mean 
fluorescence intensity at 37°C was divided by the mean fluorescence at 4°C, 
generating a ratio at each time point. To directly compare differences between the 
different age points, ratio data was calculated fir each point for each time point, as 
shown LC from 4-day-old mice took longer to reach maximum uptake compared 
with adult LC. Each value is representative of three separate experiments. 
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4.2.4.3 Phagocytosis of opsonised Zymosan by MHC-It epidermal LC during the 
developmental period 
To examine whether opsonisation increased the efficiency of phagocytosis, 
epidermal preparations prepared from 4-, 7-, 14-day and 6-week-old mice were 
pulsed with IgG-complexed Zymosan in vitro. Figure 4.12 demonstrates that there 
was no difference in the phagocytic capacity with age of the animal. LC isolated 
from 4-day-old mice were associated with the same profile of uptake as LC isolated 
from 6-week-old mice, indicating that the phagocytic potential of LC remained 
constant with age (Figure 4.13). Although LC express moderate levels of the 
receptor CD 16/32, known to recognise IgG, opsonisation did not increase the amount 
of antigen internalised in vitro. 
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Figure 4.12 Uptake of opsonised Zymosan by MHC-II + LC during development. In 
vitro uptake of opsonised Zymosan at 37°C and 4°C was assessed in epidermal cells 
isolated from mice at 4 days (top panel), 7 days (second top panel), 14 days (second 
bottom panel) and 6 weeks (bottom panel) following birth. The filled squares 
represent Zymosan-BODIPY fluorescence intensity at 37°C. The open squares 
represent Zymosan-BODIPY fluorescence intensity at 4°C. Data is representative of 
two or more experiments 
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Figure 4.12 Uptake of opsonised Zymosan by MHC-II + LC during development 
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Figure 4.13 Uptake of opsonised Zymosan by MHC-II + LC isolated from 4-day and 
6-week-old mice. In vitro uptake of opsonised Zymosan at 37°C and 4°C was 
assessed in epidermal cells isolated from mice at 4 days and 6 weeks following birth. 
The filled squares represent the fluorescence intensity at 37°C. The open squares 
represent the fluorescence intensity at 4°C. Data is representative of two or more 
experiments. 
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4.2.4.4 Ratio data Zymosan uptake by epidermal MHC-It LC during the 
developmental period. 
To account for variations in antigen binding at 4°C, BODIPY fluorescence intensity 
at 37°C was divided by the intensity at 4°C. This generated a ratio value for both age 
groups throughout the assay (Figure 4.14). When ratio values were calculated it was 
evident that LC were associated with a low phagocytic capacity, evident as a slight 
increase in ratio values over the assay. 
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Figure 4.14 Ratio data for uptake of opsonised Zymosan by MHC-II ± LC during 
development. In vitro uptake of opsonised Zymosan at 37°C and 4°C was assessed in 
epidermal cells isolated from mice at 4 days and 6 weeks following birth. To account 
for any variations in non-specific or receptor binding of the antigen at 4°C, the mean 
fluorescence intensity at 37°C was divided by the mean fluorescence at 4°C, 
generating a ratio at each time point. To directly compare differences between the 
different age points, ratio data was calculated fir each point for each time point, as 
shown LC from 4-day-old mice took longer to reach maximum uptake compared 
with adult LC. Each value is representative of three separate experiments. 
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4.2.4.5 Phagocytosis of E. coli by MHC-It epidermal LC during the developmental 
period 
To further characterise the potential for phagocytosis, LC isolated from 4-day- and 6- 
week-old epidermis were first incubated with fluorescently labelled E. coli. Results 
demonstrate only a slight increase in fluorescence intensity with time, suggesting that 
epidermal LC were weakly phagocytic for uptake of E.coli (Figure 4.15 (a). In a 
similar fashion to Zymosan uptake, fluctuations in binding of antigen at 4°C resulted 
in variable ratio values over time. 
To determine if LC can bind and internalise opsonised E. coli, LC were incubated 
with IgG-coated particles. Figure 4.15 (b) demonstrates little difference in 
fluorescence intensity with time, suggesting that at each age point LC were weakly 
phagocytic for opsonised antigen. 
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Figure 4.15 Uptake of E.coli (a) and opsonised E.coli (b) by MHC-II+ LC isolated 
from 4-day and 6-week-old mice. In vitro uptake of E.coli at 37°C and 4°C was 
assessed in epidermal cells isolated from mice at 4 days and 6  weeks following birth. 
The blue squares represent the fluorescence intensity associated with LC isolated 
from 4-day-old epidermis. The orange squares represent the fluorescence intensity 
associated with LC isolated from 6-week-old epidermis. Data  is representative of 
two or more experiments. 
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4.2.4.6 Phagocytosis of E. coli by adult MHC-Ir spleen cells 
To identify phagocytosis, FITC-E. coil particles were incubated with whole spleen 
suspensions at 37°C and 4°C. Within the splenic population are macrophages, 
previously demonstrated to possess high phagocytic capacity. Figure 4.16 (a) is 
representative of uptake at 37°C whilst panel (b) demonstrates the degree of binding 
of antigen at 4°C. It is evident that at 37°C there were two populations of FITC + 
cells in spleen suspensions that were absent from the profile of binding at 4°C. The 
first MHC-II-PE bright population was associated with a low FITC fluorescence 
intensity and is designated FITC I'MHC-II. The second MHC-II-PE bright 
population was associated with a high FITC fluorescence intensity and is designated 
FITChiMHC-III". As both populations were absent from the 4°C profile this is 
suggestive of metabolically active E. coli phagocytosis. As there are two populations 
of FITC+ cells this suggests variable phagocytic activity within the splenic 
population. Although phagocytosis of E.coli or Zymosan by epidermal LC was not 
evident in 4.2.4.4, the demonstration of internalisation of E.coli by spleen cells 
validates this protocol as a reliable assay of phagocytosis. 
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Figure 4.16 Uptake of E.coli by adult spleen cells. In vitro uptake of E.coli at 37°C 
(a) and 4°C (b) was assessed in spleen cells isolated from mice 6 weeks following 
birth. Note the FITC -E.coli+ population (circled) that is present in (a) and not in (b). 
This population represents cells that had internalised the antigen. 
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4.3 Discussion 
To enhance the efficacy of mannose recognition and internalisation, LC express 
members of the C-type lectin family of receptors, including DEC-205 and Langerin 
(Kato et al. 1998; Kato et al. 2000; Valladeau et al. 2000; Valladeau et al. 2003). 
DEC-205 has been suggested to initiate uptake and strongly enhance presentation of 
mannose-conjugated antigens, and an absence of lectin receptors may impact on the 
ability of LC to scavenge for antigen (Reis et al. 1993; Kato et al. 1998). LC resident 
in 3-day-old epidermis lack expression of DEC-205 and demonstrate a reduction in 
dendritic processes (Dewar et al. 2001). If antigen is applied to neonatal 
epidermis there is a deviation in the immune response from immunity to antigen-
specific immune suppression (Dewar et al. 2001; Simpson et al. 2003). It has been 
proposed that a contributing factor in the induction of suppression was the decreased 
ability of epidermal LC to trap and internalise antigen via a receptor-mediated 
pathway (Dewar et al. 2001). The findings from Chapter 3 furnished evidence 
supporting this hypothesis, with Langerin expression on LC from 4-day-old 
epidermis significantly reduced compared to adult LC. A gradual acquisition of 
receptor expression occurred and, by day 14 following birth, the expression of 
Langerin was equivalent to that found within adult epidermis. These results indicate 
that LC resident in neonatal epidermis mature during development. 
The delay in surface expression of DEC-205 and Langerin on neonatal LC suggests 
that these cells would have a reduced capacity to internalise antigen via a receptor-
mediated pathway. To address this hypothesis the in vitro uptake of fluorescently 
labelled FITC-dextran was assessed in LC isolated from neonatal, juvenile and adult 
epidermis. When analysing the fluorescence profile at 4°C it was noted that LC 
isolated from 6-week-old epidermis were associated with greater fluorescence 
intensity than LC from 4-day-old epidermis. As metabolism is inhibited at 4°C, the 
observed increase in fluorescence associated with adult LC was due to either non-
specific binding of antigen or binding via specific receptors, rather than by 
internalised antigen. The latter hypothesis is highly feasible as immuno-phenotyping 
data presented in Chapter 3 clearly demonstrated that adult LC express significantly 
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more mannose-type receptors than neonatal LC. At 37°C both adult and neonatal LC 
were capable of antigen uptake, evident by a time-dependent increase in FITC-
dextran fluorescence intensity. It was also clear that the magnitude of fluorescence 
differed significantly, with LC isolated from adult epidermis associated with greater 
fluorescence intensity than LC from neonatal epidermis. However, to ascertain 
metabolically active uptake of antigen, the surface binding of antigen at 4°C must be 
considered. To account for these fluctuations, the fluorescence intensity at 37°C was 
divided by the intensity at 4°C, generating a ratio value for each time point. Ratio 
data demonstrated that, despite the reduced expression of DEC-205 and Langerin, 
LC from 4-day-old mice were efficient at uptake of FITC-dextran than adult LC, as 
they displayed a higher ratio value. As neonatal LC continued to internalise antigen 
over a longer period of time, this suggests that the pathway used to internalise FITC-
dextran was more difficult to saturate. 
When FITC-dextran uptake assays were repeated in the presence of blocking doses 
of mannan and mannose, LC from adult epidermis demonstrated a greater percent 
decrease in uptake compared with LC from neonatal epidermis. This finding 
strongly suggests that adult LC are more dependent on a mannose-type receptor-
mediated pathway than neonatal LC. Due to the decreased dependency on a 
mannose-type receptor mediated pathway, it is plausible that neonatal LC utilise a 
receptor-independent pathway, such as macropinocytosis, to internalise antigen. 
Macropinocytosis provides an efficient method of sampling the extracellular 
environment for soluble or non-binding antigens (Swanson and Watts 1995). 
Macropinocytosis utilises the actin cytoskeleton to form macropinosomes, vesicles 
that arise when surface ruffles fold back against neighbouring ruffles or against the 
cell wall (Swanson 1989). It has been previously demonstrated that 1 mg/mL of 
FITC-dextran is sufficient to saturate uptake via the mannose receptor, therefore 
differences in uptake between the age points will primarily reflect changes in 
macropinocytosis (Sallusto et al. 1995; Buentke et al. 2000). Previous in vitro studies 
have shown that in the presence of mannan, which is the functional equivalent of an 
absence of specific receptors, LC could still internalise mannosylated antigens in the 
fluid phase (Kato et al. 2000). As maximum uptake occurred at a lower level in the 
adult than the neonate, this suggests that adult LC are saturated at a lower 
concentration. This may be a result of receptor expression, or more likely, that 
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neonatal LC take up FITC-dextran via a pathway that is more difficult to saturate, 
such as a receptor-independent pathway. Evidence for an efficient fluid phase 
pathway was obtained with LY, previously shown to be a definitive marker of 
macropinocytosis (Piemonti et al. 1999). When incubated with Lucifer Yellow, LC 
from neonatal epidermis demonstrated a greater ratio value at the end of uptake 
compared to LC isolated from adult epidermis. These results were further supported 
by the effective inhibition of FITC-dextran accumulation in neonatal LC by the 
phosphatidylinositol 3-kinase inhibitor wortmannin, previously demonstrated to 
prevent closure of membrane ruffles, thereby reducing the pinocytic potential of a 
cell (Stein and Waterfield 2000). These results strongly indicate that a fully 
functional macropinocytosis pathway is employed during the early neonatal period to 
internalise exogenous antigens. I therefore suggest that macropinocytosis is 
preferentially utilised during the early neonatal period to ensure that the capacity to 
internalise antigen is not lost. 
The epidermal LC network undergoes significant alterations during maturation 
(Dewar et al. 2001). The decreased density of LC resident in 3-day-old epidermis, 
combined with the reduction in extensive dendrites, equates to an inability to form a 
semicontiguous network (Dewar et al. 2001). As an adaptive mechanism, 
macropinocytosis may be up-regulated to ensure that the capacity to trap antigen is 
maintained. The lack of dendrites may also indirectly contribute to the increase in 
pinocytic activity demonstrated in vitro. When dendrites are formed the cytoskeleton 
is extended and anchored firmly to the extracellular matrix (Ross et al. 2000). Adult 
LC possess a well-developed, anchored dendritic network, with little membrane 
available for ruffling during macropinocytosis. Conversely, neonatal LC exhibit a 
more rounded morphology (Dewar et al. 2001), therefore increasing available 
membrane. As a consequence the magnitude of antigen internalised by 
macropinocytosis is increased. By day 14 following birth, the dendritic morphology 
of the LC network is improved (Dewar et al. 2001), and it is at this stage of 
development that the amount of antigen internalised in vitro is reduced and parallel 
to adult controls. 
The results of this study suggest that the capacity to internalise antigen via a 
receptor-mediated pathway is not acquired until late in development. In contrast the 
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heightened in vitro fluid phase activity of neonatal LC indicates that this pathway is 
functional from an early age. Despite the efficient internalisation of antigen via 
macropinocytosis, in vivo antigen exposure results in a reduction in the amount of 
antigen transported to the draining lymph node (Dewar et al. 2001). Although ratio 
data suggests that, in vitro, neonatal LC are more efficient at pinocytosis than adult 
LC, antigen may still be transported to the draining LN by adult LC via association 
of antigen to the cell membrane or via non-metabolically active binding of antigen to 
surface receptors. As a consequence the amount of antigen transported is increased. 
It is also possible that although neonatal LC are associated with efficient pinocytic 
pathways, their ability to possess the internalised antigen is inept. The aim of the 
next and final chapter will be to determine the fate of ingested antigen and whether 
neonatal LC are capable of responding to maturation stimuli, a crucial event in the 
acquisition of potent APC function. 
It has been demonstrated that a gradual increase in the density of MHC-II+ cells in 
the epidermis occurs during development, from relatively few positive cells in 3-day-
old epidermis increasing to a level which, at day 14, is comparable with that found in 
adult epidermis (Dewar et al. 2001). There is an increase in MHC-II + cells during 
the early neonatal period, yet these cells do not migrate from the epidermis following 
antigenic challenge. I propose that neonatal LC are actively retained in the epidermis 
to avoid inducing inappropriate immune response at a time of postnatal epidermal 
development and maturation. As a result of high cell turnover, one would expect an 
increase in both harmless soluble antigens as well as self- and protein particulate 
antigens within the epidermis (Haake and Cooklis 1997). Rather than 
macropinosomes fusing with degradative lysosomes (Nair et al. 1992), neonatal LC 
may recycle antigen back to the extracellular space in a clearance and scavenging 
mechanism (Steinman et al. 1976; Amyere et al. 2002). In such a way neonatal LC 
may use macropinocytosis to regulate the induction of immune responses to self-
peptide and harmless soluble antigens. 
In conclusion, this chapter has shown that in the absence of the C-type lectins DEC-
205 and Langerin, LC isolated from neonatal epidermis preferentially utilise a 
wortmannin-sensitive fluid phase pathway, such as macropinocytosis, to internalise 
small exogenous antigens. The effective pinocytic capacity of neonatal LC is 
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acquired prior to their ability to initiate effective immunity. The aptitude of neonatal 
LC to sample their external environment without inducing immunity has important 
biological consequences for the protection against inappropriate immune responses 
during the developmental period. 
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Chapter 5 
Characterisation of Antigen Processing and Maturation by 
Epidermal Langerhans During the Developmental Period 
5.1 Introduction 
Processing and presentation of internalised antigen is essential to the generation of 
protective immune responses, and the dynamic life cycle of LC equip them ideally 
for these physiologically distinct processes (Cella et al. 1997b). During their 
residence in the epidermis LC possess an array of uptake pathways that 
accommodate most antigens, including small and large particulate antigens as well as 
soluble and non-binding peptides (Katz and Sunshine 1986; Swanson and Watts 
1995; Goldstein et al. 1996; Watts 1997). Exposure to foreign antigen occurs 
simultaneously to inflammation or tissue damage and the mediators that are released 
during these events provide maturation triggers for the LC (Elbe et al. 1989; 
Girolomoni et al. 1990; Cumberbatch et al. 1991). Following receipt of maturation 
stimuli, LC down-regulate their attachment to the epidermal network and migrate via 
the afferent lymphatics to the regional LN (Kimber and Cumberbatch 1992b; 
Cumberbatch et al. 2000). During transit they undergo a process of differentiation 
such that they are transformed from a cell primarily involved in antigen uptake to a 
cell capable of antigen presentation (Cumberbatch et al. 2000). Associated with this 
change in function is an alteration in phenotype, where the expression of co-
stimulatory molecules becomes apparent and newly formed immunogenic MHC-II-
peptide complexes are transported to the cell surface (Bigby et al. 1993; Peguet-
Navarro et al. 1993; Weinlich et al. 1998b; Stoitzner et al. 2003). It is the binding of 
these molecules with ligands on the surface of the naive T cell that provides the 
appropriate signals required for T cell activation (Peguet-Navarro et al. 1993). 
Antigen exposure during the neonatal period results in a deviation of the T cell 
response away from protective immunity and towards immune suppression (Dewar 
et al. 2001). Contributing factors in the induction of suppression have been proposed 
to be a decrease in the amount of antigen presented and a reduction in surface 
expression of the costimulatory molecules CD80 and CD40 (Dewar et al. 2001; 
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Simpson et al. 2003). It was originally proposed that the reduction in antigen 
transport was a consequence of a diminished capacity to internalise antigen via a 
receptor-mediated pathway (Becker et al. 1991; Dewar et al. 2001; Simpson et al. 
2003). However, chapter 4 furnished evidence that neonatal LC were able to employ 
an alternative uptake pathway to offset the reduction in mannose-specific lectin 
receptors, DEC-205 and Langerin. Due to the inhibition of FITC-dextran 
internalisation in the presence of the macropinocytosis inhibitor wortmannin, the 
pathway was proposed to be fluid phase macropinocytosis. Via this pathway 
neonatal LC were able to efficiently internalise antigen in vitro with the same 
efficiency as adult counterparts. 
It is now accepted that the mode of antigen uptake influences the fate of internalised 
antigen (Steinman et al. 1976). Lutz et al demonstrated that antigen internalised via 
receptor-mediated endocytosis is targeted to lysosome associated membrane protein 
(LAMP)-1 + degradative vesicles (Lutz et al. 1997). LAMP-1, is expressed on early 
endosomes, vesicles that acquire antigen shortly after ingestion as well as early and 
late lysosomes that contain MHC-II (Lutz et al. 1997). Amyere et al (2002) 
demonstrated that within macrophages, macropinosomes bypass the endocytic 
pathway and exocytose the digested antigen back to the extracellular space (Amyere 
et al. 2002). In this situation antigen uptake is utilised as a scavenging and clearance 
mechanism. The aim of this study was to determine the capacity of LC to process 
exogenous particulate antigen and to respond to maturation stimuli in vitro. To 
ascertain the processing and maturation capacity during the developmental period, 
LC were isolated from the epidermis of 4-day- and 6-week-old mice and were 
analysed for expression of the lysosome-associated membrane protein (LAMP)-1 + 
proteolytic vesicles, trafficking of antigen to the cell surface and the up-regulation of 
CD86 in response to LPS. 
5.2 Results 
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5.2.1 Characterisation of LAMP-1 expression by adult and neonatal MHC-II+ 
epidermal Langerhans cells. 
The endocytic pathway consists of a series of compartments that facilitate antigen 
proteolysis and MHC-II:peptide complexing (Lutz et al. 1997). These vesicles can 
be distinguished by expression of LAMP-1 (Lutz et al. 1997). To assess the relative 
level of endocytic compartments during development, expression of LAMP-1 was 
assessed in LC isolated from neonatal and adult epidermis. Figure 5.1 is a 
representative experiment, demonstrating LAMP-1 expression within MHC-If+ LC 
isolated from the epidermis of 4-day-old and 6-week-old mice. Analysis of LAMP-1 
expression within LC from 4-day- and 6-week-old epidermis demonstrated similar 
distribution of LAMP-1 + vesicles. In both adult and neonatal LC, fluorescently 
labelled vesicles were found within the cytoplasm, in close proximity to the 
membrane. It was also evident that a proportion of MHC-II was located in 
intracellular LAMP-1 + vesicles, demonstrated by double positive staining (Figure 
5.1c). Identification of LAMP-1 vesicles within LC from 4-day-old epidermis 
suggests the presence of endocytic compartments within neonatal LC. Based on this 
observation, neonatal LC should possess proteolytic activity. 
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Figure 5.1 Expression of LAMP-1 on viable MHC-II LC isolated from 4-day- and 
6-week-old epidermis. The expression of the lysosomal marker LAMP-1 was 
assessed in MHC-II+ cells isolated from 4-day- (a) and 6-week-old (b) epidermis. 
Using Magnafire caption program single colour images were taken and subsequently 
merged in Photoshop. Note the co-localisation of MHC-II and LAMP-1 in the 
merged images. Two representative sets of results are shown for each age point. 
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Figure 5.1 Expression of LAMP-1 on viable MHC-II ±LC isolated from 4-day- 
and 6-week-old epidermis 
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5.2.2 Identification of DQ-OVA proteolysis by adult and neonatal MHC-II + 
epidermal LC. 
To determine the capacity of LC to proteolyse antigen during development, LC 
isolated from epidermis of 4-day- and 6-week-old mice were incubated with the 
fluorescent antigen DQ-Ovalbumin (OVA) for 24 hours at 37°C and 4°C. DQ-OVA 
emits fluorescence upon proteolysis, and proteolysed antigen is identified as green 
fluorescent punctate vesicles. In contrast to other proteolytic dyes DQ-OVA is 
conjugated to the pH insensitive dye BODIPY, translating to stable fluorescence 
intensity over a broad pH range of 3-9. Another advantage of DQ-OVA is that the 
level of background fluorescence is more highly quenched, translating to fewer 
fluorophores required per protein molecule. As such the antigenic epitopes of the 
protein are preserved. Lutz and colleagues demonstrated that OVA is preferentially 
internalised via a fluid phase pathway (Lutz et al. 1997), therefore DQ-OVA was 
chosen as an indication of macropinocytosis. Following internalisation via 
macropinocytosis, proteolysis can be identified as the appearance of fluorescence 
positive vesicles. Due to the stablility of the dye at acidic pH it will not be degraded 
within the endocytic pathway, allowing visualisation of the vesicles as they traffic 
through the cell. Figure 5.2 is a representative experiment and demonstrates the 
localisation of DQ-OVA+ vesicles within adult LC 24 hours following incubation 
with antigen. Following overnight culture at 37°C green fluorescent vesicles were 
identified within the cytoplasm of MHC-II + LC. Results also demonstrate that none 
of the vesicles co-localised with either intracellular or cell surface MHC-II. These 
results suggest that LC isolated from 6-week-old epidermis were capable of 
proteolysing antigen. Once proteolysed the antigen-containing vesicles were 
localised to the cytoplasm. As antigen did not co-localise with intracellular MHC-II, 
proteolysed DQ-OVA was retained in an MHC-If compartment. LAMP-1 and 
MHC-II have been demonstrated to co-localise therefore the retention compartment 
was also negative for LAMP-1. 
Figure 5.3 is a representative experiment, demonstrating DQ-OVA proteolysis by LC 
isolated from the epidermis of 4-day-old mice. Following incubation with DQ-OVA, 
antigen-positive vesicles were identified within the cytoplasm of MHC-II + LC. 
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Results also demonstrate that DQ-OVA did not co-localise with MHC-II in the 
cytoplasm or on the cell surface. These results suggest that, like adult LC, the LC 
isolated from 4-day-old epidermis were capable of proteolysing antigen, and that 
proteolysed DQ-OVA was retained in a MHC-II compartment. LC from adult 
epidermis and neonatal epidermis appeared to handle DQ-OVA in a similar manner 
as there were no differences in either localisation or number of antigen-positive 
vesicles was observed. 
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Figure 5.2 Proteolysis of DQ-OVA by MHC-II + LC isolated from 6-week-old 
epidermis. The proteolysis of the labeled dye DQ-OVA was assessed in MHC-II + 
cells isolated from 6-week-old epidermis at 4°C (a) and 37°C (b). Using Magnafire 
caption program single colour images were taken and subsequently merged in 
Photoshop. Note the DQ-OVA+ vesicles when the cells were incubated with antigen 
at 37°C. Two representative sets of results are shown. 
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Figure 5.2 Proteolysis of DQ-OVA by MHC-II + LC isolated from adult 
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Figure 5.3 Proteolysis of DQ-OVA by MHC-II+ LC isolated from 4-day-old 
epidermis. The proteolysis of the labeled dye DQ-OVA was assessed in MHC-II + 
cells isolated from 4-day-old epidermis at 4°C (a) and 37°C (b). Using Magnafire 
caption program single colour images were taken and subsequently merged in 
Photoshop. Note the DQ-OVA+ vesicles when the cells were incubated with antigen 
at 37°C. Two representative sets of results are shown. 
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Figure 5.3 Proteolysis of DQ-OVA by MHC-Ir LC isolated from 4-day-old 
epidermis 
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5.2.3 Trafficking of DQ-OVA to the cell surface by adult and neonatal MHC-II + 
epidermal LC 
Concomitant with receipt of maturation stimuli is the loading of proteolysed antigen 
fragments onto newly synthesised intracellular MHC-II. Following loading, the 
MHC-II:peptide complexes are transported through the cell to the cell membrane for 
presentation. To assess the capacity of epidermal LC to transport processed peptides 
to MHC-II+ compartments and to traffic MHC-II:antigen complexes to the cell 
surface, DQ-OVA proteolysis assays were repeated in the presence of LPS. The 
concentration of LPS used has been previously demonstrated to induce DC 
maturation in vitro. Figure 5.4 is a representative of two separate experiments and 
demonstrates the localisation of DQ-OVA+ vesicles in the presence (Figure 5.4a) or 
absence (Figure 5.4b) of LPS. Vesicles bearing proteolysed antigen were evident as 
punctate fluorescent green vesicles. If such vesicles were expressed on the MHC-II + 
cell membrane (MHC-II staining with red fluorescence), then co localisation was 
visualised as yellow staining. Figure 5.4 demonstrates that DQ-OVA + vesicles were• 
evident on the cell membrane, in close association with MHC-II. As DQ-OVA was 
clearly evident on the cell membrane this suggests that DQ-OVA was able to gain 
access to MHC-II + compartments, a site of antigen loading. Results also demonstrate 
that a small proportion of DQ-OVA + vesicles were retained within the cell, which 
was not co-localised to intracellular MHC-II. These vesicles however, were in close 
proximity to the membrane. 
Figure 5.5 is a representative of DQ-OVA proteolysis by LC isolated from 4-day-old 
epidermis in the presence (Figure 5.5a) or absence (Figure 5.5b) of LPS. Although a 
small proportion of DQ-OVA + vesicles were found on the cell membrane, evident as 
co localisation with surface MHC-II, the majority of antigen-bearing vesicles were 
retained in a cytosolic MHC-II- compartment. These results strongly suggest that 
following exposure to LPS, neonatal LC do not efficiently traffic proteolysed antigen 
to MHC-II+ compartments. 
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Figure 5.4 Proteolysis of DQ-OVA by MHC-II+ LC isolated from 4-day-old 
epidermis. The proteolysis and trafficking of the labeled dye DQ-OVA was assessed 
in MHC-II+ cells isolated from 6-week-old epidermis in the presence (a) and absence 
(b) of LPS. Using Magnafire caption program single colour images were taken and 
subsequently merged in Photoshop. Note the DQ-OVA + vesicles co-localised with 
the cell membrane when cells were incubated with antigen in the presence of LPS. 
Two representative sets of results are shown. 
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Figure 5.4 Trafficking of DQ-OVA following exposure to LPS by MHC-II + LC 
isolated from 6-week-old epidermis 
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Figure 5.5 Trafficking of DQ-OVA following exposure to LPS by MHC-I1 + LC 
isolated from 4-day-old epidermis. The proteolysis and trafficking of the labeled dye 
DQ-OVA was assessed in MHC-I1 + cells isolated from 4-day-old epidermis in the 
presence (a) and absence (b) of LPS. Using Magnafire caption program single 
colour images were taken and subsequently merged in Photoshop. Note the DQ-
OVA+ vesicles co-localised with the cell membrane when cells were incubated with 
antigen in the presence of LPS. Two representative sets of results are shown. 
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Figure 5.5 Trafficking of DQ-OVA following exposure to LPS by MHC-II± 
LC isolated from 4-day-old epidermis 
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5.2.4 Trafficking of MHC-II to the cell surface by adult and neonatal MHC-II + 
epidermal LC 
Results furnished in this study suggest that although capable of efficiently 
proteolysing antigen, neonatal LC are inept at the loading and transport of MHC-
II:peptide complexes to the cell surface. One step that may account for the reduced 
expression of membrane complexes, is the trafficking of MHC-II to the cell surface. 
To characterise MHC-II transport, LC isolated from 4-day- and 6-week-old 
epidermis were analysed for MHC-II localisation 24 hours following incubation with 
LPS. Figure 5.6 is a representative experiment and demonstrates MHC-II and 
LAMP-1 localisation in freshly isolated neonatal (a) and adult (b) LC, and 24 hours 
following exposure to LPS. Results demonstrate that neonatal and adult LC 
transported intracellular MHC-II from a LAMP-1 + compartment to the cell 
membrane. This was evident by an absence of co-localisation of MHC-II and 
LAMP-1. Consequently, in LC isolated from neonatal and adult epidermis MHC-II 
was trafficked out of the LAMP-1 compartments to the cell membrane. Results also 
demonstrate alterations in LAMP-1 localisation following stimulation. In freshly 
isolated LC, LAMP-1 was localised to a perinuclear location. Following incubation 
with LPS, LAMP-1 was in a distinct cytoplasmic location. Based on this observation, 
transport of MHC-II alone was not responsible for the reduced expression of antigen 
on the cell membrane. 
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Figure 5.6 Trafficking of MHC-II following exposure to LPS by LC isolated from 4- 
day- and 6-week-old epidermis. The trafficking of MHC-II to the cell membrane 
was assessed in MHC-II+ LAMP-1 + cells isolated from 4-day- (a) and 6-week-old (b) 
epidermis in the presence and absence of LPS. Using Magnafire caption program 
single colour images were taken and subsequently merged in Photoshop. Note the 
absence of intracellular MHC-II staining when cells were incubated with antigen in 
the presence of LPS. Two representative sets of results are shown. 
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Figure 5.6 Trafficking of MHC-II following exposure to LPS by LC 
isolated from 4-day- and 6-week-old epidermis 
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5.2.5 Up-regulation of CD86 by adult and neonatal MHC-II+ epidermal LC 
Occurring simultaneously to the transport of MHC-II:peptide complexes to the cell 
surface is the up-regulation of membrane costimulatory molecules, such as CD86. 
To ascertain the capacity of LC to up-regulate costimulatory molecule expression 
following exposure to maturation-inducing stimuli, LC isolated from 4-day- and 6- 
week-old epidermis were analysed for CD86 expression 24 hours following exposure 
to LPS in vitro. Figure 5.7 is a representative experiment and demonstrates CD86 
expression on neonatal and adult LC at 0 and 24 hours following incubation with 
LPS. Although freshly isolated neonatal LC expressed reduced levels of CD86 
compared to adult counterparts, LC from neonatal epidermis up-regulated CD86 
expression in response to LPS to the same extent as adult controls. These results 
suggest that neonatal LC were capable of up-regulating CD86 expression following 
exposure to LPS. 
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Figure 5.7 CD86 expression on viable MHC-II ± LC isolated from 4-day- and 6- 
week-old epidermis following exposure to LPS. The expression of CD86 was 
assessed in MHC-II± cells isolated from 4-day- and 6-week-old epidermis prior to 
after 24 hours following incubation with LPS. Results are representative of 2 
separate experiments 
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5.3 Discussion 
Results from Chapter 4 indicated that during the early developmental period LC 
preferentially utilise a fluid phase, wortmannin-sensitive pathway, such as 
macropinocytosis, to internalise small particulate antigen. By 6-weeks of age the 
reliance on macropinocytosis is reduced and alternatively cell surface antigen uptake 
receptors are employed to recognise and bind antigen, and this correlates to 
successful antigen presentation. As the pathway utilised to internalise antigen has 
important implications for effective MHC-II:peptide presentation (Langenkamp et al. 
2002), it was of great interest to determine the fate of antigen internalised during 
neonatal development. To characterise the antigen processing potential of LC during 
the early neonatal period, LC were isolated from 4-day- and 6-week-old epidermis 
and analysed for expression of proteolytic vesicles, as well as their ability to 
proteolyse antigen and up-regulate CD86 following in vitro exposure to maturation 
stimuli. 
Following receptor-mediated endocytosis, antigens progress through a sequence of 
maturing proteolytic compartments whose functions are to digest antigen into smaller 
peptide fragments and to facilitate loading of peptides onto newly synthesised MHC-
II (Kleijmeer et al. 1995; Xu and Pierce 1995; Turley et al. 2000). These organelles 
can be distinguished by expression of LAMP-1, and is expressed in low levels on 
early endosomes, vesicles that acquire antigen shortly after ingestion as well as early 
and late lysosomes that contain MHC-II (West et al. 1994; Kleijmeer et al. 1995; Xu 
and Pierce 1995). In contrast, antigens that gain access to the cell via 
macropinocytosis are engulfed within macropinosomes that are negative for LAMP-
1. It is not until the cell commences maturation that the vesicle acidifies and 
acquires LAMP-1 expression (Lutz et al. 1997). As OVA is preferentially 
internalised via macropinocytosis (Lutz et al. 1997), the fluorescent DQ-OVA 
provides an ideal antigen to follow the fate of antigen following macropinocytosis by 
both adult and neonatal LC. Despite the observation of LAMP-1 and MHC-II co-
localisation in unstimulated LC, proteolysed DQ-OVA did not associate with 
intracellular MHC-II, and therefore LAMP-1. This suggests that DQ-OVA is not 
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proteolysed in a vesicle continuing LAMP-1 and MHC-II and that it is retained 
within a LAMP-1 - compartment. This is consistent with the statement that antigen 
engulfed by macropinocytosis is targeted to a LAMP-1 - vesicle and provides, 
evidence for a functional macropinocytosis pathway during the early neonatal period. 
Consequently, neonatal and adult LC target macropinocytosed antigen to a similar 
LAMP-1 - compartment. But this is where the similarity ends and the proposal is that 
neonatal LC are unable to transport the antigen to MHC-II + compartments and 
subsequently to the cell membrane in association with MHC-II. As the vesicles do 
not express LAMP-1 this suggests that at this stage the cell has not yet commenced 
maturation. By coordinating maturation with antigen presentation ensures that the 
cell has reached full APC potency prior to interaction with naïve T cells. 
Under normal situations, exposure to inflammatory mediators signals LC to 
commence a process of maturation that includes transport of MHC-II into the 
endocytic pathway (Pierre et al. 1997; Turley et al. 2000). Within the endocytic 
route, MHC-II+ LAMP + vesicles fuse with vesicles containing degraded antigen 
(West et al. 1994; Lutz et al. 1997; Pierre et al. 1997). The peptide fragments are 
then exchanged for the CLIP fragment occupying the peptide-binding groove of 
MHC-II, and the resulting complexes shuttled to the cell surface in association with 
costimulatory molecules (Turley et al. 2000). Turley and colleagues demonstrated 
that antigen is only loaded onto MHC-II following receipt of maturation stimuli, and 
that antigen can be retained in vesicles for extended periods of time until the correct 
signal is received (Turley et al. 2000). It is apparent that neonatal LC do not respond 
normally to maturation stimuli as DQ-OVA was not directed to an MHC-II + 
compartment and therefore it does not become expressed on the cell membrane. 
Although neonatal LC can transport MHC-II to the membrane in the absence of 
antigen, they are unable to transport MHC-II:peptide complexes to the cell surface. 
This strongly suggests that within neonatal LC antigen cannot gain access to 
intracellular MHC-II, and these findings strongly indicate that the outcome of 
antigen processing by neonatal LC is different from adult LC. 
As there is more than one possible outcome for antigens internalised via 
macropinocytosis (Watts 1997; Amyere et al. 2002), it is likely that the fate of 
antigen ingested by neonatal LC will differ from the fate of antigens internalised by 
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adult LC. A comparison can be made to macrophages that can internalise antigen via 
fluid phase pinocytosis and this antigen is exocytosed in a clearance mechanism 
(Amyere et al. 2002). Whilst it is possible that neonatal LC regurgitate some 
degraded antigen into the extracellular space, the presence of intracellular antigen 24 
hours following exposure to maturation stimuli suggests that neonatal LC retain a 
proportion of antigen within the cell. Consequently an alteration in one of the steps 
involved in the processing pathway is more likely to be responsible for the reduction 
in surface complexes 
Following dimerisation of a and 13 subunits of MHC-II is the association of the Ii 
(Pure et al. 1990; Cresswell 1996). Not only does the Ii bind to the antigen cleft of 
MHC-II, and hence inhibit loading of endogenous antigen, but it also contains a 
signalling sequence that directs the MHC-II from the ER, through the Golgi and into 
the endocytic pathway (Bakke and Dobberstein 1990; Lotteau et al. 1990). If this 
signalling motif is deficient in neonatal LC then MHC-II will be directed away from 
the endocytic route, straight to the cell surface. As a consequence antigen will be 
retained in a MHC-If cytoplasmic location, evident 24 hours following incubation 
with antigen. Cathepsin S may also play a role as this enzyme has been shown to be 
integrally involved in the exit of MHC molecules from an intracellular compartment 
where they are held prior to encountering antigen (Nakagawa and Rudensky 1999; 
Villadangos et al. 1999; Lennon-Dumenil et al. 2002a; Lennon-Dumenil et al. 
2002b). If cathepsin S is deficient then MHC-II containing endosomes may be 
routed directly to the cell surface, and hence bypass interaction with antigen positive 
vesicles. Not only is cathepsin S involved in transit of MHC-II but also in the 
degradation of the invariant chain, Ii (Nakagawa and Rudensky 1999; Villadangos 
and Ploegh 2000). For effective loading of antigen, Ii must be cleaved to free the 
intracellular antigen-binding site (Alfonso and Karlsson 2000b; Alfonso and 
Karlsson 2000a). In unstimulated LC cathepsin S is found within late endosomes 
and is partially inhibited by high levels of cystatin C (Pierre and Mellman 1998). 
After activation of LC, cystatin C is downregulated allowing cathepsin S to cleave Ii 
and MHC-II is redistributed to the surface for antigen presentation (Meraner et al. 
2000; Fiebiger et al. 2001; Lautwein et al. 2002). If neonatal LC, following receipt 
of maturation stimuli, do not down-regulate cystatin C activity, cathepsin S-mediated 
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cleavage of Ii will not occur and MHC-II:peptide complexes will not be exported to 
the cell surface. This is a particularly exciting possibility as a preliminary 
proteomics study within our research group has identified an abundance of stefin A 
(cystatin C) in neonatal skin (Scott. BSc(Hons) thesis). It has been previously 
demonstrated that antigen that is not bound to MHC-II is quickly degraded into 
smaller fragments, and this could account for the large number of small antigen 
containing vesicles evident in neonatal LC following exposure to LPS. As a result 
divergent cathepsin S activity has important ramifications on both the loading of 
antigen onto intracellular MHC-II but also the transit of resulting complexes to the 
cell surface. 
An alternative hypothesis for the reduced surface expression of MHC-II:peptide 
complexes is that, although neonatal LC express MHC-II on the plasma membrane, 
the complexes are endocytosed prior to interactions with nave T cells. Wilson and 
colleagues demonstrated the alterations in the antigen presenting properties during 
DC maturation (Wilson et al. 2003). DC located in lymphoid organs were found to 
present mainly self antigens on the cell surface and that these complexes were 
degraded quickly after their transient expression on the cell surface (Wilson et al. 
2003). With this in mind it is possible that via a combination of altered cathepsin S 
activity and MHC-II endocytosis and degradation the majority of antigen is not 
loaded onto MHC-II. Those antigens that manage to bind to MHC-II and are 
subsequently trafficked to the cell membrane are degraded before the antigen can be 
effectively presented to naïve T cells resident in the draining LN. 
A consequence of having two parallel processing steps in the generation of MHC-
II:peptide complexes is that by inhibiting either proteolytic step could result in 
impaired T cell recognition. It is not likely to be exposure to maturation stimuli 
alone that is responsible for the reduction in surface MHC-II:peptide complexes as 
neonatal LC are capable of up-regulating CD86 following incubation with LPS, a 
process that is not dependent on prior exposure to antigen. Rather it is the 
combination of antigen processing and environmental stimuli that is responsible for 
the reduced traffic of antigen to the cell surface. Despite the capacity to up-regulate 
CD86 in response to maturation stimuli in vitro, in vivo LC that migrate to the 
draining LN following antigen exposure to neonatal epidermis express significantly 
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reduced surface CD86. This is further evidence supporting the impact on the in vivo 
environment on the maturation of epidermal LC. Selective regulation of endosomal 
proteolysis in neonatal LC could have profound implications for control of immunity 
against infection, as well as autoimmunity. Neonatal LC continuously sample their 
environment, one that alters during development period from one with a higher 
proportion of self-proteins to one of foreign, potentially harmful antigens. As such 
there is a shift from retaining proteolysed antigen in an immunologically safe 
intracellular environment to presenting the antigen on the cell surface for T cell 
recognition. 
In conclusion I propose that a divergence exists within the exogenous processing 
pathway during the developmental period that contributes significantly to the 
diminished transport of MHC-II:peptide complexes to the cell membrane. This study 
has been fundamental in demonstrating how processing pathways differ during 
maturation, however further analysis is required to determine what stage in 
processing results in the decreased redistribution of MHC-II:peptide complexes to 
the cell surface. Although neonatal LC are proficient at pinocytosis of exogenous 
antigen in vitro a divergence in the intracellular processing of antigen contributes to 
the reduced surface MHC-II:peptide complexes. By actively retaining antigen within 
the cell, neonatal LC may utilise macropinocytosis to avoid presenting antigen at a 
time at which the immune system is developing. During the early neonatal period 
danger signals, such as proinflammatory cytokines, are reduced possibly to avoid 
induction of self-immunity at a time of high cell turnover and tissue remodelling. 
Rather, following internalisation of antigen, the presence of tolerance inducing 
cytokines gestures to the LC to maintain an immature state and prevent presentation 
of antigen by retaining antigen within the cell. Following exposure to high doses of 
antigen, or maturation of the epidermal cell network with age, the danger signals 
increase in potency. In response LC up regulate the expression of costimulatory 
molecules and traffic the antigen to the plasma membrane in association with MHC-
II. Presentation of antigen combined with ligation of costimulatory molecules leads 
to the induction of T cell activation. The flexibility of neonatal LC ensures that 
during the developmental period tolerance is established and inappropriate immune 
responses are avoided. This is brought about by an up regulation of scavenging 
macropinocytosis and down regulation of antigen presentation. However when the 
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correct danger signals are provided LC increase their APC potency accordingly to 
enable T cell activation and immunity. 
162 
Discussion 
Chapter 6 
Discussion 
The neonatal skin microenvironment is unique in antigen composition. The 
extracellular milieu is rich in self and protein antigen, resulting from tissue 
remodelling and formation of new epidermal layers following birth (Haake and 
Cooklis 1997; Hoeger and Enzmann 2002). As opposed to adult counterparts, 
neonatal epidermis is low in particulate antigens as a consequence of epidermal and 
keratin thickening, increasing the physical barrier of the skin (Scott. BSc(Hons) 
thesis in preparation). If antigens were to breach the epidermal barrier, they would 
consist mainly of common environmental antigens and skin commensals. This 
uniqueness in antigenic composition has important implications for the immune 
consequence following antigen exposure. As the neonatal immune system has yet to 
acquire immunological memory (Kovarik and Siegrist 1998; Benschop et al. 2001; 
Siegrist 2001; Adkins et al. 2004b), it is essential for neonatal LC to be able to 
establish a tolerant state to environmental and self-antigen (Schurmans et al. 1990). 
If neonatal LC were to respond strongly to all antigens a chronic state of hyper-
responsiveness and inflammation would result (Adkins et al. 2004b). Persistent 
inflammation is detrimental to skin development due to the negative impact on the 
establishment of self tolerance as well postnatal maturation of the epidermis (Adkins 
et al. 2004b). It is essential that immune cells resident in the epidermis are equipped 
with a means by which to scrutinize their extracellular environment, and according to 
the antigens encountered, elicit protective or tolerant responses. Exposure to self-
antigen will lead to the induction of tolerance (Kurts et al. 1997; Banchereau and 
Steinman 1998a; Belz et al. 2002a). However when the epidermal barrier is crossed 
by potential pathogens mechanisms must be in place to induce protective immune 
responses (Sallusto et al. 1995). 
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Neonatal mice mount a limited response to infection and the insufficiency of the 
immune system is evident in the decreased protective response to vaccination during 
infancy (Siegrist 2001). Studies of the possible mechanisms for immune 
incompetence have focused primarily on neonatal T cells and their qualitative and 
quantitative differences compared to immune competent adult counterparts (Adkins 
and Hamilton 1992; Forsthuber et al. 1996; Adkins and Du 1998a; Adkins et al. 
2004b). Although neonatal T cells are uniquely susceptible to tolerisation, recent 
investigations have highlighted that the maturation state of the APC is a determining 
factor in the outcome of antigen presentation (Dewar et al. 2001; Woods et al. 2001; 
Simpson et al. 2003). Following antigenic challenge, neonatal APC are intimately 
involved in tolerance induction, nevertheless the underlying mechanisms are yet to 
be fully clarified. It was recently demonstrated by Vollstedt and colleagues that the 
low number of functionally mature DC in murine lymphoid tissue resulted in an 
increased susceptibility to microbial infection (Vollstedt et al. 2003). It has also been 
demonstrated that the way in which antigen is handled and subsequently presented 
has important implications for the generation of protective or tolerant immune 
responses (Langenkamp et al. 2002). During infancy the ability to induce tolerance 
is an invaluable mechanism to maintain non-reactivity to self-antigen, beneficial skin 
commensals and harmless protein antigens (Min et al. 2001; Adkins et al. 2004b). 
Understanding the underlying mechanisms of cutaneous tolerance during the 
neonatal period provides insight into immune function. This knowledge provides a 
basis for development of strategies to enhance or suppress the immune response for 
anti-pathogen or cancer protection, or suppressing anti-self responses in autoimmune 
diseases respectively. 
During maturation of the neonatal epidermis there is an associated maturation of the 
skin immune system, which is linked to the development of LC (Dewar et al. 2001). 
At 4 days of age, neonatal LC fail to induce an immune response, whereas at 20 days 
of age the LC are proficient at inducing immunity (Dewar et al. 2001; Simpson et al. 
2003). As previous reports have shown that neonatal LC have a reduced expression 
of antigen uptake receptors it would suggest that during the early neonatal period LC 
have a reduced ability to internalise antigen (Dewar et al. 2001). This would be a 
convenient mechanism to prevent induction of an immune response, as diminished 
antigen uptake would translate to reduced antigen presentation and T cell activation 
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(Sallusto et al. 1995; Zinkernagel 2000). Chapter 3 furnished evidence to suggest that 
the ability to bind and internalise mannosylated antigen via a receptor-mediated 
pathway would be diminished as DEC-205 was absent and Langerin dramatically 
reduced on LC isolated from 4-day-old epidermis. As the epidermal network 
matured there was a gradual increase in receptor expression. By day 14 the level of 
expression had increased and was comparable to adult counterparts. These results 
strongly suggest that LC acquire functional maturity during development. Early 
studies have demonstrated that uptake by DEC-205 was as efficient as uptake by the 
macrophage mannose receptor and that uptake strongly enhanced the presentation of 
mannose-conjugated antigen (Reis et al. 1993; Kato et al. 1998b). As the majority of 
microbes possess mannose on the cell surface, an absence of mannose-specific 
receptors would translate to an inability to scavenge mannose-conjugated particulate 
antigen via receptor-mediated endocytosis (Jiang et al. 1995; Sallusto et al. 1995; 
Buentke et al. 2000). This is of particular importance as chapter 4 furnished 
evidence to suggest that epidermal LC are unable to employ phagocytosis to 
internalise particulate antigen. It is highly plausible that neonatal LC down-regulate 
expression of mannose-specific receptors to ensure that responsiveness to skin 
commensals is avoided and tolerance maintained. This hypothesis was further 
supported by the finding that neither adult nor neonatal LC possessed the LPS-
specific receptor CD 14. By limiting the expression of LPS and mannose receptors 
on LC throughout development the incidence of reactivity to commensals is 
diminished. Results from our department have demonstrated that application of 
contact sensitisers on the day of birth accelerates the acquisition of DEC-205 
expression (Wonzniak BSc(Hons) thesis). With this in mind it is possible that as the 
antigen composition of the epidermal environment alters during maturation from 
soluble self-antigen to particulate antigen that mannose receptors, such DEC-205, are 
up-regulated accordingly for antigen-specific recognition and internalisation. 
Based on the diminished expression of mannose-type receptors it would appear that 
if pathogens were to breach the neonatal epidermal barrier they would not be 
internalised by LC. Whilst this is beneficial for avoiding responses to commensal 
organisms, neonatal LC must maintain the capacity to internalise pathogenic 
organisms to protect the underlying dermis from attack. To compensate for the 
diminished expression of mannose-type receptors, LC possess receptors for 
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opsonised antigen from an early age. This is an interesting dichotomy as, on the one 
hand receptors capable of binding directly to antigen are reduced but receptors 
capable of binding opsonised antigens are expressed. Where does the opsonised 
antigen come from if the neonatal immune system is incapable of synthesising 
antibody in response to antigen exposure? This incompetence is overcome by 
maternal antibody. Maternal IgG is capable of crossing through epithelia and 
placenta, and provides protection whilst the newborn immune system is incapable of 
producing antibodies (Kovarik and Siegrist 1998; Benschop et al. 2001; Siegrist 
2001; Adkins et al. 2004b). Once across the intestinal epithelia and into the blood 
stream, maternal antigen-specific IgG is available to opsonise foreign antigen. The 
mother has already been exposed to similar environmental pathogens the neonate 
may encounter and such immunological knowledge is transferred to the neonate via 
maternal IgG (Kovarik and Siegrist 1998). Expression of the IgG receptor complex 
CD 16/32 during the neonatal period would be expected to enable responsiveness to 
antigen opsonised with maternal IgG. The beauty of the neonatal immune system is 
that under certain stimuli immune responses are avoided to prevent responsiveness to 
non-threatening environmental antigens. As the mother has initiated tolerance to 
such antigen, specific antibody will not be transferred to the neonate. However if 
potential pathogens gain access to the epidermis, antigen specific maternal IgG 
provides protection at a time at which their developing immune system is insufficient 
(Kovarik and Siegrist 1998). Interestingly, expression of CD16/32 may also aid 
further in the regulation of immune responses to self-tissue as maternal IgG only 
binds foreign antigen and not self-tissue (Esposito Farese et al. 1995; Fanger et al. 
1996). 
Aside from the impact on primary and recall responses, the inability of the neonate to 
synthesise antibody would prevent the activation of the complement cascade via the 
classical pathway. However, microbial surfaces can activate complement via the 
alternative pathway without the necessity of bound antibody (Koppenheffer 1987). 
Chapter 3 also demonstrated that the receptor for C3b, CD1 1 b and CD18 (CR3) is 
expressed on LC isolated from 4-day-old mice. As such neonatal LC may use 
complement receptors to bind microbial antigens that breach the epidermal barrier 
until the more specific, carbohydrate-recognition receptors such as DEC-205 are 
expressed. This further supports the hypothesis that neonatal LC learn and adapt 
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according to the antigen present in the extracellular environment. An alternative 
hypothesis is neonatal LC may use complement receptors to further maintain 
tolerance to self-tissue. Apoptotic debris can be opsonised by C3b and it is well 
understood that uptake of apoptotic bodies via C3b on DC results in antigen-specific 
immune suppression (Nauta et al. 2004). This is essential to ensure non-reactivity to 
self-antigens and its importance following cutaneous UV exposure is well 
characterised (Aubin 2003). Expression of receptors for C3b ensures that self-
tolerance during a time of epidermal development is maintained. . Chapter 3 has 
furnished strong evidence that suggests, via expression of specific uptake receptors, 
neonatal LC can modulate the internalisation of antigen for the generation of 
appropriate immune responses. Through the down-regulation of mannose-specific 
receptors responsiveness to skin commensals would be avoided. Via thickening of 
the epidermal barrier, increased keratin and antimicrobial substances provides the 
neonatal epidermis with an efficient barrier to infection and attack (Marchini et al. 
2002). However, if pathogens do cross the epidermal barrier neonatal LC possess 
receptors such as CD16/32 and CD1 1 b/CD18 that facilitate antigen recognition and 
internalisation for generation of protective immunity (Okada et al. 1988; Esposito 
Farese et al. 1996; Fanger et al. 1996). 
Based on the dramatic reduction in mannose specific receptors it is logical to propose 
that neonatal LC are inefficient at the internalisation of the mannose-conjugated 
antigen FITC-dextran. Despite this reduction, Chapter 4 demonstrated that neonatal 
LC were efficient at the uptake of small particulate antigens, such as FITC-dextran. 
However, further analysis demonstrated that if mannose specific receptors were 
competitively blocked by unlabelled sugar, which is the functional equivalent of a 
lack of receptor expression, antigen was internalised (Kato et al. 2000). The fact that 
neonatal LC demonstrated less inhibition in the presence of blocking agents than 
adult LC suggested that LC from neonatal epidermis are less dependent on receptor-
mediated endocytosis to internalise marmosylated antigens. Based on the effective 
inhibition of uptake by wortmannin it is likely that during the early neonatal period 
LC preferentially utilise a wortmannin-sensitive fluid phase pathway, such as 
macropinocytosis, to internalise small particulate and non-binding antigens. As the 
majority of antigen in the neonatal environment is soluble or non-binding (Adkins et 
al. 2004b) I propose that neonatal LC employ macropinocytosis to internalise 
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extracellular antigens, such as apoptotic debris and protein antigen. Given that the 
way in which antigen is internalised influences the outcome of antigen processing 
and presentation (Langenkamp et al. 2002), neonatal LC may up-regulate 
macropinocytosis to direct the pathway utilised to process the internalised antigen. 
Chapter 4 has clearly shown that the pathway utilised to internalise antigen alters 
with acquisition of functional maturity. Ratio data demonstrated that by day 14 the 
amount of antigen internalised via macropinocytosis is reduced and comparable to 
that associated with adult LC. Topical application of contact sensitisers results in a 
decreased amount of antigen transported to the draining LN in association with 
surface MHC-II compared to adult counterparts (Dewar et al. 2001). As neonatal LC 
demonstrated an efficient pinocytic activity a divergence in processing must occur to 
prevent full expression of antigen on the cell membrane. The primary role of 
receptor-mediated endocytosis is to bind and ingest antigen and to deliver the 
digested peptides to LAMP-1 + vesicles containing MHC-II (Jiang et al. 1995; Lutz et 
al. 1997). In contrast, studies by Lutz and colleagues indicated that following 
macropinocytosis of OVA, degraded antigen localised to large vesicles, negative for 
LAMP-1 (Lutz et al. 1997). Although chapter 5 demonstrated colocalisation of 
intracellular MHC-II with LAMP-1, the absence of colocalisation of proteolysed 
antigen with intracellular MHC-II in both neonatal and adult LC suggested that 
antigen is proteolysed within a LAMP-1" compartment. As it is known that OVA is 
internalised via macropinocytosis (Lutz et al. 1997), antigen is likely to be 
proteolysed within immature, LAMP-1 -MHC-If macropinosomes. Very 
importantly, these results clearly demonstrate that neonatal and adult LC utilise a 
similar pathway to internalise and proteolyse OVA. However for proteolysed 
antigen to move out of retention compartments and into MHC-II processing 
compartments exposure to maturation stimuli is required (Pierre et al. 1997; Turley 
et al. 2000). Steinman and colleagues have demonstrated that DC are able to retain 
antigen within the cell for up to several days prior to exposure to maturation stimuli 
(Turley et al. 2000). Therefore, in order to investigate the relative capacity of 
neonatal LC to load antigen onto MHC-II and to subsequently traffic these 
complexes to the cell surfaces LC were exposed to maturation-inducing doses of LPS 
in vitro. 
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Receipt of maturation stimuli induces the maturation of macropinosomes and the 
subsequent exchange of Ii for antigens in the peptide-binding groove of MHC-II 
(Lutz et al. 1997). Although this is the most characterised outcome of maturation, 
under certain circumstances macropinosomes can bypass the endocytic pathway 
(Amyere et al. 2002). It has been demonstrated that in B cells and macrophages 
macropinosomes bypass the endocytic compartment and fuse with the plasma 
membrane. In doing so degraded antigen is regurgitated back to the extracellular 
space (Amyere et al. 2002). Rather than utilising macropinocytosis for antigen 
presentation on MHC-II molecules, it is possible macropinocytosis can be employed 
as a scavenging and clearance mechanism. Following exposure to LPS surface 
MHC-II: peptide complexes were evident on the surface of adult LC. This suggests 
that macropinosomes within adult LC mature in response to LPS and that antigen can 
be successfully loaded onto MHC-II. In contrast there was a significant reduction in 
surface MHC-II: peptide complexes on the surface of neonatal LC, with the majority 
of vesicles retained in a cytoplasmic location distal to the cell membrane. I propose 
that unlike adult counterparts, macropinosomes within neonatal LC do not mature in 
response to LPS. As such the machinery required for exchange and loading of 
digested antigen is not acquired in neonatal LC, thereby reducing the volume of 
MHC-II: peptide complexes shuttled to the cell surface. As a consequence the 
relative amount of antigen presented to naive T cells is reduced. By retaining 
antigen within the cell it cannot be recognised by T cells and as a result effector 
immune responses are avoided. Therefore despite the high pinocytic activity of 
neonatal LC they are unable to present antigen to naive T cells effectively. This 
finding is supported by the recent study of Chang-Rodriguez and colleagues (Chang-
Rodriguez et al. 2004). The results suggested that although newborn dendritic 
epidermal leukocytes were twice as efficient as LC in the uptake of mannosylated 
antigens, they were incapable of presenting OVA in a MHC-II restricted manner 
(Chang-Rodriguez et al. 2004). Interestingly when newborn dendritic epidermal 
leukocytes were enriched to discount for exogenous inhibitory effects the cells 
maintained the inability to present antigen. However, when the same proportion of 
cells were isolated from 3-day-old skin the cells presented antigen almost as 
effectively as LC (Chang-Rodriguez et al. 2004). In comparison to the results of this 
study where whole preparations were incubated in LPS, it is highly possible that 
factors secreted by other epidermal cells, such as IL-10, maintain the neonatal LC in 
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an immature state, rendering them incapable of presenting the OVA efficiently (Enk 
and Katz 1992b). This is a critical finding as IL-10 inhibits the differentiation, 
maturation and function of epidermal LC (Willems et al. 1994; Beissert et al. 1995; 
Peguet-Navarro et al. 1995). In chapter 5 it was suggested that cathepsin S is 
inactive in neonatal LC, thereby limiting the dissociation of CLIP from the binding 
groove of MHC-II, thereby limiting the exchange of antigen. Recently it has been 
demonstrated that IL-10 also inhibits the function of this enzyme (Fiebiger et al. 
2001). It was demonstrated that inhibiting cathepsin through IL-10 delayed 
complexing of MHC-II and digested peptides and subsequently reduced the number 
of complexes transported to the cell surface (Fiebiger et al. 2001). This finding 
clearly supports the hypothesis of this study, where although neonatal LC are capable 
of proteolysing antigen, a combination of heightened cystatin C activity and secreted 
IL-10, diminishes the capacity of neonatal LC to form immunogenic MHC-II:peptide 
complexes. 
The results furnished from this study have suggested that LC acquire functional 
maturity during development. As the epidermal network matures there is a 
subsequent up-regulation of receptor-mediated endocytosis, and application of 
antigen to this epidermis results in the generation of T cell activation (Dewar et al. 
2000). Results from recent studies into the acquisition of functional maturity have 
demonstrated that the ability to present antigen improved with age (Chang-Rodriguez 
et al. 2004). When immature APC were isolated at 3 and 6 days post birth the cells 
demonstrated approximately 47% and 75% of the adult response. Given that at 4- 
days following birth neonatal LC induce tolerance following cutaneous antigen 
exposure, the percent function demonstrated by Chang-Rodriguez is insufficient to 
elicit T cell activation (Chang-Rodriguez et al. 2004). Based on the effective up-
regulation of MHC-II and CD86 in response to LPS demonstrated in chapter 5, it is 
possible that LC resident in 4-day-old epidermis are in a state of transition between 
functionally inept newborn cells, and fully functional adult LC. These intermediate 
LC resident in 3-day-old epidermis, although capable of internalising and processing 
antigen and responding to LPS in culture, are inefficient at the trafficking of MHC-
II:peptide complexes to the cell surface. Future studies that investigate antigen 
processing of epidermal LC throughout the neonatal period is of great interest and 
worthy of future investigations. 
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Within the neonatal microenvironment LC endocytose apoptotic debris and present 
these antigens to induce self-tolerance. Via suppressive cytokines and reduced 
proinflammatory signals expression of LPS and mannose-specific receptors are 
maintained at low levels. As a result the internalisation of the majority of 
environmental and commensal organisms is reduced and the likelihood of excessive 
responses diminished (Adkins et al. 2004a). However in a stressed 
microenvironment, such as that which occurs during exposure to potential pathogens 
and pro-inflammatory cytokines (Stockwin et al. 2000) (Stockwin et al. 2000; 
Kimber et al. 2002), the antigen is presented in an immunogenic fashion so an anti 
pathogen response may be elicited (Cruz and Bergstresser 1990). Overall I propose 
that it is advantageous under most circumstances for neonates to strictly regulate 
reactions, while retaining the capacity to fully mobilise the adaptive immune system 
when faced by life threatening or highly infectious agents. Chapter 5 demonstrated 
that when incubated with high doses of LPS neonatal LC were able to up-regulate 
CD86 to the same extent as adult LC, supports this hypothesis. 
Following application of antigen to the epidermis of neonatal animals the number of 
skin derived LC resident in the draining LN was significantly reduced (Dewar et al. 
2001). I propose that those few neonatal LC that are recruited to the LN do so in an 
immature state in order to regulate immune responses to innocuous antigens. 
However the precise mechanism by which neonatal LC regulate tolerance is 
unknown. It could be hypothesised that immunological tolerance is responsible for 
the induction and maintenance of neonatal tolerance as the trafficking of cutaneous 
antigen to the draining LN is significantly reduced compared to adult counterparts 
(Dewar et al. 2001). However in regards to maintenance of tolerance and the 
outcome of secondary antigen exposure, there are unfavourable shortcomings 
associated with this mechanism. The early neonatal period is a time at which the 
immune response is educated on how to respond appropriately to foreign and self-
antigen. If an antigen is ignored, due to incomplete processing and presentation on 
behalf of the APC, then the immune system cannot distinguish it as self should it be 
encountered at a later stage. It is then that deleterious autoimmune disorders may be 
generated. Rather I propose immature neonatal LC actively induce and maintain 
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peripheral tolerance via a combination of active mechanisms to supplement passive 
tolerance. 
Anergy is a consequence of antigen presentation in the absence of the second, 
costimulatory signal (Gimmi et al. 1993). This may be applied to neonatal LC, as 
following exposure to cutaneous antigen, neonatal LC migrate away from the 
epidermis with reduced expression of CD80 and CD86 (Dewar et al 2001). At the 
LC:T cell interface insufficient signalling renders the responding T cell anergic. If 
this antigen is encountered again tolerance will be maintained (Burkly et al. 1989; 
Mueller et al. 1989). As it has been demonstrated that anergy to a second exposure 
of the same antigen leads to deletion of the anergic T cell, deletion may also be 
involved during the neonatal period (Gao et al. 1998; Elhalel et al. 2003; Huang et al. 
2003). A possible mechanism of deletion of anergic T cells is through FasL:Fas 
signalling, inducing apoptosis in selected T cells (Singer et al. 1994; Crispe 1994; 
Nagata and Golstein 1995). However, as it is possible to break anergy with potent 
immunogenic signalling (Nossal 1993), additional mechanisms must work in concert 
with anergy (Takahashi et al. 1998; Thornton and Shevach 1998; Fazekas de St. 
Groth 2001). 
As stated previously, the presence of IL-10 during antigen uptake has significant 
ramifications for the ability of LC to process and present ingested antigen (Steinbrink 
et al. 1999; Brossart et al. 2000; Faulkner et al. 2000). The tolerising effect of IL-10 
may also extend to the outcome of antigen presentation (Xia and Kao 2003). If 
exposed to IL-10 at the time of antigen uptake, neonatal LC may migrate away from 
the epidermis in an immature state, associated with reduced expression of 
costimulatory molecules and a diminished capacity to synthesis IL-12p70. 
Following presentation of antigen, these two defects may result in not only anergy 
(Enk et al. 1993; Enk et al. 1994; Steinbrink et al. 1999), but also a skewing in the 
Thl -Th2 balance towards tolerance inducing Th2 cells at the second encounter with 
the same antigen (Adkins et al. 1999). Th2 cells can then act on anti-self effector 
Thl cells and down regulate their activity (Mosmann et al. 1986; Haas et al. 1992; 
Oswald et al. 1992; Romagnani 1992b; Noble et al. 1993; Gajewski et al. 1994; 
Schwarz et al. 1994; Ullrich 1994). This hypothesis is supported by several studies 
172 
Discussion 
by Adkins and colleagues. Firstly, both neonatal mice and humans show a strong 
bias towards Th2 polarisation (Adkins 1999). Secondly, although capable of 
eliciting Thl type immune responses if exposed to strong inflammatory mediators 
(Adkins et al. 2000; Garcia et al. 2000; Kovarik et al. 2000; Kovarik et al. 2001; 
Siegrist 2001), Th2 polarisation is evident during primary as well as secondary 
responses. This contributes to long term self tolerance through the induction and 
maintenance of memory (Adkins and Du 1998b; Adkins et al. 2001). 
Aside from T cell deviation, the cytokine microenvironment may lead to the IL-10- 
dependent induction of regulatory T cells (Thompson and Thomas 2002). These T 
cells can then regulate and switch off potentially deleterious responses generated by 
anti-self effector cells (Mason and Powrie 1998; Sakaguchi 2000). In concert with 
anergy, immune deviation and regulation will act to induce tolerance as well as 
maintain memory for further encounters of the same antigen. This is of particular 
importance as results from two recent studies have demonstrated that the above-
mentioned mechanisms of tolerance act together in different ways depending on the 
type of antigen. T regulatory cells and anergy are involved in tolerance induction to 
soluble antigens, whereas regulatory T cells and CTLA4 are associated with tissue 
antigens. Finally, circulating antigens are tolerised via desensitisation of antigen 
receptors (Abbas et al. 2004). The above model of cutaneous tolerance during the 
neonatal period is summarised in diagram 6.1. 
The hypothesis that neonatal LC actively migrate to the draining LN in order to 
actively participate in tolerance is supported by the findings of Geissman and 
colleagues, who suggested that in chronically inflamed skin, LC migrate to the LN 
without associated maturation. Depending on further signals provided in the LN, 
these immature LC either induce tolerance or, following receipt of maturation 
stimuli, induce immunity (Geissmann et al. 2002). As chapter 5 has demonstrated 
that neonatal LC are fully capable of up-regulating MHC-II and CD86 in response to 
LPS, it is highly possible in vivo neonatal LC are not provided with the correct 
maturation stimuli when reaching the LN. During the neonatal period the immature 
LC that do migrate to the draining LN induce tolerance, via a reduction in the two 
signals required for T cell activation (see diagram 6.1). 
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Neonatal LC 
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Developing, thickened Mature epidermal barrier 
epidermal barrier 
Increased proportion of 
environmental and self-
antigen in extracellular 
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Anti-inflammatory cytokines 
Fluid phase endocytosis 
Thinner epidermal barrier 
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Pro-inflammatory cytokines 
Receptor-mediated 
endocytosis 
Decreased migration Efficient migration 
    
Lymph 
Node 
Decreased MHC-II:peptide 
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deletion and suppressor cells) 
Self Memory 
  
Immunogenic MHC-11:antigen 
complexes 
Surface CD80 and CD86. 
Pro-inflammatory cytokines 
Anti-pathogen protection 
Self Memory 
    
Diagram 6.1 Model of cutaneous tolerance induction during the early neonatal 
period. 
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In conclusion I propose that under most circumstances neonates must control 
inflammatory reactions, while retaining the capacity to fully mobilise components of 
the adaptive immune system when exposed to highly infectious agents. The aptitude 
of neonatal LC to sample their external environment without inducing immunity has 
important biological consequences for the protection against inappropriate responses 
during the developmental period. Therefore, the elasticity of neonatal immunity 
might have progressed to avoid inducing inappropriate immune responses under non-
threatening conditions through active peripheral tolerance but mature responses 
when danger is eminent 
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